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Summary 
 
Circadian rhythms represent a fundamental property of living organisms. Even when 
they are held in temporal isolation, most organisms from bacteria to humans exhibit 
behavioral and physiological rhythms with a period of approximately 24 h. These 
rhythms are driven by internal biological clocks. 
In mammals, the molecular clock mechanism is driven by transcriptional-
translational feedback loops of activator and repressor proteins. The transcriptional 
activators Circadian Locomotor Output Cycles Kaput (CLOCK) and Brain and Muscle 
ARNT-Like Protein 1 (BMAL1) heterodimerize and activate the transcription of the 
repressors Periods (Per1, Per2 and Per3) and Cryptochromes (Cry1 and Cry2) that 
in turn repress the activity of the CLOCK:BMAL1 complex. These cycles of activation 
and repression take about 24 h to complete and they generate oscillations in several 
clock-controlled genes (CCGs) with periods of ~24 h. It has been estimated that in 
any mammalian tissue, about 5-20% of the expressed genes exhibit circadian 
oscillations in their messenger RNA (mRNA) levels. Rhythms in mRNA abundance 
are the result of the interplay between the autonomous cellular clock and external 
time cues (i.e. the light/dark cycle and the fasting/feeding cycle). It has been 
demonstrated that the fasting/feeding cycle is the dominant Zeitgeber (“time giver”) 
that drives rhythms of mRNA abundance in peripheral tissues. It has been estimated 
that most cycling mRNAs do not have a corresponding rhythm in their nascent RNA, 
this suggested that post-transcriptional mechanism play an important role in 
generating mRNA and protein oscillation. However, little is known about the 
molecular mechanisms involved in generating mRNA rhythms at post-transcriptional 
level.   
The nuclear RNA binding protein Non-POU Domain Containing Octamer 
Binding (NONO) is a multifunctional protein that has been involved in many different 
steps of the mRNA life cycle from transcription, to processing, RNA stability and 
export. Furthermore, NONO is one of the main components of a subset of nuclear 
speckles called paraspeckles, whose function in the cell remains unclear. 
Importantly, NONO was found to interact with PER proteins and affect circadian 
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rhythmicity in flies and mammals, however the specific mechanisms of its function in 
circadian RNA expression are unknown.  
In my thesis I have investigated the role of NONO in mammalian circadian 
gene expression and physiology. We found that feeding induces an increase in the 
number of NONO-containing, speckle-like structures in the nuclei of liver cells. In 
order to investigate NONO function in the fasting-feeding transition, we performed 
immunoprecipitation of NONO complexes in the liver nucleus and characterized 
bound RNAs and proteins. We found that NONO interacts with several RNA 
processing factors and that it primarily binds promoter-proximal introns of transcripts. 
This led us to hypothesize that NONO might be involved in the processing of its 
target RNAs. Furthermore, we found that the number of NONO-bound RNAs 
increases upon feeding and that about 40% of NONO target genes display circadian 
rhythmicity in their mRNA expression. We then showed that NONO regulates the 
rhythmicity and phase of these genes post-transcriptionally. 
To further explore the role of NONO in liver physiology we characterized the 
function of its bound RNAs. We found that a large fraction of circadian NONO-bound 
RNAs encodes proteins implicated in glucose uptake and macronutrient metabolism.  
The absence of NONO-mediated regulation of target RNAs profoundly impacts 
metabolic health. Indeed, NONO-deficient mice exhibit impaired glucose tolerance, 
which can be rescued by re-expression of NONO specifically in the liver. NONO-
deficient mice also show reduced capacity to store glycogen and lipids in the liver. 
We also found that NONO-deficient mice burn more fat during the fasting (resting) 
phase and maintain a lean phenotype throughout their life. We therefore propose 
that NONO coordinates pre-mRNA processing of metabolic genes with the 
fasting/feeding cycle, thus allowing efficient energy utilization and storage. Disruption 
of the temporal coordination between metabolic demand and gene expression leads 
to the development of metabolic diseases, like obesity and diabetes. Our findings 
help to better understand how metabolic homeostasis is maintained in mammals, 
and identify novel therapeutic targets for treating diabetes and other associated 
metabolic dysfunctions. 
Zusammenfassung 
 
Zirkadiane Rhythmen sind eine fundamentale Eigenschaft lebender Organismen, wie 
Menschen aber auch Cyanobakterien. Unter Isolation von zeitlichen Einflüssen 
zeigen diese immer noch rhythmische Verhaltensweisen und Zellvorgänge mit einer 
Zeitspanne von ca. 24 h. Diese Rhythmen werden von unseren inneren biologischen 
Uhr bestimmt. 
Bei Säugetieren wird dieser molekulare Taktmechanismus durch 
transkriptionelle und translatorische Rückkopplungsschleifen angetrieben. Die 
Transkriptionsaktivator-Proteine, CLOCK und BMAL1, bilden heterogene Komplexe 
und aktivieren die Transkriptionsrepressoren PERIOD (PER1, PER2, PER3) und 
CRYPTOCHROME (CRY1, CRY2), welche wiederum die Aktivität des 
CLOCK:BMAL1-Komplexes unterdrücken. Diese Aktivations-Repressions-Zyklen 
dauern ungefähr 24 Stunden und erzeugen Oszillationen mit der gleichen 
Periodenlänge in weiteren Uhr-gesteuerten Genen (CCGs). Mehrere Studien haben 
gezeigt, dass etwa 5-20% der exprimierten Gene in Säugetiergeweben zirkadiane 
Oszillationen in ihrer mRNA-Konzentration aufweisen. Diese rhythmischen 
Unterschiede in der mRNA Konzentration ist das Resultat des Zusammenspiels 
zwischen der unabhängigen zellulären Uhr und von externen Zeiteinflüssen. Zu 
diesen gehören beispielsweise der Licht/Dunkel Zyklus durch die Sonne aber auch 
der Zeitpunkt der Ernährung.  Es ist bekannt, dass der Fasten/Fütterungszyklus der 
dominierende Zeitgeber für rhythmische RNA-Expression im peripheren Gewebe ist.  
Es wird angenommen, dass die meisten zyklischen mRNAs in ihrem naszierenden 
Zustand keinen Rhythmus aufweisen. Die deutet darauf hin, dass post-
transkriptionelle Mechanismen eine Rolle bei der Erzeugung von Oszillationen in der 
mRNA- oder Protein-Konzentration spielen. Allerdings ist bis heute wenig über die 
grundlegenden molekularen Vorgänge bekannt, welche bei den rhythmischen post-
transkriptionellen Modifikationen beteiligt sind. 
Das multifunktionale, nukleäre, RNA-bindende Non-POU Domäne 
enthaltende Oktamer bindende Protein (NONO) ist in vielen verschiedenen Schritten 
des mRNA-Lebenszyklus wie Transkription, Verarbeitung, Stabilität und Export 
beteiligt. Darüber hinaus ist NONO einer der Hauptkomponente einer Sorte 
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zellkerninterner Aggregate, welche Paraspeckles genannt werden. Deren exakte 
Funktion in der Zelle ist bisher aber unklar. Eine wichtige Aufgabe von NONO ist 
jedoch seine Interaktion mit PER-Proteinen, wodurch es durch bisher unbekannte 
Mechanismen die zirkadiane Rhythmizität bei Fliegen und Säugetieren beeinflusst.  
Das Ziel dieser Arbeit ist die Charakterisation der Rolle von NONO in der 
zirkadianen Genexpression und der Physiologie von Säugetieren. Wir haben 
herausgefunden, dass Ernährung eine Zunahme der Anzahl NONO-haltiger, 
aggregatartiger Strukturen im Zellkern der Leberzellen hervorruft. Um die NONO-
Funktion im Ernährungs-Zyklus zu studieren, führten wir Immunopräzipitation von 
NONO-Komplexen im Leber Zellkern durch und charakterisierten gebundene RNAs 
und Proteine. Wir haben herausgefunden, dass NONO mit mehreren RNA-
Verarbeitungsfaktoren interagiert und dass es primär proximale Promotor Introns von 
Transkripten bindet. Dieses Resultat führte uns zu der Hypothese, dass NONO an 
der Verarbeitung seiner assoziierten RNAs beteiligt sein könnte. Darüber hinaus 
haben wir festgestellt, dass die Anzahl der NONO-gebundenen RNAs bei der 
Fütterung zunimmt und dass etwa 40% der NONO-assoziirten Gene eine zirkadiane 
Rhythmizität in ihrer mRNA-Expression aufweisen. Wir haben ebenfalls gezeigt, 
dass NONO die Rhythmizität und Phase dieser Gene post-transkriptionell reguliert. 
Um die Rolle von NONO in Leberzellvorgängen weiter zu erforschen, 
analysierten wir die Funktion der gebundenen RNAs. Ein grosser Teil der 
zirkadianen NONO-gebundenen RNAs kodiert Proteine, welche wichtig für die 
Glukoseaufnahme und den Makronährstoffmetabolismus sind. Abwesenheit NONO-
vermittelter Regulation assoziirter RNAs wirkt sich stark auf die metabolische 
Gesundheit aus. Tatsächlich zeigen NONO-defiziente Mäuse eine beeinträchtigte 
Glukosetoleranz. Diese kann jedoch durch spezifische Expression des Proteins in 
der Leber NONO-defizienter Mäuse normalisiert werden. NONO-defiziente Mäuse 
zeigen auch eine reduzierte Kapazität, Glykogen und Lipide in der Leber zu 
speichern und verbrennen mehr Fett während der Fasten-/Ruhe-Phase, was zu 
einem mageren Phänotyp während ihres ganzen Lebens führt.  
Unser Fazit ist deshalb, dass NONO die prä-mRNA-Verarbeitung 
metabolischer Gene mit dem Fasten-/Fütterungszyklus koordiniert und so eine 
effiziente Energienutzung und -speicherung ermöglicht. Störung zeitlicher 
Koordination zwischen metabolischer Nachfrage und Genexpression kann zur 
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Entwicklung von Stoffwechselerkrankungen wie Fettleibigkeit und Diabetes führen. 
Unsere Ergebnisse helfen deshalb, besser zu verstehen, wie metabolische 
Homöostase bei Säugetieren funktioniert, und zur Identifikation neuer 
therapeutischer Massnahmen zur Behandlung von Diabetes und anderer damit 
verbundenen metabolischen Dysfunktionen. 
 

1. GENERAL INTRODUCTION 
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BASIC PRINCIPLES OF MAMMALIAN CIRCADIAN BIOLOGY 
(adapted from Benegiamo et al., 2016) 
Circadian rhythms represent a fundamental property of living organisms. Most 
organisms, from bacteria to humans exhibit behavioral and physiological rhythms 
when kept in temporal isolation. These rhythms are driven by biological clocks and 
have a period of approximately 24 h (Bell-Pedersen et al., 2005; Dunlap, 1999; 
Panda et al., 2002a). Internal clocks have two main features: (1) they are 
temperature-compensated (i.e. they do not have shorter or longer period with low or 
high temperatures); (2) they can be entrained by external stimuli such as light, 
temperature or feeding schedules. In this way, the internal time becomes predictive 
of the external (solar) one (Takahashi et al., 2008). Thus, circadian clocks confers an 
adaptive advantage to the organism by anticipating the day-night cycle and by 
temporally segregating mutually antagonistic processes (Reddy and O’Neill, 2010). 
Indeed, it has been demonstrated in prokaryotes, plants and mammals, that 
circadian clocks confer competitive advantage (Dodd et al., 2005; Libert et al., 2012; 
Woelfle et al., 2004), whereas disruption of circadian timing in humans, as seen in 
rotational shift workers, causes significant long-term health costs (Barger et al., 
2009). 
In mammals, the molecular clock mechanism is driven by transcriptional-
translational feedback loops of activator and repressor proteins. The transcriptional 
activators CLOCK and BMAL1 heterodimerize and activate the transcription of the 
repressors Periods (Per1, Per2 and Per3) and Cryptochromes (Cry1 and Cry2). 
PERs and CRYs heterodimerize, translocate to the nucleus, and repress the activity 
of the CLOCK:BMAL1 complex (Lee et al., 2001). Subsequently, the PER-CRY 
repressor complex is degraded, and CLOCK:BMAL1 can now activate a new cycle of 
transcription. In an interconnected loop, the nuclear hormone receptors REVERBs 
and RORs act as repressors and activators respectively, to drive rhythmic 
transcription of clock components (Preitner et al., 2002; Sato et al., 2004) (Figure 1). 
These cycles of activation and repression take about 24 h to complete and they 
generate oscillations in several clock-controlled genes (CCGs) with periods of ~24 h. 
It has been estimated that in any mammalian tissue, about 5-20% of the expressed 
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genes exhibit circadian oscillations in their mRNA levels (Zhang et al., 2014). The 
molecular oscillator is cell autonomous and is present in every cell of multicellular 
organisms. The communication between individual cells of the same tissue 
generates organ-specific clocks. This crosstalk ensures that different cells of the 
same organ are synchronized to the same phase. The oscillation of a large network 
of cells is more robust than the oscillation of one single cell (Hogenesch and Herzog, 
2011). The whole system is synchronized and aligned with the environment through 
signals emanating form the hypothalamic Suprachiasmatic Nucleus (SCN), a region 
in the brain consisting of ~20,000 neurons referred to as the master circadian clock 
(Mohawk et al., 2012). The SCN receives direct light input from the retina. The 
external light/dark cycle is the most important external stimulus that synchronizes the 
circadian clock (Dibner et al., 2010). After reaching the SCN, light stimulates the 
activation of signaling cascades that result in both neuronal and humoral output. 
These signals are transmitted to the peripheral tissue clocks. The light acts as a 
resetting signal for the SCN, which then synchronizes the peripheral tissue clocks 
accordingly (Figure 2). 
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Most of our knowledge about genome-wide regulation of circadian gene expression 
in peripheral organs comes from experiments in mouse liver. In these experiments 
adult mice are fed a normal diet ad libitum and are entrained to a 12 h light: 12 h 
dark (LD) cycle. If the mice are held under LD cycle conditions during sample 
collection, the sampling times are defined as zeitgeber time (ZT) (from the German 
‘time giver’), where the time of lights-on is considered ZT0. If the mice are 
transferred to constant darkness prior to sample collection, the timing is represented 
as circadian time (CT), where CT0 corresponds to the subjective time of lights-on 
(equivalent to ZT0). The data collected from different times of at least one full day 
are fitted to a wave function, so that the probability values related to robustness of 
oscillation and the peak time of oscillation (phase) can be derived. Detected 
oscillation in molecules or their activities in the associated phases can be used to 
explain potential sequence of regulatory events. Due to changes in experimental 
conditions and sampling frequency, the circadian rhythm parameters might differ 
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among different studies. 
CIRCADIAN REGULATION OF GENE EXPRESSION 
The circadian cistrome (adapted from Benegiamo et al., 2016) 
Although previous studies investigated the transcriptional regulation of 
CLOCK:BMAL1 on specific target genes, the identity of the circadian cistrome (i.e. 
the in vivo genome-wide location of core clock transcription factor binding-sites) has 
only recently been identified. Using chromatin immunoprecipitation followed by 
sequencing (ChIP-seq), several research groups have identified genome-wide DNA-
binding sites for BMAL1, CLOCK, PER1, PER2, CRY1 and CRY2 in the mouse liver 
(Koike et al., 2012; Menet et al., 2012; Rey et al., 2011; Yoshitane et al., 2014). 
CLOCK and BMAL1 bind to more then 4600 and 5900 sites, respectively, 
corresponding to ~3000 unique genes in the liver (Koike et al., 2012). On a genome-
wide level, CLOCK and BMAL1 occupancy peaks during the middle of the day (ZT3-
5), however, although CLOCK:BMAL1 target genes are significantly enriched for 
rhythmic transcribed genes, there is a large discrepancy between the phases of 
rhythmic BMAL1 DNA binding and the phases of rhythmic transcription. The peaks of 
transcription of CLOCK:BMAL1 target genes appear much more broadly distributed. 
This wide, disconnect between the peak phases of CLOCK:BMAL1 DNA binding and 
the phases of rhythmic transcription of the target genes suggests that other factors 
and/or mechanisms may collaborate with CLOCK:BMAL1 binding and are critical to 
determine oscillation phases. In contrast to the activators, the repressors PER1, 
PER2 and CRY2 bind genome-wide at night between CT12 and CT20, peaking 
between CT15 and CT17. CRY1 has a distinct bimodal pattern, with a major peak at 
CT0. The repressors CRY1 and CRY2 bind to significantly more sites in the genome 
than PER1 and PER2, with many thousands of these sites being independent of 
CLOCK-BMAL1 and containing DNA-binding motifs for nuclear receptors (Koike et 
al., 2012; Takahashi, 2017) 
Circadian regulation, RNAPII occupancy and chromatin states (adapted 
from Benegiamo et al., 2016) 
In order to characterize global rhythms in transcription, RNA polymerase II (RNAPII) 
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occupancy has been measured during the circadian cycle in the mouse liver (Koike 
et al., 2012; Le Martelot et al., 2012). The large subunit of RNAPII contains a 
carboxy-terminal domain (CTD) that is post-translationally modified at different 
stages of transcription. When RNAPII gets recruited to the pre-initiation complex is 
hypophosphorylated (recognized by the 8WG16 antibody), whereas the first step in 
the initiation of RNAPII involves phosphorylation on Ser5 of the CTD (Chapman et 
al., 2007; Jones et al., 2004). Both RNAPII-8WG16 and RNAPII-Ser5 occupancy are 
highly circadian in the mouse liver, indicating that both recruitment and initiation of 
RNAPII are under circadian control (Koike et al., 2012). Rhythmic loading of RNAPII 
to promoters, rather than a rhythmic transition from a paused state to a productive 
elongation, seem to be responsible for the majority of rhythmic transcription in the 
mouse liver (Le Martelot et al., 2012). 
Histone modifications associated with RNAPII transcription during the 
circadian cycle have also been investigated in recent studies (Koike et al., 2012; Le 
Martelot et al., 2012; Vollmers et al., 2012). Histone modifications define, alone or in 
a combinatorial manner, major chromatin domains at promoters (H3K4me3, 
H3K27ac, and H3K9ac), gene bodies (H3K36me3 and H3K79me2) and enhancers 
(H3K27ac and H3K4me1). Histone H3K4me3, H3K9ac, H3K27ac and H3K4me1 
show robust circadian rhythms at transcription start sites (TSSs). Also the elongation 
marks, H3K36me3 and H3K79me2, display circadian modulation. Rhythmic histone 
modifications are observed both at promoter proximal sites and at distal intergenic 
enhancer sites. The genome-wide analysis of the rhythmicity and phase of these 
histone marks revealed that several genes exhibit circadian rhythms in histone 
modifications. However, the total number of histone modification sites does not seem 
to vary on a circadian basis. The recruitment (and initiation) of RNAPII seems to 
drive the variation in the amplitude on histone marks. Thus, circadian transcriptional 
regulation appears to be involved in the initial stages of RNAPII recruitment and 
initiation and the histone modification associated with these events to set the stage 
for gene expression on a global scale (Koike et al., 2012; Le Martelot et al., 2012; 
Vollmers et al., 2012).  
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Genome-wide circadian RNA expression analysis (adapted from 
Benegiamo et al., 2016) 
To examine the functional consequences of the circadian cistrome, rhythmic RNAPII 
occupancy and rhythmic histone modifications, RNA sequencing (RNA-seq) has 
been used to profile cycling mRNA expression in the mouse liver (Koike et al., 2012; 
Le Martelot et al., 2012; Menet et al., 2012; Vollmers et al., 2012). As mentioned 
above thousands of genes (~5-20% of expressed genes) were found to cycle at the 
steady-state mRNA level in the liver as well as in many other tissues (Hughes et al., 
2009; Zhang et al., 2014) and more then half of all genes have been found to cycle 
at the mRNA level in at least one tissue (Zhang et al., 2014).  
A wide range of cycling RNA species has been found using RNA-seq. In 
addition to cycling protein-coding transcripts, oscillating long non-coding RNAs, 
microRNAs and antisense RNA transcripts have been found in the mouse liver. 
Furthermore, in addition to circadian transcription at promoters, circadian 
transcriptional activity at enhancer regions was recently demonstrated in the mouse 
liver (Fang et al., 2014) using global run-on sequencing (GRO-seq) (Core et al., 
2008). Transcriptional activity at enhancers produces enhancer associated non-
coding RNAs called enhancer RNAs (eRNAs; Kim and Shiekhattar, 2015). 
Thousands of circadian eRNAs have been found to oscillate in diverse phases and 
each phase group is enriched in binding motives for different classes of clock 
transcription factors. For example, E-box motifs are enriched between ZT6 and ZT9, 
corresponding to the peak of CLOCK-BMAL1 occupancy, whereas RORE and REV-
DR2 motifs are enriched between ZT8 and ZT24, corresponding with the trough of 
REV-ERB repression. Circadian eRNAs transcription correlates and can predict 
rhythmic transcription of nearby genes. Circadian transcription factors like 
CLOCK/BMAL1 and REV-ERB bind multiples sites in the genome; however, many 
of these genes are bound but don’t seem to be regulated, due perhaps to inactive 
binding or long distance looping at different genes. Transcriptional activity at 
enhancers could be used as a marker to assess where a transcription factor is 
actually functional (Fang et al., 2014). 
The contribution of transcriptional mechanisms in generating steady-state 
mRNA rhythms has been examined in the mouse liver either by using the intron 
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RNA-seq signal as a proxy for premature RNA (pre-mRNA) and the exon RNA-seq 
signal as a proxy for mature mRNA (Koike et al., 2012), or by using nascent-seq and 
mRNA-seq as a proxy for transcriptional activity and mature mRNA levels, 
respectively (Menet et al., 2012). In the mouse liver, cycling pre-mRNA levels (using 
the intron RNA signal) are coordinately expressed in time with a peak at CT15. Thus, 
there is a peak of globally coordinated circadian transcription that occurs at the 
beginning of the night during the active portion of the mouse circadian rhythm, which 
is not seen at the mRNA level (which has a bimodal pattern). The intron RNA peak 
also correlated with the peak of RNAPII-8WG16 occupancy at CT14 (Koike et al., 
2012). These studies identified two divergent sets of cycling genes: cycling nascent 
transcripts and cycling mRNA levels. Only ~30% of cycling mRNAs also had a 
corresponding cycling nascent transcript, indicating that other RNA processes are 
likely to be contributing to steady-state circadian mRNA expression. At least three 
different classes of cycling transcripts have been observed: (1) cycling transcription 
and cycling steady-state mRNA; (2) cycling transcription and no cycling mRNA; (3) 
no detectable cycling transcription but cycling mRNA levels. To the first class belong 
the core circadian genes and their high-amplitude direct targets. The second class is 
typically composed of highly expressed genes in the liver that have mRNAs with long 
half-lives, such as albumin. The third class includes transcripts that may become 
rhythmic via circadian oscillation in post-transcriptional mechanisms such as mRNA 
turnover, splicing, polyadenylation, microRNA regulation and others (Takahashi, 
2017). Taken together, steady-state mRNA rhythms are only one of a multitude of 
layers of circadian regulation in gene expression. Virtually every regulatory stage in 
gene expression that has been examined in detail – including transcription, splicing, 
termination, polyadenylation, nuclear export, microRNA regulation, translation and 
RNA degradation – has revealed additional layers of circadian control (Kojima and 
Green, 2015; Lim and Allada, 2013). 
Evidences for the relevance of post-transcriptional mechanisms on 
circadian gene expression (adapted from Benegiamo et al., 2016) 
Although circadian regulation of mRNA expression at the transcriptional level is 
important for circadian rhythms in gene expression, a growing body of evidence 
suggests that transcriptional mechanisms are not sufficient to sustain all rhythmic 
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mRNA expression. The transcription rate varies significantly in cells from different 
tissues (Schmidt and Schibler, 1995), yet the free-running endogenous circadian 
oscillator shows remarkable stability in period length among tissue types. Thus, the 
oscillator possesses a mechanism that allows compensating for differences in 
transcription rates. Furthermore, partial inhibition of transcription by -amanitin 
treatment in mouse fibroblasts reduces RNAPII dependent transcription rate by up to 
threefold, but doesn’t stop the cell-autonomous oscillator. The circadian oscillator, as 
measured by translated protein, continues to oscillate, albeit with dampened 
amplitude and slightly shorter periodicity (Dibner et al., 2009). This suggests that 
post-transcriptional mechanisms potentially involving mRNA-binding proteins can 
support translational rhythm even when transcriptional oscillation is blunted or 
inhibited.  
Studies in human red blood cells, which have no DNA or nucleus (and 
therefore cannot perform transcription), showed that, at least in some cases, 
transcription is not required for circadian oscillation, and that non-transcriptional 
events seem to be sufficient to sustain peroxiredoxin rhythms. Indeed, it was 
demonstrated that red blood cells (RBCs) exhibit robust rhythms in peroxiredoxin 
redox cycles. This finding is consistent with the presence of a circadian clock within 
these cells despite the lack of nucleus and thus the inability to make new RNA. In 
normal nucleated cells, there is probably an intricate interplay between transcription-
dependent processes and non-transcriptional oscillation, as there seems to be 
reciprocal regulation between these systems (O’Neill and Reddy, 2011).  
A first study analyzing the liver circadian proteome using two dimensional 
difference gel electrophoresis (2D-DIGE) found up to 20% of soluble proteins in 
mouse liver being subject to circadian control and only 50% of them had a 
corresponding cycling mRNA, revealing for the first time the extent of post-
transcriptional control mechanisms as circadian control points for protein oscillations. 
More recently, SILAC technology has been applied to study the circadian liver 
proteome (Mann, 2006). In two different studies about 3000 and 5000 different 
proteins were identified and 6-10% of them were determined to be rhythmic in the 
mouse liver. Among these proteins however only 50-80% had rhythmically 
expressed corresponding mRNAs, further indicating that rhythmicity in mRNA and 
rhythmicity in protein do not necessarily correlate (Mauvoisin et al., 2014; Robles et 
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al., 2014). Furthermore, for rhythmic proteins with corresponding rhythmic 
transcripts, there was a significant difference in the phase distribution between 
cycling transcripts and corresponding proteins. This divergence in the distribution of 
transcript and protein phase indicates that the cycles of protein abundance in the 
mouse liver do not always reflect mRNA changes and are instead likely influenced 
by post-transcriptional mechanisms. The delay between the peak phase of 
expression of each rhythmic transcript and its oscillating protein is about 2-6 h for 
almost 50% of the cycling mRNA and proteins. However, around 40% of oscillating 
proteins peaked more then 6 h later than their corresponding transcripts. This time 
delay between peaks of mRNA and protein revealed that post-transcriptional 
mechanisms likely define the circadian phases of the proteome. Importantly, 
rhythmic proteins associated to specific pathways had similar phases of oscillation 
regardless of whether and in which phase their transcripts were cycling. This implies 
that circadian post-transcriptional regulation coordinates individual metabolic 
pathways in the liver (Robles et al., 2014). Taken together, recent transcriptome and 
proteome studies revealed that post-transcriptional regulatory mechanisms are an 
important feature of the circadian clock and contribute to both steady state mRNA 
and protein oscillations. 
Circadian regulation of splicing (adapted from Benegiamo et al., 2016) 
Alternative splicing is a regulated process during gene expression that results in a 
single gene coding for multiple proteins. In this process, particular exons of a gene 
may be included within, or excluded from, the final, processed mRNA. Alternative 
splicing is of particular importance amongst the post-transcriptional processes that 
regulate gene expression, as it allows the human genome to direct the synthesis of 
many more proteins than would be expected from its 20,000 protein-coding genes. 
Alternative splicing is widespread in mammalian genes, affecting approximately 95% 
and 80% of multi-exon genes in humans and mice, respectively (Mollet et al., 2010; 
Wang et al., 2008). Moreover, alternative splicing is highly regulated by the activity, 
abundance and binding position of various splicing factors and heterogeneous 
nuclear ribonucleoproteins, and by the kinetics of transcription elongation and 
chromatin modifications (Luco et al., 2011; Nilsen and Graveley, 2010; Witten and 
Ule, 2011). Evidence for the existence of circadian oscillation in mammalian 
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alternative splicing came recently from a study that found several exons to be 
alternatively spliced in a circadian manner in the mouse liver (McGlincy et al., 2012). 
In a microarray based approach, 55 exon-probesets from 47 genes where identified 
to have significant circadian variation, corresponding to 0.4% of the genes detectable 
in the array. The 47 genes were enriched in pathways representing the circadian 
clock itself, drug detoxification, caffeine and retinol metabolism and the peroxisome 
proliferator-activated receptor (PPAR) signaling pathway. The circadian regulation of 
alternative splicing was shown to be tissue dependent, in terms of both phase and 
amplitude. For some of the exons identified the temporal relationship between 
alternative splicing and transcript level expression was preserved across tissues, 
suggesting that these two processes may be coupled. Alternative splicing of the 
identified exons was demonstrated to be under the control of the local liver clock 
(McGlincy et al., 2012). However, the proportion of alternative splicing events 
regulated by the circadian clock seems to be modest compared to other clock-
controlled processes (e.g. circadian regulation of mRNA abundance, affecting 5-20% 
of expressed genes).  
The same microarray study also reported circadian mRNA expression of 62 
RNA-binding proteins, which might be involved in the regulation of circadian RNA-
processing events. These 62 proteins include some known regulators of alternative 
splicing (Srsf3, Srsf5, Tra2b and Khdrbs1 (Sam68)), one component of the U2 
snRNP (Sf3b1), two RNA helicases (Ddx46 and Dhx9), three hnRNP proteins 
(Hnrnpdl, Cirbp (hnRNP-A18) and Pcbp2 (hnRNP E2)), and six other RNA-binding 
proteins that have less well characterized roles in RNA metabolism (Gtl3, Rbms1, 
Thoc3, Pcbp4 and Topors). Some of these circadian splicing factors were found to 
be under the control of the liver clock, while others were rhythmic in response to 
systemic cues. Some of the known exon targets of these splicing factors where 
previously identified to be cycling exons. The discovery of robustly circadian splicing 
factors, and the fact that a number of their previously characterized target exons are 
circadian, provide candidates for further study into the molecular mechanisms 
regulating circadian exons and other post-transcriptional processes (McGlincy et al., 
2012). The first functional connection between alternative splicing and the 
mammalian circadian clock was described for the mRNA encoding U2-auxiliary-
factor 26 (U2AF26). U2AF26 undergoes rhythmic alternative splicing that contributes 
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to the regulation of Per1 stability (Preußner et al., 2014). Specifically, U2AF26 
undergoes circadian and light-induced alternative skipping of exons 6 and 7 (U2AF
E67) in mouse cerebellum and this splicing switch generates a shift in the mRNA 
reading frame. Skipping of U2AF26 exons 6 and 7 generates a domain with 
homology to Drosophila TIM and enables cytoplasmic, circadian expression of the 
U2AF26 E67 isoform. U2AF26 E67 interacts with PER1 and induces its 
proteasomal degradation; this limits the light induced increase of PER1 and its 
proposed as buffering mechanism against sudden light changes (Preußner et al., 
2014). 
Circadian regulation of transcription termination (adapted from 
Benegiamo et al., 2016) 
Transcriptional termination is a newly identified target for negative feedback 
regulation of the clock. In addition to its well known transcriptional repressor function, 
PER rhythmically associates with the RNA helicases DEAD-box polypeptide 5 
(DDX5), DEAH-box protein 9 (DHX9) and Senataxin (SETX). DDX5 and DHX9 are 
components of the 3’ transcriptional termination complex (Shi et al., 2009). This 
PER-containing termination complex specifically binds clock gene transcripts such 
as Per1 and Cry2 mRNAs in a circadian time-dependent manner. After cleavage of 
the nascent transcript, unwinding of the RNA-DNA duplex by SETX at the 3
 
termination site permits the XRN2 nuclease to degrade the downstream 3
 RNA 
and thereby release the polymerase (Skourti-Stathaki et al., 2011). PER complex 
inhibits SETX activity, blocking subsequent processing by XRN2 and thus blocking 
transcription termination. Inhibition of termination reduces the rate of transcription, 
and as a consequence during the negative feedback, RNA polymerase II 
accumulates at the 5
 site as well as at the 3
 site of Per and Cry genes 
(Padmanabhan et al., 2012). Thus, the mammalian PER complex has at least two 
actions in circadian feedback: (1) it represses transcription by recruiting a SIN3 
histone deacetylase complex to clock gene promoters (Duong et al., 2011), and (2) it 
inhibits termination by antagonizing the action of SETX at the 3
 termination site. 
Both processes contribute to circadian Per gene repression, but one or the other 
could predominate at different target genes (Padmanabhan et al., 2012). 
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Circadian regulation of polyadenylation (adapted from Benegiamo et al., 
2016) 
In eukaryotes, polyadenylation of RNA (i.e. the addition of a tail consisting of multiple 
adenosine monophosphates at the 3’ end of an RNA) is part of the process that 
produces mature mRNA. Most eukaryotic mRNAs are polyadenylated and this 
process is required for nuclear export and stability of mature transcripts and for 
efficient translation (Sachs, 1990). The length of the poly(A) tail is important, as 
mRNAs with tails that are too short are, in general, subjected to enzymatic 
degradation (Guhaniyogi and Brewer, 2001) or stored in a translationally dormant 
state (D’Ambrogio et al., 2013). Although the addition of a poly(A) tail seems to occur 
by default, the subsequent control of its length is highly regulated both in the nucleus 
and in the cytoplasm, thereby contributing to the regulation of the stability, transport 
and translation of mature transcripts (Zhang et al., 2010).  
One of the earliest examples of daily regulation of poly(A) tail lengths was 
reported for vasopressin, a key rhythmic neuropeptide in the SCN (Robinson et al., 
1988). Later, the deadenylase nocturnin (Noc) was identified as a rhythmically 
expressed gene in the Xenopus laevis retina (Green and Besharse, 1996), as well as 
in several mouse tissues (Wang et al., 2001). A serum shock and the phorbol ester 
TPA can induce Noc transcript levels in quiescent NIH3T3 cultures while 
dexamethasone and forskolin, which are known to induce other clock genes in 
culture, have no effect. Hence, in addition to its robust circadian regulation, Noc 
expression can be regulated acutely and it can respond directly and specifically to 
physiological cues (Garbarino-Pico et al., 2007). In mice, disruption of the Noc gene 
confers resistance to diet induced obesity but does not affect free-running locomotor 
rhythms or clock gene expression, suggesting its role in circadian output pathways 
(Green et al., 2007). 
The question of global clock control of polyadenylation state has been 
addressed most completely in the mouse liver (Kojima et al., 2012). About 2.3% of 
all expressed mRNA exhibit statistically significant rhythmicity in their poly(A) tail 
length. Most of these “poly(A) rhythmic” (PAR) mRNAs have their peak in  poly(A) 
tail length during the night (ZT16-ZT20). Based on the pre-mRNA and steady-state 
mRNA profiles, the PAR mRNAs can be categorized into three classes: Class I PAR 
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mRNAs (49.2%) are rhythmic in their poly(A) tail length and pre-mRNA and steady-
state mRNA levels, class II PAR mRNAs (32.3%) are rhythmic in their poly(A) tail 
length and pre-mRNA expression but not in steady-state mRNA levels, and class III 
PAR mRNAs (18.5%) are rhythmic in their poly(A) tail length rhythms but not in pre-
RNA or steady-state mRNA levels. Most likely, for the class I/II PAR mRNAs, nuclear 
polyadenylation follows rhythmic transcription, since both classes exhibit rhythmic 
pre-mRNA levels. The defining characteristics of these two classes are the 
differences in the steady-state mRNA rhythmicity and mRNA stability (the lack of 
rhythmicity in the class II PARs mRNAs probably reflects the longer half-lives of 
these mRNAs). Class III mRNAs display robust rhythmicity in their poly(A) tail length, 
but are not rhythmically transcribed and have longer half-lives. Thus, this class 
employs some non-transcriptional mechanisms to control their rhythmic poly(A) tail 
lengths. The analysis of the peak phase distribution of class III PAR mRNAs 
revealed that for more then 80% of them the longest poly(A) tail occurred during the 
day. The mRNA level of several components of the cytoplasmic polyadenylation 
machinery in the liver were rhythmically expressed with phases similar to the 
majority of the class III PAR mRNAs. These components included the Cytoplasmic 
Polyadenylation Element Binding Protein 2 and 4 (Cpeb2, Cpeb4), the Polyadenylate 
Specific Ribonuclease (Parn), and Gld2. Thus, the poly(A) rhythms of the class III 
mRNAs are likely to be controlled by rhythmic cytoplasmic polyadenylation 
mechanisms. The rhythmic poly(A) tail lengths correlate with the circadian 
expression profiles of the corresponding protein, with the protein usually peaking ~4–
8 h after the time of the longest poly(A) tail. In conclusion, it was demonstrated that 
poly(A) tail rhythms are capable of generating rhythmic protein levels even when in 
the absence of rhythm in the steady-state mRNA levels (Kojima et al., 2012). 
Circadian regulation of mRNA stability (adapted from Benegiamo et al., 
2016) 
The control of mRNA half-life can potentially generate rhythms in mRNA abundance 
in the absence of rhythms in newly synthesized pre-mRNA. The post-transcriptional 
regulation of mRNA stability is mediated by cis elements in the mRNAs that interact 
with RNA-binding proteins and/or microRNAs. In most cases, these cis elements 
reside in the 3’ untranslated region (UTR). The 3’ UTR-dependent mRNA decay is 
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involved in the regulation of the circadian oscillation of Per2 mRNA. The 
polypyrimidine tract binding protein (PTB), also known as heterogeneous nuclear 
ribonucleoprotein I (hnRNPI), binds to Per2 3’ UTR and destabilizes its mRNA. 
Indeed, rhythmic abundance in Per2 mRNA is in antiphase with that in cytoplasmic 
PTB protein levels and depletion of PTB results in Per2 mRNA stabilization (Woo et 
al., 2009). The 3
 UTR is also important for the mRNA stability of Cry1. The 3’ UTR 
of Cry1 contains a destabilizing element that affects its mRNA stability. The RNA-
binding protein hnRNPD was found to oscillate and bind to the middle region of Cry1 
3’ UTR with a rhythmic profile. The binding of hnRNPD to Cry1 3’ UTR is responsible 
for the rapid decay of its mRNA during its declining phase and modulates Cry1 
circadian rhythm (Woo et al., 2010). The stability of mouse Period3 (Per3) is also 
regulated in a circadian phase-dependent manner. In the case of (Per3), the control 
of its circadian mRNA stability requires the cooperative function of both the 5’ and 3’ 
UTRs. The RNA-binding protein hnRNPQ binds to both the 5’ and 3’ UTR in the Per3 
mRNA and destabilizes the mRNA. Indeed, downregulation of hnRNPQ reduces the 
translation efficiency but also increases Per3 mRNA stability. The binding of 
hnRNPQ to Per3 5’ UTR is phase dependent and maintains robust Per3 oscillation 
(Kim et al., 2011). 
Circadian regulation of translation and ribosome biogenesis (adapted 
from Benegiamo et al., 2016) 
In addition to mRNA stability, cis-regulatory elements can influence the translation 
efficiency of the mRNA. Heterogeneous nuclear ribonucleoproteins (hnRNPs) have 
been shown to be involved in translation of clock and clock-related transcripts 
through their association with target UTRs in mammals. The RNA binding protein 
RBM4 (homologous of the Drosophila Lark) has been shown to activate the post-
transcriptional expression of the mouse Per1 mRNA. A strong circadian cycling of 
the RBM4 protein is observed in the suprachiasmatic nuclei with a phase similar to 
that of PER1, although the level of the Rbm4 transcripts are not rhythmic. RBM4 
protein binds directly to a cis-element in the 3’ UTR of the Per1 mRNA and causes 
increased PER1 protein levels, by activating Per1 mRNA translation. Alterations of 
Rbm4 expression in cycling cells causes significant changes in circadian period, with 
Rbm4 knockdown by siRNA resulting in a shorter circadian period, and Rbm4 
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overexpression resulting in a lengthened period (Kojima et al., 2007). HnRNPQ 
binds and activates internal ribosome entry site (IRES)-dependent translation 
(hence, cap-independent) from 5’ UTRs in Per1 and the arylalkylamine N-
acetyltransferase (AANAT) gene, which encodes an enzyme important for pineal 
melatonin rhythms (Kim et al., 2007; Lee et al., 2012). IRES-dependent translation of 
Rev-erbα is also enhanced by hnRNPQ and PTB (Kim et al., 2010).  
Interestingly, among rhythmically expressed genes in the liver, there are a 
large number of genes encoding proteins involved in translation. These proteins 
include components of the translation pre-initiation complex (Hughes et al., 2009; 
Panda et al., 2002b). In the inactive state, the pre-initiation complex is composed of 
the mRNA cap-binding protein eukaryotic translation initiation factor 4E (EIF4E) 
bound to the hypophosphorylated form of EIF4E-binding protein (4E-BP) that acts as 
a repressor of translation. Upon stimulation, 4E-BP is phosphorylated and EIF4E is 
released. EIF4E can then interact with the eIF4G and with the rest of the EIF4F 
complex (EIF4A, EIF4B, and EIF4H) to initiate translation. Analyses of other factors 
involved in translation initiation by reverse transcription (RT)-PCR confirmed that the 
mRNAs of most of them are rhythmically expressed. While their protein abundance 
does not oscillate, these factors undergo rhythmic phosphorylation. The relative 
amount of polysomal RNA fraction (a RNA subfraction composed mainly of actively 
translated RNAs) follows a diurnal cycle, suggesting that rhythmic translation does 
occur in the mouse liver. Approximately 2% of the expressed genes are rhythmically 
translated but have no rhythm in mRNA abundance. While the total mRNA levels are 
constant, the polysome-bound mRNA levels oscillate with a period of 24h. Among 
genes regulated at the level of translation, 70% were found in polysomes in the 
same time interval. Most of the translationally regulated genes had phases starting at 
ZT8, before the start of the mouse feeding phase, and finishing at the end of the dark 
phase (Jouffe et al., 2013). More recently ribosome profiling coupled with RNA-seq 
(RPF-seq) was used to determine the position of translating ribosomes transcriptome 
wide and to establish a quantitative, high-resolution map of the mouse liver 
translatome around the clock. This strategy identified a set of 147 rhythmically 
translated, but otherwise non-oscillating, mRNAs with a dominant peak phase 
distribution around the day-to-night transition (ZT10-ZT16) (Janich et al., 2015). 
Interestingly, mRNAs coding for ribosomal proteins (RPs) are also associated with 
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polysomes only towards the end of the light phase (ZT8) and during the dark phase. 
Therefore, RPs oscillates with highest expression during the night. The synthesis of 
the 45S rRNA (a ribosome constituent precursor) is also circadian and it’s 
synchronized with RP mRNA transcription. This indicated that all the elements 
involved in ribosome biogenesis are transcribed in concert and coordinated with the 
feeding period. Ribosomal protein synthesis in eukaryotes is a major metabolic 
activity that involves hundreds of individual reactions; this energy-consuming 
process has to be confined to a time when energy and nutrients are available in 
sufficient amounts, which, in the case of rodents, is during the night (Jouffe et al., 
2013).  
THE RNA-BINDING PROTEIN NONO (P54NRB) 
The regulation of gene expression involves the dynamic interaction between 
proteins, DNA and RNA. To control and integrate numerous different components 
throughout gene regulation, cells need factors that can bridge nucleic acids and 
proteins. One such example of bridging protein is the ‘multifunctional’ RNA-binding 
protein Non-POU domain-containing octamer-binding (NONO, a.k.a. p54nrb) (Knott 
et al., 2016). NONO belongs to the Drosophila behavior human splicing (DBHS) 
family of RNA binding proteins. The DBHS family as well as the multiple known 
functions of NONO are discussed below. 
The DBHS family 
The DBHS proteins are defined by highly conserved tandem N-terminal RNA 
recognition motifs (RRMs), a NonA/paraspeckle domain (NOPS) that mediates 
protein-protein interactions and a C-terminal low complexity coiled-coil. These 
domains constitute the conserved core of ~300 amino acids defined as the ‘DBHS 
domain’ (Dong et al., 1993). Outside of this conserved domain, the members of the 
DBHS family are significantly different, both in their length and in their sequence 
complexity (Figure 3). The DBHS proteins are found exclusively within vertebrates 
and invertebrates. In mammals, there are three members of the family: NONO, 
splicing factor proline/glutamine rich (SFPQ a.k.a PSF) and paraspeckle protein 
component 1 (PSPC1 a.k.a. PSP1). In contrast, invertebrates have one or two 
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members: NonA and NonA-like in Drosophila melanogaster, and NONO-1 in 
Caenorhabditis elegans. DBHS proteins are predominantly nuclear as their C-
terminus contains a nuclear localization signal. In certain conditions, these proteins 
can be found in subnuclear bodies named paraspeckles or localized to chromatin or 
DNA damage foci (Bond and Fox, 2009; Fox and Lamond, 2010; Shav-Tal and 
Zipori, 2002). All the three members of the DBHS family can form homo- and 
heterodimers with each other and structural and biological data suggest that they 
rarely function alone. Possessing both protein-protein and protein-nucleic acid 
binding sites, DBHS proteins can behave as a ‘molecular scaffold’. 
 
 
NONO functions at multiple levels to regulate gene expression 
NONO can act as a transcriptional co-activator and co-repressor 
NONO, alone or in complex with other members of the DBHS family, has been 
involved in both transcriptional activation and repression. Transcriptional repression 
seem to be largely driven by and dependent on interaction with SFPQ and 
recruitment of epigenetic silencers such as Sin3A and HDAC (Dong et al., 2005, 
2007, 2009). Instead, transcriptional activation seems to be driven mostly by NONO, 
and it involves both the binding and processing of the nascent RNA as well as the 
interaction with components of the transcriptional machinery. SFPQ/NONO 
heterodimer can act as transcriptional repressors by sequestering activators away 
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from target promoters (Dong et al., 2005). Contrary to transcriptional silencing, it 
appears that transcriptional activation is dependent on the presence of the nascent 
RNA, which may act as a scaffold (Knott et al., 2016). NONO can associate with 
many transcriptionally active genes (Yadav et al., 2014). In order to mediate 
transcriptional activation, NONO interacts with other transcriptional activators. For 
example, NONO interact with photoreceptor transcription factor, and enhances 
rhodopsin expression (Yadav et al., 2014). NONO was found to facilitate the 
association of RNAPII with cAMP-dependent promoters (Amelio et al., 2007). The 
recruitment of NONO into transcriptionally active contexts appear to be also 
dependent on the presence of the RNA, as for the activation of Survivin expression 
(Yamauchi et al., 2012). It is not clear if these functions of transcriptional activation 
can be attributed to NONO alone, or in complex with other DBHS members. Whether 
NONO acts as an activator or a repressor on a specific gene might be dependent on 
its binding partners, modification status, cell-type specific expression and localization 
(Knott et al., 2016). 
The role of NONO in post-transcriptional processing, RNA stability and export 
It has been suggested that NONO may couple transcription to post-transcriptional 
processing (Emili et al., 2002; Montes et al., 2012), namely through a persistent 
association with nascent RNA. NONO and SFPQ have been identified as 
spliceosome-associated proteins (Gozani et al., 1994; Hallier et al., 1996; Lutz et al., 
1998) and associated with U5 snRNA early in the formation of the spliceosome 
(Peng et al., 2002). NONO interacts with the 5’ splice site (Kameoka et al., 2004) 
and SFPQ was found in the spliceosome (Peng et al., 2006). However, DBHS 
proteins are not essential components of the spliceosome, but rather play a role in 
alternative and co-transcriptional splicing. The SFPQ/NONO heterodimer can also 
facilitate polyadenylation and pre-mRNA cleavage (Hall-Pogar et al., 2007; Kaneko 
et al., 2007; Liang and Lutz, 2006). 
Beyond post-transcriptional processing, NONO is thought to contribute to 
maintaining transcript stability. For example, NONO and SFPQ are known to 
regulate the stability of non-coding RNA, such as the non-coding RNA Neat1 (Fox et 
al., 2002). Given its diffuse localization and broad nucleic acid specificity; it is likely 
that NONO may function in degenerately coating nascent transcripts for stabilization 
(Knott et al., 2016). 
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NONO can also remain associated with the processed messenger 
ribonucleoprotein particle (mRNP) once formed. In neuronal cells NONO and SFPQ 
are components of RNA transport granules in the neurites (Kanai et al., 2004).  RNA 
transport in neurons is important for local translation at the synapses. SFPQ and 
NONO can stimulate the export of snRNA by facilitating the recruitment of the 
phosphorylated adaptor for RNA export (PHAX) (Izumi et al., 2014).  
Paraspeckle formation and nuclear RNA retention 
NONO is a main component of nuclear paraspeckles. Paraspeckles are subnuclear 
bodies located in the interchromatin space of the nucleus (Fox et al., 2002) and are 
defined by the colocalization of the DBHS proteins with the long non-coding RNA 
Neat1. NONO seem to be essential for paraspeckle formation and integrity, as 
paraspeckles disassemble upon siRNA knockdown of NONO (Sasaki et al., 2009). 
NONO directly bind Neat1 and likely stabilizes the RNA, as loss of NONO was 
reported to reduce Neat1 levels (Sasaki et al., 2009). Although the function of 
paraspeckles is not fully understood, the identity of the associated proteins provides 
some clues (Scadden, 2009). Specifically, the presence of NONO in paraspeckles 
suggests that they may be involved in retention of mRNAs that have undergone A-to-
I editing by dsRNA-dependent adenosine deaminases (ADARs). Indeed, previous 
studies showed that a NONO-containing complex specifically interacts with mRNAs 
having structured or edited 3’-UTRs to prevent their nuclear export (Chen and 
Carmichael, 2009; Chen et al., 2008; Zhang and Carmichael, 2001). mRNAs subject 
to this type of regulation include those with inverted repeated Alu (IRAlu) elements 
within their 3’UTR. One example of RNA regulated in this way is the mouse nuclear 
transcript CTN-RNA, which is edited within its 3’UTR and localizes to paraspeckles. 
During stress, CTN-RNA is cleaved and released into the cytoplasm as mCat2 
mRNA (Prasanth et al., 2005). Although the precise molecular mechanism is still 
unclear, NONO may mediate nuclear retention by interacting simultaneously with 
both Neat1 and the target mRNA within paraspeckles. While the precise 
physiological role of paraspeckle is unknown, and they seem to be not essential in 
mice (Nakagawa et al., 2011), a general consensus that paraspeckle fine-tune gene 
expression under stress conditions is emerging (Bond and Fox, 2009; Fox and 
Lamond, 2010; Nakagawa and Hirose, 2012; Sasaki and Hirose, 2009)!
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The role of NONO in the circadian clock and cell cycle 
NONO is involved in coordinating cell cycle and circadian rhythm by regulating 
different nodes of the circadian network (Kowalska et al., 2013). NONO has been 
found in complex with PER proteins; the reduction of NONO expression by RNA 
interference attenuates circadian rhythms in mammalian cells, and fruit flies carrying 
a hypomorphic allele are arrhythmic (Brown et al., 2005). The binding of NONO to 
PER protein displays circadian rhythmicity and NONO has later been shown to 
interact with PER at Dbp and REV-ERB promoters acting as a co-repressor 
(Kowalska et al., 2012). SFPQ has been also found in complex with PER (Duong et 
al., 2011). Both factors can recruit SIN3A-HDAC complex to the DNA to repress 
transcription (Dong et al., 2007; Duong et al., 2011). In mice, loss of NONO leads to 
increased cell proliferation and decreased senescence. This is likely because NONO 
binds to the p16-Ink4A cell cycle checkpoint gene promoter and potentiates its 
circadian activation in a PER protein dependent fashion (Kowalska et al., 2013). As a 
regulator of circadian gene expression NONO can act as both an activator and a 
repressor of transcription depending on the molecular and cellular context. It has 
later been demonstrated that all the three members of the DBHS family play a role in 
the mammalian circadian oscillator by binding directly to the promoter of Rev-erb 
in a circadian and PER protein-dependent fashion. In cultured cells overexpression 
or silencing of any one of the DBHS family members affects clock period and 
amplitude. However, these roles are likely redundant since NONO-deficient mice 
show only a 20-min reduction in circadian behavioral period when in constant 
darkness (Kowalska et al., 2012).  
BASIC PRINCIPLES REGULATING METABOLIC HOMEOSTASIS 
Metabolism is a combination of two processes: anabolism and catabolism. Anabolic 
pathways require energy to generate macromolecules such as glycogen, lipids and 
nucleotides, whereas the catabolic pathway breaks molecules to produce energy. 
Catabolic and anabolic pathways are tightly interconnected with the fasting/feeding, 
rest/activity and sleep/wake circadian cycles, during which homeostasis is 
!!
General Introduction 
!
! !
29 
maintained by reciprocal activation of glucose and lipid metabolism (Schwartsburd, 
2017). Although free fatty acids are the main fuel for most organs, glucose is the 
obligate metabolic fuel for the brain under physiologic conditions and decreased 
plasma glucose levels (hypoglycemia) can lead to impaired brain function and death. 
On the other hand, even mildly elevated plasma glucose concentrations, which occur 
in patients with impaired glucose tolerance, dramatically increase risk for 
cardiovascular morbidity (Shrayyef and Gerich, 2010). Thus, the survival of 
multicellular organisms depends on the organisms’ ability to maintain glucose 
homeostasis in times of low/high nutrient availability or low/high energy needs. This 
is achieved by the organisms’ ability to support equilibrium between energy-
producing catabolic processes and energy consuming anabolic pathways that makes 
possible to maintain metabolic homeostasis during fasting/feeding and sleep/wake 
cycles (Schwartsburd, 2017). Glucose homeostasis is regulated by nutrient sensing 
mechanisms and hormonal signaling. These mechanisms control the rate at which 
glucose is utilized and produced by each tissue (Sharabi et al., 2015). The main 
tissues that contribute to the maintenance of normal blood glucose levels are the 
liver, muscle, adipose tissue and brain. After a carbohydrate-rich meal, about 33% of 
the glucose is taken up by the liver, about 33% is taken up by muscle and fat tissue, 
and the rest of the glucose is taken up by brain, kidney and RBCs (Moore et al., 
2012).  
The liver plays a central role in metabolic homeostasis 
As the major site in the body for carbohydrate and lipid biosynthesis, the liver has a 
central role in the regulation of systemic glucose and lipid fluxes during feeding and 
fasting.  
Liver metabolism during the fasted state 
Under fasting conditions, when nutrients become scarce, insulin levels decrease and 
glucagon is secreted by the pancreas to promote hepatic glucose production (HGP). 
HGP is achieved by two main mechanisms: glycogen breakdown (glycogenolysis) 
and de novo glucose synthesis (gluconeogenesis) from available precursors like 
pyruvate, lactate, glycerol and amino acids. Glucagon, via protein kinase A (PKA)-
mediated phosphorylation, activates glycogen phosphorylase while inhibiting 
glycogen synthase (Sharabi et al., 2015). Nearly 80% of the endogenous glucose 
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production comes from the liver and the rest from the kidney (Gerich, 2010). Liver 
glycogen content is limited and is mostly depleted after an overnight fast. Therefore, 
while glycogenolysis is predominant during short-term fasting, gluconeogenesis 
becomes the main source of glucose after prolonged fasting. The adipose tissue 
contributes to liver gluconeogenesis by releasing free fatty acids (FFAs) and glycerol 
that are taken up by the liver. The inflow of FFAs from adipose tissue lipolysis 
sustains an increased flux through -oxidation in the liver. The acetyl-CoA produced 
is fully oxidized to CO2 by the Krebs cycle. This process generates an abundance of 
ATP and reducing equivalents that sustain the conversion of pyruvate, glycerol and 
other anaplerotic substrates into glucose via gluconeogenesis. Under conditions 
where acetyl-CoA generation from -oxidation exceeds the oxidative capacity of the 
Krebs cycle, the acetyl-CoA overflow is diverted into ketone body synthesis (Jones, 
2016).  
Liver metabolism during the fed state 
The liver plays a unique role in postprandial nutrient metabolism because it has first 
access to most ingested nutrients by virtue of their absorption into the hepatic portal 
vein. As a result the liver is exposed to higher nutrient levels than are other 
peripheral tissues (Moore et al., 2012). Under this condition, the liver receives a 
range of different nutrients via the portal vein, including simple sugars, amino acids 
and short chain fatty acids. Some, such as fructose, glycerol, butyrate and 
propionate, are efficiently extracted and rapidly incorporated into hepatic 
intermediary metabolism. Others, such as glucose and lactate, are only partially 
cleared from the circulation. The abundance of these substrates in portal vein blood, 
in conjunction with high level of insulin resulting from beta cells stimulation, promotes 
hepatic glycogen synthesis and de novo lipogenesis, while fatty acid oxidation and 
endogenous glucose production are suppressed (Jones, 2016). 
Insulin and glucose regulate hepatic glycogen synthesis through mechanisms 
that alter the activity of three enzymes: glucokinase (GCK), glycogen synthase 
(GYS2) and glycogen phosphorylase. The transport of glucose into the hepatocytes 
occurs by facilitated diffusion through glucose transporter 2 (GLUT2), and, 
consequently, intrahepatic glucose concentrations parallel those in the plasma. 
GLUT2 has high capacity for glucose but low affinity, and thus functions as a 
“glucose sensor”. Unlike other glucose transporters present in other tissues, GLUT2 
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does not rely on insulin for facilitated diffusion. Once glucose has entered the 
hepatocyte, GCK – which catalyzes the phosphorylation of glucose to glucose-6-
phosphate – functions as the gatekeeper for glucose metabolism in the hepatocytes  
(Petersen et al., 2017). In its phosphorylated form, glucose can no longer be 
exported to the circulation and it’s retained in the hepatocytes. Unlike other 
hexokinases, GCK has low affinity for glucose (thus it’s most active when glucose 
concentration is high) and it’s not inhibited by its product. GCK strongly regulates 
hepatic glycogen deposition. Transgenic mice that have an extra copy of the Gck 
displayed more then threefold greater hepatic glycogen deposition then wild-type 
mice during hyperglycemic clamp studies. Similarly, the glucose intolerance of mice 
that have liver-specific deletions of the genes that encode AKT (Akt1-/-/Akt2-/-) is 
rescued by the liver-specific overexpression of Gck (Titchenell et al., 2016). 
Conversely, patients with maturity onset diabetes mellitus of the young type 2 
(MODY2) – which is caused by loss of function mutations in GCK – have reduced 
hepatic glycogen synthesis in the post-prandial state. Although GCK has a high 
control coefficient for glycogen synthesis in the hepatocyte, GYS2 also shares 
control (Agius, 2008). This shared control of glycogen synthesis is probably partly 
attributable to the GCK-dependent production of glucose-6-phosphate, which is the 
key allosteric activator of GYS2. Furthermore, insulin stimulates hepatic glycogen 
synthesis. By activating Akt, insulin induces phosphorylation and inactivation of 
GSK-3 and a subsequent activation of GYS2 (Sharabi et al., 2015). Another 
important action of insulin is the inhibition of adipose tissue lipolysis. Insulin-
mediated suppression of lipolysis indirectly suppresses hepatic gluconeogenesis 
through two main mechanisms: first, it decreases the delivery of FFA to the liver, 
which results in an acute reduction in hepatic mitochondrial acetyl-CoA levels and a 
consequent decrease in pyruvate carboxylase activity; second, it decreases the 
turnover of glycerol, which decreases hepatic gluconeogenesis from this substrate 
(Petersen et al., 2017). 
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INTERPLAY BETWEEN THE CIRCADIAN CLOCK AND 
METABOLISM 
Although 5-20% of genes display 24 h oscillation in transcript abundance in each 
tissue, the identity of those cyclic genes differs significantly between tissues, 
suggesting organ-specific integration of central cues and local signals to induce 
cyclic fluctuations relevant to the organ (Zhang et al., 2014). In the liver, these 
transcripts encode key or rate-limiting enzymes important or glucose, lipid and bile 
acid metabolism as well as mitochondrial function (Panda, 2016), anticipating fasting 
and feeding phases and participating to the partitioning of exclusive metabolic 
pathways (Mayeuf-Louchart et al., 2017).  
The molecular players mediating the entrainment of the circadian clock 
by energetic status 
The identification of the molecular links that permit sensing of the metabolic status by 
the clock is an intense area of research. The alternation of feeding and fasting 
periods is paralleled by variations of the AMP/ATP and NAD+/NADH ratios that 
reflect changes in energy state. Recent studies have demonstrated that clock 
proteins are directly regulated by energy sensors that modify their expression or 
stability (Mayeuf-Louchart et al., 2017). AMP kinase (AMPK) senses the AMP/ATP 
ratio and is activated by a low energy state. On the one hand, AMPK activity as well 
as nuclear localization is circadian in the mouse liver indicating that it is controlled by 
the molecular clock. On the other hand, AMPK directly phosphorylates CRY1 thus 
increasing its degradation, conveying rhythmic changes in energy status directly to 
clock components (Lamia et al., 2009). The clock is also sensitive to changes in the 
NAD+/NADH ratio. NAD+ levels increase upon fasting or after exercise, but decrease 
upon high fat diet. NAD+ is a co-factor for many metabolic enzymes and for sirtuins 
(SIRT). SIRT display protein (including histone) deacetylation activity, thereby 
transducing changes in metabolic status to transcriptional/chromatin modifications 
(Mayeuf-Louchart et al., 2017). The CLOCK:BMAL heterodimer directly activates the 
transcription of the gene coding for the nicotinamide phosphoribosyltransferase 
(NAMPT) which is the rate limiting enzyme of the NAD+ salvage pathway, resulting in 
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circadian oscillation of the intracellular NAD+ level (Nakahata et al., 2009; Ramsey et 
al., 2009). NAD+ is a co-factor for cytosolic and nuclear SIRT1 and 6, as well as 
mitochondrial SIRT3 whose activity is circadian. SIRT1 rhythmically deacetylases 
BMAL1 as well as PER2 promoting their degradation, and exerts feedback on 
CLOCK:BMAL1 transcriptional activity (Asher et al., 2008; Nakahata et al., 2008) 
while the nuclear SIRT6 controls circadian recruitment to chromatin to regulate 
specific hepatic transcriptional networks involved, for instance, in lipid metabolism 
(Masri et al., 2014). FAD is another co-factor catalyzing metabolic reactions and a 
sensor of the intracellular redox state. Riboflavin kinase, an enzyme of the FAD 
synthesis pathway, oscillates in the nucleus, resulting in rhythmic FAD levels. In turn, 
FAD controls CRY stability by competing with the ubiquitin ligase FBXL3 which 
labels CRY for degradation (Hirano et al., 2017). Sensing of the cellular metabolic 
state results in the fine adjustment of the clock by nutrient availability, and points to a 
potential mechanism by which alteration of the metabolic state, by high-fat content 
food or by food intake at irregular times, may deteriorate clock function (Mayeuf-
Louchart et al., 2017). Vice versa, disruption of the clock leads to metabolic 
disorders. The reciprocal regulation of metabolism and the circadian clock and the 
deleterious effects of its dysregulation on metabolic health are summarized in the 
next two sections. 
Disruption of the clock leads to metabolic disorders in mouse models 
and humans 
Peripheral organs contain autonomous endogenous oscillators as was shown by 
culturing ex vivo liver, lung and muscle tissues (Yamazaki et al., 2000). Oscillations 
in peripheral tissues progressively dampened and were desynchronized in SCN 
lesioned animals, suggesting that the SCN synchronizes peripheral clocks (Yoo et 
al., 2004). Mice with whole-body loss of function of hypomorphic alleles of circadian 
genes often develop perturbations in glucose and lipid homeostasis, insulin 
resistance, and other hallmarks of metabolic disease (Zarrinpar et al., 2016). Early 
observations of severe metabolic dysregulation in Clockmut and Bmal1-/- mice (Rudic 
et al., 2004) led to a systematic investigation of metabolic homeostasis in almost 
every circadian mutant mouse model. Later studies demonstrated that local clocks 
are also necessary for circadian function and metabolic homeostasis (Atger et al., 
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2017; Brown, 2016). For example, mice with a liver-specific deletion of Bmal1 
exhibited hypoglycemia restricted to the fasting phase, exaggerated glucose 
clearance, and loss of rhythmic expression of hepatic glucose regulatory genes. The 
liver clock is thus important for buffering circulating glucose in a time-of-day-
dependent manner (Lamia et al., 2008). Loss of pancreatic clocks caused a delay in 
the phase of oscillation of islet genes involved in growth, glucose metabolism and 
insulin signaling. Both Clock and Bmal1 mutants show glucose intolerance, defective 
insulin production, and defects in size and proliferation of pancreatic islets that 
worsen with age (Marcheva et al., 2010; Perelis et al., 2015; Sadacca et al., 2011). 
Adipocyte-specific deletion of  Bmal1 results in obesity in mice. Ablation of the 
adipocyte clock is also associated with a reduced number of polyunsaturated fatty 
acids in adipocyte triglycerides (Paschos et al., 2012). The relationship between 
clock function and metabolism is bidirectional. Environmental disruption of the 
circadian cycle can lead to metabolic disease (Arble et al., 2010). For example, a 
classic ‘shift work’ experiment, in which nocturnal rats are required to be active 
during daytime, leads to alteration of circadian gene rhythmicity, obesity, and other 
metabolic disturbances (Salgado-Delgado et al., 2008). When mice are housed in 
constant bright/dim light, they consume more food during the subjective light phase. 
These mice exhibit significantly increased body mass and reduced glucose tolerance 
compared with mice under standard light/dark cycles, despite similar caloric intakes 
and total motor activity (Fonken et al., 2010). Restricting feeding of mice to daytime 
leads to weight gain (Arble et al., 2009).  
There is strong evidence that this phenomenon also exists in humans. 
Several clock gene polymorphisms have been associated with altered metabolic 
parameters. For example, polymorphisms in Cry2 have been associated with 
elevated fasting glycaemia and reduced liver fat content in large cohorts (Dupuis et 
al., 2010; Machicao et al., 2016). Two known common Clock polymorphisms were 
associated with the development of the metabolic syndrome (Scott et al., 2008). 
Similarly, two Bmal1 haplotypes were associated with type 2 diabetes and 
hypertension (Woon et al., 2007). Furthermore, polymorphisms in Rev-erb and 
Per2 were associated with obesity (Garaulet et al., 2010, 2014). Environmental 
disruption of the circadian cycle in humans has been studied at a population level in 
shift workers, as well as under laboratory settings. There is strong evidence that shift 
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workers are particularly predisposed to obesity and metabolic syndrome (Brum et al., 
2015; Canuto et al., 2013; van Drongelen et al., 2011; Wang et al., 2014). This is 
perhaps due to uncoupling of clock systems and the hypothalamus-pituitary-adrenal 
(HPA) axis (Fujino et al., 2006; Nicolaides et al., 2014; Sookoian et al., 2007). 
Simulated night shit work laboratory studies on humans induced a reduction in daily 
energy expenditure of approximately 12-16% (McHill et al., 2014). Decreased levels 
of leptin and peptide YY, which signal satiety, were also observed. When individuals 
were subjected to circadian misalignment for 10 days they had elevated post-
prandial glucose, elevated insulin, and increased mean arterial pressure (Scheer et 
al., 2009). In conclusion, there is mounting evidence in both animal models and 
humans that genetic and environmental disruption of circadian clock severely affects 
metabolic homeostasis leading to metabolic disease. 
Systemic cues and the circadian clock 
The SCN entrains peripheral clock rhythmicity through the modulation of hormone 
secretion, body temperature rhythms, and feeding/fasting rhythms (Balsalobre et al., 
2000; Brown et al., 2002; Damiola et al., 2000; Vujovic et al., 2008). Fasting/feeding 
rhythms influence both temperature and humoral rhythms. Feeding behavior is highly 
rhythmic. Mice consume about 80% of their total daily food intake in the dark phase 
(Atger et al., 2017). SCN-lesioned rats eat similar amounts of food during the light 
and dark phase. Thus, a functional clock is required for proper feeding rhythms 
(Nagai et al., 1978). Genetic alterations of the molecular clock components disrupt 
rhythmic food consumption in multiple whole-body circadian mutant models (Lamia 
et al., 2008; Turek et al., 2005; Vollmers et al., 2009).  
Daily feeding-fasting rhythms were shown to be the predominant Zeitgeber for 
peripheral oscillators. An inverted feeding regimen can rapidly invert peripheral 
clocks in liver, kidney, heart, and pancreas but has almost no effect on the central 
oscillator (Damiola et al., 2000; Stokkan et al., 2001). The phase shifting induced by 
food occurs in both light-dark conditions and in constant darkness. This indicates 
that synchronization of peripheral clocks under restricted feeding conditions is likely 
independent of the SCN. Furthermore, restricted feeding can in part restore 
rhythmicity of gene expression in liver of mutant mouse models with a disrupted 
clock (Vollmers et al., 2009). Phase shifting of peripheral clocks induced by food 
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occurs only progressively; 12 h inversions of liver oscillation take approximately 1 
week (Damiola et al., 2000; Saini et al., 2013). However, in SCN-ablated mice 
entrainment of the peripheral clocks by inverted feeding occurred more  rapidly. 
Thus, the SCN may play a role in counteracting peripheral clocks uncoupling 
imposed by an altered food regimen, this is likely mediated by the rhythmic secretion 
of glucocorticoids (Le Minh et al., 2001).  
The SCN is connected to the adrenal gland and controls the daily release of 
glucocorticoids (Buijs et al., 1999). Glucocorticoids increase during the light phase 
and reach their peak at the transition between day and night. In nocturnal rodents 
this glucocorticoid peak anticipates the active/feeding phase (Ishida et al., 2005). 
Glucocorticoid response elements are present in the promoter of core clock genes 
like Bmal1, Cry1, Per1, and Per2 (Reddy et al., 2007; So et al., 2009; Yamamoto et 
al., 2005), thus the two systems are tightly interconnected (Weger et al., 2016). 
Glucocorticoids are indeed capable of entraining peripheral clocks, as suggested by 
the ability of dexamethasone to synchronize oscillations in rat fibroblasts (Balsalobre 
et al., 2000).  
Temperature oscillations were also proven to synchronize peripheral clocks 
(Brown et al., 2002; Buhr et al., 2010; Saini et al., 2012). Temperature rhythms can 
modulate circadian periods in fibroblasts (Dibner et al., 2009). Temperature can also 
affect rhythmic gene expression through the modulation of mRNA splicing efficiency, 
as it was demonstrated recently for the cold-inducible RNA-binding protein CIRBP 
(Gotic et al., 2016).  
Restricting food access to only a few hours during the resting phase 
enhances rhythmicity of metabolic factors like glucose, FFAs, and glucocorticoids 
(Krieger, 1974). This short time window of food availability during the day alters 
behavioral rhythms and enhances locomotor activity that anticipates food availability 
(Stephan, 2002; Stephan et al., 1979). Food-anticipatory activity (FAA) persists even 
when the food is removed. Importantly, most of the mouse models with a disrupted 
circadian clock exhibit normal FAA (Pitts et al., 2003; Stephan, 2002; Storch and 
Weitz, 2009). Furthermore, entrainment to food can occur in SCN-lesioned mice. 
This indicated that the neuronal locations responsible for the FAA are at least in part 
distinct from those responsible for entrainment to light (Krieger et al., 1977; Stephan, 
2002). Although the brain locations responsible for FAA still need to be identified, 
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some studies suggested that peripheral organs might participate in FAA through 
humoral signals. For example, oxyntomodulin secreted by the gut is involved in the 
entrainment of the clock through feeding stimuli (Landgraf et al., 2015). Furthermore, 
Ghrelin-secreting cells in the stomach represent another potential food-entrainable 
oscillators. The hormone ghrelin stimulates food intake, and Ghrelin receptor-
deficient mice exhibit a reduction in FAA (Laermans et al., 2015; LeSauter et al., 
2009). Per2 has recently been shown to mediate the action of the liver upon FAA. 
Whole-body Per2 mutant animals have impaired food anticipation and the liver-
specific Per2 mutation is sufficient to disrupt this circadian behavior (Chavan et al., 
2016; Feillet et al., 2006). The adipocyte clock constitutes another example because 
it’s involved in the rhythmic leptin secretion (Paschos et al., 2012). Leptin induces a 
reduction in appetite, and its signaling is attenuated in animals with disrupted clock 
(Kettner et al., 2015). Specific deletion of Bmal1 in adipocytes results in disrupted of 
leptin levels in plasma, as well as altered feeding behavior. To conclude, the 
regulation of feeding behavior seem to integrate several layers of regulation that 
involve not only the central clock but also food-entrainable oscillators employing 
central and peripheral organs. 
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Immediately after transcription initiation and throughout their life cycles, RNAs are 
bound by a large number of RNA-binding proteins (RBPs), some of which remain 
stably bound while others are subject to dynamic exchange. These complexes 
containing RNAs and their associated proteins constitute the ribonucleoprotein 
particles. The combination of factors binding to a particular RNA and their position 
along the transcript determines every step of RNA regulation throughout its lifetime. 
Very little is known about the role of RNA binding proteins in regulating circadian 
mRNA expression in mammals. The RNA binding protein NONO has been shown to 
interact with clock components and affect circadian rhythmicity in flies and mammals, 
however the specific mechanisms of its function in circadian RNA expression are 
unknown. 
The liver is the most studied organ in the circadian field, and it has been 
demonstrated that the feeding/fasting cycle is the main Zeitgeber for the peripheral 
organs, including the liver. The first objective of my thesis project was to determine 
whether NONO expression and/or localization was changing in the liver nucleus 
following fasting or feeding. As a first step, liver staining, imaging and image analysis 
techniques had to be optimized in order to quantify changes in NONO localization 
and abundance. After successful implementation of these techniques we found that 
NONO abundance was unchanged following fasting and re-feeding (feeding after 12 
h fasting), however the number of NONO-containing speckle-like structures 
increased in number in the liver nuclei 2 h after re-feeding.  
Since we observed changes in NONO localization following re-feeding, the 
second objective was to determine NONO protein and RNA interactors in the liver 
nucleus upon fasting and re-feeding. NONO was immunoprecipitated from liver 
nuclei in native conditions and either bound proteins or bound RNAs were isolated. 
Among NONO interacting proteins we found that several HNRNPs, splicing factors 
and RNA-binding proteins. We also found that the number of RNAs bound by NONO 
increased upon re-feeding. Gene ontology annotation of NONO targets revealed 
carbohydrate and lipid metabolism as major clusters. 
Given that NONO bound to several genes regulating metabolic processes and 
the number of bound targets increases upon re-feeding the third objective was to 
determine the profile of expression of NONO target genes in WT and NONO-
deficient mice. We found that 36% of NONO target genes had 24 h rhythm in 
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expression that was abolished or delayed in NONO-deficient mice. 
Finally, since nono has a profound effect on the rhythmicity of its target genes, 
and these genes are mainly involved in glucose and lipid homeostasis; the 4th aim of 
the project was to determine the metabolic consequences of NONO deficiency both 
in the liver and at the whole organism level. We found that NONO-deficient mice 
have impaired glucose tolerance, reduced capacity to store glycogen and lipids in 
the liver, and a lean phenotype. Our data demonstrates that NONO coordinates 
circadian mRNA expression of metabolic genes with the feeding/fasting cycle, 
thereby playing a critical role in energy homeostasis. 
3. RESULTS 
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Abstract 
The mechanisms by which feeding and fasting drive rhythmic gene expression for 
physiological adaptation to daily rhythm in nutrient availability are not well 
understood. Here we show that, upon feeding, the RNA binding protein NONO 
accumulates within speckle-like structures in liver cell nuclei. Combining RNA-
immunoprecipitation and sequencing (RIP-seq), we found that an increased number 
of RNAs are bound by NONO after feeding. We further show that NONO binds and 
regulates the rhythmicity of genes involved in nutrient metabolism post-
transcriptionally. Finally, we show that disrupted rhythmicity of NONO target genes 
has profound metabolic impact. Indeed, NONO-deficient mice exhibit impaired 
glucose tolerance and lower hepatic glycogen and lipids. Accordingly, these mice 
shift from glucose storage to fat oxidation, and therefore remain lean throughout 
adulthood. In conclusion, our study demonstrates that NONO post-transcriptionally 
coordinates circadian mRNA expression of metabolic genes with the feeding/fasting 
cycle, thereby playing a critical role in energy homeostasis. 
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Introduction 
Diurnal rhythms in gene expression are crucial for metabolic homeostasis. Such 
rhythms synchronize the transcription of genes necessary for anabolic and catabolic 
metabolism with periods of feeding and fasting, respectively (Panda, 2016). These 
oscillations are driven in part acutely in response to feeding and fasting, in part by an 
endogenous circadian oscillator present in nearly all cells and tissues, and in part 
systemically (Brown, 2016). Indeed, genetic disruption of the molecular clock or an 
erratic eating pattern can each disrupt the temporal coordination between metabolic 
demand and gene expression, leading to metabolic disease (Baron and Reid, 2014; 
Bass and Takahashi, 2010; Zarrinpar et al., 2016). However, mechanisms by which 
the feeding/fasting cycle and gene expression are temporally coordinated have not 
been fully elucidated.  
The liver plays an important role in metabolic homeostasis, as it is the primary 
site for the daily metabolism of macronutrients (e.g. carbohydrates, lipids and amino-
acids). In turn, glycogen is predominantly stored there during feeding, and during 
fasting this glycogen is largely returned to glucose each day. Consistent with this 
rhythmic function, ~24h rhythms in both mRNA and protein levels are associated 
with a large fraction of the liver coding genome (Hughes et al., 2009; Reddy et al., 
2006; Vollmers et al., 2012; Zhang et al., 2014). While a number of these genes 
have daily expression patterns driven primarily by transcriptional rhythms, cycling of 
most mature mRNAs is not driven by underlying rhythms in transcription (Koike et 
al., 2012; Menet et al., 2012), suggesting the importance of as yet unknown post-
transcriptional mechanisms.  
Importantly, comparing genes induced by fasting and feeding with genes that 
exhibit diurnal patterns of gene expression (in terms of mature mRNA levels) 
revealed a dramatic overlap. This indicates that the feeding/fasting cycle is a critical 
driver of daily rhythm in mRNA levels (Atger et al., 2015; Damiola et al., 2000; Sobel 
et al., 2017; Vollmers et al., 2009). Accordingly, when fasted mice are given food, a 
large number of liver transcripts are rapidly upregulated. Such increases in mRNA 
levels also likely involve both transcriptional and post-transcriptional mechanisms.  
Circadian rhythms in cellular function are mostly driven by a circadian 
oscillator composed of a cell-autonomous transcriptional-translational feedback loop, 
!!
Results 
!
! !
48 
in which heterodimers of the activator proteins CLOCK and BMAL bind to E-box 
promoters and drive the expression of the repressors CRYs (Cry1, Cry2) and PERs 
(Per1, Per2, Per3). CRY and PER heterodimers then translocate back into the 
nucleus, and repress activities of the BMAL-CLOCK complex, thus establishing 
circadian rhythmicity in gene expression (Lowrey and Takahashi, 2011; Panda et al., 
2002a). 
Post-transcriptional regulatory mechanisms (such as splicing, localization, 
polyadenylation, stabilization and degradation) are driven by RNA binding proteins 
(RBPs) that often mediate complex activities involving interactions with other 
proteins and RNA species (Uren et al., 2012). The RBP non-POU domain-containing 
octamer binding (NONO) belongs to the Drosophila Behavior Human Splicing 
(DBHS) family that includes the paralogues SFPQ and PSPC1. These predominantly 
nuclear proteins have two RNA-recognition motives (RRMs) and are defined as 
‘multifunctional’, as they regulate gene expression in numerous ways, affecting 
transcriptional activation and inhibition, as well as RNA splicing, stabilization, and 
export (Knott et al., 2016). NONO, SFPQ, and PSPC1, together with other pre-
mRNA splicing factors, transcription factors, and heterogeneous nuclear 
ribonucleoproteins (hnRNPs), are also components of paraspeckles - subnuclear 
bodies assembled on the long non-coding RNA Neat1 (Fox and Lamond, 2010; Fox 
et al., 2002; Yamazaki and Hirose, 2015). Interestingly, NONO interacts with PER 
proteins and affects circadian rhythmicity in flies and in mammalian cell lines (Brown 
et al., 2005; Kowalska et al., 2012, 2013). A second, and likely not mutually 
exclusive, aspect of DBHS family proteins is their role in regulating RNA expression 
in response to stress stimuli (Prasanth et al., 2005). 
Here we find that feeding increases the number of NONO-containing, speckle-
like structures in nuclei of liver cells. NONO interacts with RNA processing factors in 
the liver and the number of NONO-bound RNAs increases upon feeding. NONO 
primarily binds promoter-proximal introns of transcripts. A large fraction of NONO-
bound RNAs encodes proteins implicated in glucose uptake and macronutrient 
metabolism. Furthermore, we demonstrate that NONO post-transcriptionally 
regulates mRNA levels of these genes in response to a nutritional stimulus. The 
absence of NONO-mediated regulation of target RNAs profoundly impacts metabolic 
health. Indeed, NONO-deficient mice exhibit impaired glucose tolerance, reduced 
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capacity to store glycogen and lipids in the liver, and a lean phenotype. Together 
these results indicate that NONO coordinates the pre-mRNA processing of metabolic 
genes in response to nutritional stimuli. We therefore propose that post-
transcriptional mechanisms directed by NONO represent an important regulatory 
node at the intersection between cycles of feeding/fasting and rhythmic gene 
expression. 
 
Results 
Feeding increases the number of NONO-containing speckle-like structures in 
nuclei of liver cells 
To investigate whether NONO plays a role in driving feeding-dependent rhythms in 
mRNA levels, we first analyzed NONO protein levels in the mouse liver in response 
to fasting and feeding. Mice were fed a normal chow only during the dark phase of a 
12 h light:12 h dark cycle (i.e., a 12:12 LD cycle) for one week. Livers were then 
harvested after 12 h of fasting, after 2 h of re-feeding (i.e., 2 h of feeding following 
the 12 h fast) or 60 minutes after an intraperitoneal glucose injection following light-
phase fasting. In these conditions, NONO protein levels remained unchanged, as 
shown by immunoblotting and nuclear immunostaining (Figure S1A, S1B and S1E). 
Using super-resolution microscopy, however, we observed dramatic changes in 
NONO subnuclear localization (Figure 1A and 1D). In general, NONO was diffusely 
distributed throughout liver-cell nuclei after fasting. After feeding, or an 
intraperitoneal administration of glucose, the number of NONO-containing 
subnuclear speckle-like structures increased (Figure 1B, 1C, 1E, and 1F). This 
increase in the number of speckle-like structures was not due to an increase in 
nuclear volume (Figure S1C, S1D, S1F, S1G). Feeding-induced speckle-like 
structures localized to the interchromatin space of the nucleus, spatially separated 
from heterochromatin rich DAPI foci. The increased number of NONO-containing 
speckle-like structures in liver nuclei after feeding or an acute glucose challenge 
suggests that NONO may play a role in hepatic responses to nutritional stimuli. 
NONO interacts with RNA processing factors  
Most RBPs interact with each other and with other proteins in macromolecular 
complexes to regulate every step of the RNA life cycle, such as transcription, 
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splicing, transport, and translation (Gehring et al., 2017). To characterize NONO-
containing macromolecular complexes in different nutritional conditions, we 
performed immunoprecipitation followed by mass spectrometry (IP-MS) of NONO 
from mouse liver nuclei collected at three different times of the day. Again, mice 
were fed only during the dark phase of a 12:12 LD cycle, and samples were 
collected after 10 h of fasting (ZT10), 2 h after re-feeding (ZT14), and towards the 
end of the feeding period (ZT22) (Figure S2A and S2B). We found that the most 
abundant interactions were common to all the three time points (Figure S2C). 
Among NONO interacting proteins were the two known paralogues and direct NONO 
interactors; SFPQ and PSPC1. We also found that several HNRNPs, some splicing 
factors, RNA-binding proteins and one of the main components of the DBC1–ZIRD 
complex (DBIRD) were NONO interactors (Table 1). Several of these interacting 
factors also localize to paraspeckles (Naganuma et al., 2012; Yamazaki and Hirose, 
2015) and/or were previously identified as components of messenger 
ribonucleoprotein complexes (mRNPs), involved in mRNA metabolism and post-
transcriptional gene regulation (Close et al., 2012; Mannen et al., 2016; Sánchez-
Jiménez and Sánchez-Margalet, 2013; Weidensdorfer et al., 2009). Although NONO 
was previously shown to interact with the PER protein complex (Brown et al., 2005), 
no circadian clock proteins were identified in our IP-MS analysis, suggesting that the 
circadian sub-complex may not be a major component of the NONO complex in the 
liver. This detailed characterization of NONO complexes suggests that NONO 
interacts with ribonucleoprotein complexes in the liver and may play a role in mRNPs 
assembly, RNA metabolism and post-transcriptional gene regulation.  
The number of transcripts bound by NONO increases upon feeding 
To identify RNAs bound by NONO complexes in different nutritional conditions, we 
performed RNA immunoprecipitation followed by sequencing (RIP-seq) of NONO 
from mouse liver nuclei collected after 10 h of fasting (ZT10), 2 h after re-feeding 
(ZT14) and towards the end of the feeding period (ZT22) (for mice fed during the 
dark phase of a 12:12 LD cycle) (Figure 2A and 2B). We identified a total of 1140 
transcripts that bound NONO during at least one of the three time points. 
Importantly, NONO bound more transcripts at ZT14 (2h after re-feeding), compared 
with the two other time points; NONO bound 373 genes at ZT10, 833 at ZT14, and 
452 at ZT22 (Figure 2C). At ZT14 the average size of NONO binding peaks (i.e., the 
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number of base pairs encompassed by each peak) also increased; average peak 
sizes were 2203 ± 1611 bp at ZT10, 3060 ± 1723 bp at ZT14 and 2202 ± 1141 bp at 
ZT22 (Figure 2D and 2E). This difference was confirmed when we compared only 
the 134 transcripts that were common to the three time-points (Figure S3A), 
suggesting increased binding of NONO to its target RNAs at the beginning of the 
feeding phase. Among NONO targets at ZT10 was the non-coding RNA NEAT1, 
which serves as a scaffolding RNA for the formation of paraspeckles (Fox et al., 
2002). About 80% of NONO binding sites were within introns, especially in the 5’ 
proximal introns (Figure 2F and 2G). Relative distance of the identified intron peaks 
from the TSS normalized to gene size showed similar results (Figure S3B). 
Moreover, NONO did not bind uniformly throughout each intron, but instead was 
enriched within specific regions of each bound intron (Figure 2I and Figure S3C-E). 
In silico analyses identified 6 putative binding-site motifs significantly enriched at 
introns (Figure 2H). (It should be noted that although the composition of these 
binding site motifs was consistent across time points, more stringent mapping 
techniques and mutation analyses would be needed to establish more precise 
consensus sequences). Together, these data suggest that: 1) NONO primarily binds 
to pre-mRNA, 2) the number of NONO-bound RNAs increases at the beginning of 
the feeding phase, and 3) NONO may regulate the processing of its target RNAs in 
response to nutritional stimuli.  
NONO regulates the rhythmicity of its target RNAs post-transcriptionally 
The liver’s circadian transcriptome results from the combined actions of the circadian 
clock and feeding/fasting rhythms (Damiola et al., 2000; Vollmers et al., 2009). 
Since: 1) the number of NONO-containing speckle-like structures increased in 
response to feeding, 2) NONO interacted with RNA processing factors, and 3) 
NONO bound to introns of a large number of protein coding genes; we hypothesized 
that NONO may contribute to the daily rhythm of hepatic gene expression. To 
address whether NONO contributes to rhythmic gene expression in response to 
feeding/fasting, circadian liver transcriptomes were assessed in nonogt mice (i.e. 
mice lacking Nono mRNA and protein expression; Kowalska et al., 2012) and 
wildtype (WT) littermates. Nonogt mice exhibit a slight change in circadian period 
length when placed in constant darkness, but under a 12:12 LD cycle their daily 
activity:rest cycle is indistinguishable from WT littermates (Kowalska et al., 2012). 
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Mice were habituated to have food available only at lights off (ZT12-24) for one 
week. During the second week, mice were collected every 2 h throughout the 24h 
day (Figure 3A). Both total and nuclear RNAs from a pool of two biological replicates 
were sequenced at two-hour resolution (Figure 3B). (For statistical reasons to 
determine accurate circadian phase, we favored a higher density of time points over 
a lower one with conventional identically-timed replicates (Li et al., 2015)). In these 
conditions NONO mRNA and protein levels showed constant amount across the 24 
h (Figure S4A and S4B). 
In the total-RNA fraction the majority of reads (71%) mapped to exons, 
whereas in the nuclear-RNA fraction, 76% of reads mapped to introns, suggesting 
that the nuclear RNA is enriched in pre-mRNAs and newly transcribed RNAs (Figure 
3C). Thus, for further analysis we considered the exon FPKM (Fragments Per 
Kilobase per Million mapped reads) from the total-RNA fraction (tExon) as an 
estimation of mature mRNA levels, and the intron FPKM from the nuclear-RNA 
fraction (nIntron) as an approximation of pre-mRNA levels and transcriptional activity 
(Gaidatzis et al., 2015).  
In the experimental conditions described above, 22% (3152 out of 14527) of 
the genes expressed in the liver of WT mice showed a 24 h rhythm in mature mRNA 
levels (tExon dataset, Figure 3D left), with peak mRNA levels coinciding with the 
end of fasting or feeding time periods (Figure S4E), in agreement with other recent 
studies (Atger et al., 2015; Vollmers et al., 2012). However, only 32% of these 
cycling mRNAs were transcribed in a cyclical fashion (nIntron dataset). This 
suggests that post-transcriptional mechanisms likely account for the cycling of most 
mature mRNAs, as has been suggested by other recent reports (Koike et al., 2012; 
Menet et al., 2012). Comparing the NONO RIP targets that resulted to be expressed 
in the liver (n=943) with the cycling transcriptome revealed that 36% (338) of these 
NONO targets exhibited circadian rhythm in mature mRNA levels (Figure 3D right). 
Importantly, daily fluctuations in the mature mRNA levels for these genes were 
altered in nonogt mice, such that mature mRNA levels for 107 genes were no longer 
rhythmic, and peak levels of mature mRNA for 231 genes were delayed by 2h on 
average (Figure 3E and 3G). This delay is likely induced post-transcriptionally: for 
the subset of genes that were rhythmic both transcriptionally (nIntron dataset) and at 
the level of mature mRNA accumulation (tExon dataset), 58 genes in total, the delay 
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in peak expression between nonogt and WT mice was only observed in the tExon 
dataset (Figure 3F, right), whereas timing within the nIntron dataset remained 
identical between the two genotypes (Figure 3F, left).  
Even at the genome-wide level, for genes that cycled in both WT and nonogt 
mice, irrespective of whether or not they were NONO targets, peak levels of mature 
mRNAs were also delayed by 1h on average, but peak levels of transcription were 
not (Figure S4C-F). The phase delay observed when exon sequences from the total 
RNA were compared with intron sequences from the nuclear RNA did not result from 
differences in RNA preparation, since we did not observe any delay when comparing 
the intron phases of expression from the nuclear and total RNA fractions (nIntron vs 
tIntron, Figure S4F). Together, these data suggest that: 1) for NONO direct targets, 
the loss of NONO severely impacts both rhythmicity and phase of their mature 
mRNA, but not transcription of the genes themselves, and 2) the loss of NONO also 
indirectly affects the phase of oscillation for mature mRNAs associated with other 
cycling genes in the liver.  
Daily patterns of both mature mRNA levels (tExon) and transcription (nIntron) 
of known core circadian clock components did not show large alterations in their 
oscillation profile in nonogt liver (Figure S5H-J). All core clock genes showed strong 
rhythmicity in transcription, which preceded rhythms in mature mRNA levels by 1-2 h 
in both genotypes. Thus, the effects we document are likely independent of 
oscillations in core clock components.  
NONO regulates glucose-induced gene expression post-transcriptionally and 
is required for normal glucose homeostasis 
We have shown that the number of NONO-bound RNAs increases upon feeding and 
that NONO regulates the oscillation of its target mRNAs post-transcriptionally. To 
test the physiological relevance of NONO function, we examined the predicted 
functions of its rhythmic target genes. NONO target genes were significantly 
enriched in gene ontology terms related to metabolism. KEGG functional annotation 
of the same genes revealed anabolic metabolism (specifically carbohydrate and 
amino-acid metabolism) as major functional clusters (Figure 4A, 4B).  
Consistent with the mechanistic role we propose for NONO, under a 12-h 
fasting:12-h feeding cycle, peak levels of Glucokinase (Gck) and Glucose 
transporter-2 (Glut2) mRNAs were delayed in nonogt mice (Figure S5A and S5E). 
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Correspondingly, delays in these mRNA peaks affected GCK and GLUT2 protein 
levels in the liver, as levels of both proteins were reduced at the beginning of the 
feeding phase in nonogt mice (Figure 4C). 
To further test and confirm our hypothesis that NONO is important for pre-
mRNA processing of these transcripts, we measured their expression before and 
after an acute intraperitoneal injection of glucose into WT and nonogt mice (Figure 
4D). Sixty minutes (T60) after glucose injection, the fold induction (compared to time 
0 (T0)) for Gck and Glut2 spliced mRNA was significantly lower in nonogt mice 
compared to the WT littermates. In contrast, no differences in intron induction were 
seen between the two genotypes, demonstrating that NONO regulates these genes 
post-transcriptionally in response to glucose (Figure 4E).  
Both Glut2 and Gck bind glucose with low affinity and act as glucose sensors 
for the hepatocytes during the fed state, when glucose levels rise in the blood 
(Figure 5A; Massa et al., 2011; Thorens and Mueckler, 2010). Thus, reduced levels 
of GLUT2 and GCK in nonogt mice would be predicted to cause physiological 
changes in glucose utilization. This is exactly what we find: nonogt mice showed 
increased post-prandial blood glucose levels when administered a glucose tolerance 
test (GTT) (Figure 5B), whereas their insulin sensitivity was unaffected (Figure 5C). 
In addition, nonogt and WT mice exhibited similar fasting glucose and insulin levels 
(Figure 5D and 5E). These data suggest that the impaired glucose tolerance in 
nonogt mice reflects the role played by NONO in regulating glucose uptake in the 
hepatocytes. In the liver, glucose-6-phosphate is used in glycogen synthesis, 
glycolysis, and the pentose phosphate pathway, and is eventually stored as fat 
(Figure 5A). Accordingly, we measured lower levels of hepatic glycogen at the end 
of the feeding period in nonogt mice compared to WT controls (Figure 5F).  
Changes in glucose metabolism and glycogen storage could theoretically 
derive either from alterations in the liver (the site of this metabolism and storage) or 
in the pancreas (secreting the insulin and glucagon that regulate it). To test the 
extent to which loss of NONO from adult mouse liver cells contributes to glucose 
intolerance, we restored NONO expression in nonogt mice using adeno-associated 
viruses (AAVs) that expressed NONO under the control of the liver-specific TBG 
promoter. We injected two different AAV2/8 viral vectors, one that expressed 
wildtype NONO, and one that expressed a mutant version of NONO with 4 point 
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mutations (2 in each of the RRM domains) (Figure 6A and 6B). These mutations 
disrupt the ability of NONO to bind RNA (Kuwahara et al., 2006). Levels of AAV-
derived NONO protein in liver cells were comparable to those observed in WT mice 
(Figure 6C). Glucose tolerance was tested in nonogt mice before and 4 weeks after 
AAV injection (Figure 6D). Liver-specific re-expression of WT NONO significantly 
improved glucose tolerance (Figure 6E), whereas this was not the case for mice 
expressing the NONO RRM-mutant (Figure 6F). This demonstrated that NONO 
functions in the liver to influence whole-body glucose homeostasis, and that the 
ability of NONO to bind RNA is required for this function. Together these data 
suggest that NONO binds and post-transcriptionally regulates the expression of 
glucose-responsive genes in the liver, and that NONO is important for whole-body 
glucose homeostasis and glycogen storage in hepatocytes.!
Nonogt mice store less fat and exhibit increased fat catabolism  
To further characterize the role of NONO in liver metabolism we analyzed the 
metabolomes of fasted and re-fed animals, both nonogt and WT. Livers were 
collected toward the end of the fasting phase (ZT8, ZT10, and ZT12) and toward the 
beginning of the feeding phase (ZT14, ZT16, and ZT18). Principal component 
analysis of the 12 samples showed their separation along genotype and feeding 
condition. Consistent with our RNA analyses, we found more separation between 
WT and nonogt mice when the two re-fed groups were compared (Figure S6A). We 
found 182 significantly affected bio-chemicals when comparing WT and nonogt fed 
groups, whereas only 86 metabolites changed in comparisons between WT and 
nonogt fasted groups (Figure S6B). In the fed state, nonogt livers contained 
significantly lower levels of the glycolytic intermediates 3-phosphoglycerate, and 
phosphoenol pyruvate (PEP), as well as the pentose phosphate pathway 
intermediate 6-phosphogluconate (Figure S6C-E). In contrast, the mitochondrial 
TCA cycle intermediates were elevated (Figure S6F-I). In the transcriptome dataset, 
the cycling NONO target ATP-citrate-lyase (Acly) exhibited reduced level of 
expression and a phase delay (Figure S5D). ACLY uses citrate (an intermediate in 
the TCA cycle) and coenzyme A (CoA) to synthesize cytoplasmic Acetyl CoA. 
Accordingly, we found increased amounts of citrate, aconitate, succinate, and CoA in 
nonogt livers during the fed state (Figure S6F-I). Cytoplasmic acetyl CoA is the 
building block for many molecules, including fatty acids. Another NONO target gene 
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that is important for lipid metabolism is mitochondrial glycerol-3-phosphate 
acyltransferase (Gpam). GPAM catalyzes the initial and committing step in 
glycerolipid biosynthesis and plays a pivotal role in the regulation of cellular 
triacylglycerol levels. Gpam is expressed at high level during the feeding phase, 
however nonogt mice showed delayed and reduced levels of Gpam mature mRNA 
(Figure S5B). Accordingly, nonogt livers had reduced levels of triglycerides, reduced 
overall liver lipid content, and increased levels of glycerol-3-phospate (Figure 7A, 7B 
and S6J). Increases in glycerol-3-phosphate in the fasted and fed states might be 
due to increased breakdown of triglycerides. Indeed, we also found high levels of 
triglyceride catabolism intermediates (diacylglycerols, monoacylglycerols and fatty 
acids) in the livers of nonogt mice during the fed state (Figure S6J).  
To assess the physiological consequence of NONO deficiency, we evaluated 
the metabolic phenotype of nonogt mice. Nonogt mice are born at Mendelian ratio and 
survive normally into adulthood. At 10 weeks of age, nonogt mice weighed 10% less 
than WT littermates (Figure S7A). When fed a normal chow ad libitum, nonogt mice 
and WT littermates consumed equivalent amounts of food, and exhibited comparable 
daily activity levels (Figure 7D, 7E and S7B). Over the next 32 weeks, nonogt mice 
gained less weight, such that at 42 weeks they weighed 20% less than their WT 
littermates (Figure 7C and S7A). Body composition analysis revealed that nonogt 
mice accumulated less fat mass, whereas their gains in lean mass were similar to 
those seen in WT mice (Figure 7H and 7I). Both leptin and ghrelin levels were 
reduced in nonogt mice (Figure S7C and S7D). However, since food consumption in 
any case was unaltered, we turned to energy utilization as the more likely source of 
body weight differences. 
To examine whole-body energy utilization, we assessed nonogt and WT 
littermates using indirect calorimetry. During the fed state, the respiratory exchange 
ratio (RER) for both genotypes was equivalent and close to 1, indicating that 
carbohydrates were used as the predominant energy source. However, during the 
light period, when mice are usually at rest and have reduced food intake, the RER 
slowly dropped to ~0.8 in WT mice, whereas in nonogt mice, the RER rapidly 
dropped to 0.7 (Figure 7J), indicating increased reliance on fatty acids as an energy 
source for nonogt mice. The relatively quick decline in fasting RER in nonogt mice 
may also indicate reduced energy storage during the feeding phase. nonogt mice 
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also exhibited reduced abdominal fat deposits and smaller adipocytes (Figure 7F, 
7G and 7K).  
When nonogt mice were fed a normal chow (60% of the energy coming from 
carbohydrates), they weighed less and had less body fat. This reduced adiposity 
could have resulted from a primary defect in fat absorption and storage. To test this 
hypothesis, we subjected nonogt and wt littermates to ad libitum feeding of a high fat 
diet (HFD; 60% of the energy coming from fat) for 12 weeks. The two genotypes 
consumed equivalent amounts of food (Figure S7F). After 12 weeks of a HFD, the 
nonogt  and wt mice had equivalent body weights and whole-body fat mass (Figure 
S7E and S7G). As anticipated, nonogt mice fed a HFD were more glucose intolerant 
compared to their wt littermates (Figure S7H). This demonstrates that a HFD can 
compensate for the inefficient glucose uptake seen in nonogt mice fed a normal 
chow. Together, these data indicate that nonogt mice have three inter-related 
metabolic defects in the liver: 1) reduced glucose utilization in glycolytic and 
glycogen synthesis pathways, 2) impaired triglycerides synthesis, and 3) increased 
reliance on fatty acids as an energy source during fasting. 
Discussion 
Here we report a novel role for the nuclear RNA-binding protein NONO in metabolic 
homeostasis. Specifically, NONO binds to pre-mRNAs encoding several key regulators of 
liver glucose and fat metabolism. NONO enhances the processing of these pre-mRNAs, 
allowing for robust daily oscillation in mRNA levels. This facilitates subsequent translation of 
these metabolic regulators, which is necessary to store excess nutrients (as glycogen and 
triglycerides) during the postprandial period. Mice that lack of NONO exhibit disruptions in 
this temporal regulation, such that animals shift from storing glucose as glycogen and fat to 
fat oxidation. This results in reduced glucose tolerance, reduced levels of glycogen and 
triglycerides in the liver, and reduced levels of body fat and body weight (Figure 8). 
Rhythms in gene transcription are the first step toward generating oscillations in 
mRNA levels, but recent studies have revealed that a wide range of factors contribute to this 
oscillations. Regulators of transcription elongation, as well as RNA processing, transport, 
translation, and degradation may affect steady-state mRNA levels at any given time 
(Benegiamo et al., 2016). It has been suggested that the dynamic regulation of transcription, 
mRNA processing, and mRNA degradation are all required to generate high-amplitude 
oscillation in mRNA levels (Rabani et al., 2014).  
Here we show that the RNA-binding protein NONO plays an important role in 
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coordinating the circadian expression of genes involved in glucose and fat metabolism with 
the feeding/fasting cycle. Furthermore, NONO regulates these genes post-transcriptionally. 
We propose a mechanism in which NONO enhances the processing of target RNAs to allow 
robust in-phase oscillations (Figure 8). Further studies are required to understand precisely 
how NONO affects this process. Previous studies have shown that NONO and SFPQ 
interact with the carboxy-terminal domain of RNA-polymerase II, leading to the hypothesis 
that these factors couple transcription to post-transcriptional events (Emili et al., 2002). Our 
mass spectrometry data further support this idea, and we speculate that NONO may function 
as a molecular scaffold to assemble the mRNA processing machinery on target RNAs. For 
example, levels of Gck mature mRNA peak toward the end of the night, yet NONO binds to 
Gck pre-mRNA at all time points tested (ZT10, ZT14 and ZT22). Thus, we hypothesize that 
NONO primes its target pre-mRNAs for processing. In the absence of NONO, this 
recruitment is less efficient, leading to delays in the phase of oscillation or loss of 
rhythmicity. 
In agreement with what has been demonstrated for NonA, the Drosophila homolog of 
NONO (McMahon et al., 2016), we found that NONO bound primarily to introns. Since our 
data further point to a role for NONO in post-transcriptional processing, it might therefore 
play a role in Intron-Mediated Enhancement (IME), an unknown mechanism by which introns 
may increase gene expression through recruitment of splicing and mRNA export 
machineries (Gallegos and Rose, 2015; Reed and Hurt, 2002). Consistent with this idea, our 
data show that NONO preferentially bound promoter-proximal introns, and promoter-
proximal introns are more likely to contain signal sequences important for IME (Rose et al., 
2008). 
One major unanswered question is how metabolic signals result in the accumulation 
of NONO in speckle-like structures. This question also remains for all other subnuclear 
structures containing NONO. One possibility is that increased transcription itself may play a 
role: not only is transcription required for the formation of Neat1-containing paraspeckles 
(Mao et al., 2011), but also chromatin modifying complexes associated with transcriptional 
activation (Kawaguchi et al., 2015). Since feeding in the liver is associated with increase in 
cellular RNA content (Sinturel et al., 2017), the increase in speckle-like structures may be 
due simply to increases in transcription. Alternatively, specific phosphorylation events could 
play a role, as suggested in the case of MNK kinase (Buxadé et al., 2008) or during mitosis 
(Proteau et al., 2005). 
NONO, SFPQ, and PSPC1 often function as heterodimers, and have been described 
as multifunctional proteins whose specific role in cellular processes may depend on the 
molecular and cellular context (Knott et al., 2016). Several other roles have been proposed 
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for these factors.  As the principal components of nuclear paraspeckles, NONO has been 
postulated to play a role in nuclear RNA retention by binding to stem-loop structures in the 3’ 
untranslated regions (UTRs) of messages (Prasanth et al., 2005). Such UTR regions can 
even heterologously confer circadian rhythmicity in transcript oscillations (Torres et al., 
2016). Yet again, NONO and related factors have been implicated as transcriptional 
cofactors, binding to histone modifiers to regulate chromatin structure and circadian function 
(Brown et al., 2005; Duong et al., 2011). Recent research suggests that several different 
classes of NONO-containing nuclear speckle-like structures may exist (Li et al., 2017), and 
gel filtration analyses suggest that only a subset of NONO-containing speckle-like structures 
are circadian in nature (Brown et al., 2005). It is tempting to speculate that these different 
functions may exist in spatially distinct structures such as the feeding-induced speckle-like 
structures we describe here. Indeed, our mass spectrometric analyses did not detect clock 
proteins in these feeding-induced NONO complexes, nor were chromatin-modifying 
complexes abundant, suggesting that they are entities different from the circadian structures 
described previously. It is also unclear whether these structures contain the long noncoding 
RNA Neat1 that defines bona-fide paraspeckles. 
Further studies are required to assess whether the other two members of the DBHS 
family function with NONO to regulate metabolic homeostasis. Recent studies have shown 
that PSPC1 plays a role in adipose tissue development (Wang et al., 2017). It is therefore 
likely that DBHS proteins play complementary roles in different organs to regulate different 
aspects of metabolism. In this respect, NONO itself has been shown to: 1) regulate 
phosphodiesterase mRNA splicing and degradation in human adrenocortical cells to affect 
glucocorticoids production (Lu and Sewer, 2015), 2) positively regulate lipogenesis in breast 
cancer cells through SREBP1 (Zhu et al., 2015), and 3) act as an mTOR cofactor (Amelio et 
al., 2007). We predict that each member of the DBHS family will have unique and common 
targets in each tissue, and mediate both unique and redundant functions. Here we 
demonstrate that NONO functions in the liver to maintain whole-organism glucose 
homeostasis. However, we cannot exclude the possibility that NONO plays important roles 
in other organs (e.g. the pancreas and muscle) to regulate responses to nutritional stimuli.  
Our data provide evidence that the RNA-binding protein NONO is important for 
coordinating hepatic gene expression with the feeding/fasting cycle, and for maintaining 
whole-organism metabolic homeostasis. Disruption of the temporal coordination between 
metabolic demand and gene expression leads to the development of metabolic diseases, 
like obesity and diabetes. The role of RNA-binding proteins in regulating gene expression 
under diverse environmental conditions is only now beginning to be elucidated. Our findings 
help to better understand how metabolic homeostasis is maintained in mammals, and 
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identify novel therapeutic targets for treating diabetes and other associated metabolic 
dysfunctions.  
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Materials and Methods 
Key resources table 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Normal rabbit IgG Santa Cruz Sc-2027 
Rabbit anti-GCK Santa Cruz Sc-7908 
Rabbit anti-TBP Santa Cruz Sc-273 
Rabbit anti-GLUT2 ThermoFisher 720238 
Rabbit anti-NONO Steven A. Brown Laboratory N/A 
Alexa Fluor 680 conjugate anti-rabbit IgG ThermoFisher A-10043 
Alexa Fluor 488 conjugate anti-rabbit IgG ThermoFisher A-11008 
Bacterial and Virus Strains 
AAV2/8.TBG.NONO This study N/A 
AAV2/8.TBG.NONOmut This study N/A 
Chemicals, Peptides, and Recombinant Proteins 
Insulin Novo Nordisk NDC 0169-3473-18 
D-Glucose Sigma G8270 
Protein A agarose beads Roche 11134515001 
Vanadyl Ribonucleoside Complex (VRC) NEB S1402S 
RNAse OUT Invitrogen 10777019 
Octyl -D-glucopyranoside (NOG) Sigma O8001 
Spermine Sigma S3256 
Spermidine Sigma S2626 
Trizol Invitrogen 15596018 
Bolt LDS Sample Buffer Invitrogen B0008 
Bolt Sample Reducing Agent Invitrogen B0009 
Bolt 4-12% Bis-Tris Plus Gels Invitrogen NW04125BOX 
1x Phosphate Buffered Saline (PBS) with 1% Casein BioRad 1610783 
MluI NEB R0198S 
SalI-HF NEB R3138S 
T4 ligase NEB M0202S 
Critical Commercial Assays 
Pierce BCA assay ThermoFisher 23225 
Triglyceride Quantification Kit Abcam ab65336 
Ultra Sensitive Mouse Insulin ELISA kit CrystalChem 90080 
Glucose (HK) Assay Kit Sigma GAHK20-1KT 
qScript cDNA SuperMix Quantabio 95048 
FastStart Universal SYBR Green Master Mix Roche 04913914001  
Ribo-Zero Magnetic Gold Kit Illumina MRZG12324 
Deposited Data 
RIP-seq and liver nuclear and total transcriptome This study GEO: GSE98042 
Experimental Models: Organisms/Strains 
C57BL/6-nonogt (Kowalska et al., 2012) N/A 
Oligonucleotides 
Primers for RT-PCR 
mGck_Intron GGGAAGCTACTTGAGAGAGCA (Fwd) This study; synthesized by N/A 
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ACTCTGCATGGCCTCAAACT (Rev) Integrated DNA Technologies 
mGck_Spliced TCTGACTTCCTGGACAAGCA (Fwd) This study; synthesized by 
Integrated DNA Technologies 
N/A 
CCACGATGTTGTTCCCTTCT (Rev) 
mGlut2_Intron CCCCAATTCCAACAGAAGAA (Fwd) This study; synthesized by 
Integrated DNA Technologies 
N/A 
TGGCCAACATGAAAACTCAA (Rev) 
mGlut2_Spliced GCCTGTGTATGCAACCATTG (Fwd) This study; synthesized by 
Integrated DNA Technologies 
N/A 
CGTAACTCATCCAGGCGAAT (Rev) 
mActin GGCTGTATTCCCCTCCATCG (Fwd) This study; synthesized by 
Integrated DNA Technologies 
N/A 
CCAGTTGGTAACAATGCCATGT (Rev) 
m18S rRNA TCAAGAACGAAAGTCGGAGG (Fwd) This study; synthesized by 
Integrated DNA Technologies 
N/A 
GGACATCTAAGGGCATCAC (Rev) 
Primers for genotyping 
mNono wt TTAGGGGGCCGAACTACTTGAATTG This study; synthesized by 
Integrated DNA Technologies 
N/A 
GGGCCGGGCAGATTTACTAGTTTTT 
b-GEO cassette CAAATGGCGATTACCGTTGA This study; synthesized by 
Integrated DNA Technologies 
N/A 
TGCCCAGTCATAGCCGAATA 
Recombinant DNA 
pUC57.NONO This study; synthesized by GenScript N/A 
pUC57.NONOmut This study; synthesized by GenScript N/A 
pENN.AAV.TBG.PI (Hogan et al., 2015) N/A 
Software and Algorithms 
ImageJ NIH https://imagej.nih.gov/ij/ 
ZEN Imaging 
Software 
Carl Zeiss https://www.zeiss.com/microscopy/int/products/microscope9software/zen.html 
Imaris Image 
Analysis Software 
Bitplane http://www.bitplane.com 
Prism GraphPad https://www.graphpad.com/scientific9software/prism/#1 
Matlab MathWorks https://www.mathworks.com/products/matlab.html 
R R Foundation for Statistical 
Computing 
https://www.r9project.org 
FastQC Babraham Bioinformatics http://www.bioinformatics.babraham.ac.uk/projects/fastqc 
STAR aligner (Dobin et al., 2013) http://code.google.com/p/rna9star/ 
HOMER (Heinz et al., 2010) http://homer.ucsd.edu/homer/ 
GO-Elite (Zambon et al., 2012) http://www.genmapp.org/go_elite/ 
Image Studio LI-COR https://www.licor.com/bio/products/software/image_studio/ 
Other 
Normal Chow Diet LabDiet 5001 
High Fat Diet LabDiet 58Y1 
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Mouse models 
All animal experiments were carried out in accordance with the guidelines of the 
IACUC of the Salk Institute, and the approval of the Zürich Cantonal Veterinary 
Authority. All mice were maintained in a pathogen-free environment and housed in 
clear shoebox cages in groups of five animals per cage with constant temperature 
and humidity and 12h:12h light-dark cycle.  All animals had access to water at all 
times. Unless otherwise indicated, mice were fed ad libitum with a normal chow diet 
(LabDiet-5010). For the fasting/feeding experiments mice were fasted for 12h during 
the light phase (ZT0-ZT12) and fed for 12h during the dark phase (ZT12-ZT24). For 
the HFD experiments mice were fed ad libitum with a diet containing 60% fat (58Y1). 
Nonogt mice were obtained as described previously (Kowalska et al., 2012). Briefly, 
chimeric mice were obtained from Nono gene-trapped embryonic stem (ES) cells 
(C57BL/6J genotype) via standard blastocyst injection of the ES cell clone YHA266 
into SV129 mice by the University of California, Davis. Individual chimeric mice were 
backcrossed for 10 generations against the C57BL/6J background. All experiments 
were performed by comparing wild type and mutant male littermates. 
Liver immunostaining 
The livers were perfused with 2 ml of ice-cold PBS through the spleen and 
immediately collected. Pieces of the main liver lobes were embedded in optimal 
cutting temperature (O.C.T.) compound (Tissue-Plus, Scigen, 4583) and frozen at -
80C. For cryosectioning the embedded liver was equilibrated at -20C in a 
cryostat chamber and 10m thick sections were cut. Liver slices were collected on 
25x75x1.0mm microscope slides (Superfrost Plus, Fisherbrand) and stored at -80
C. For immunostaining frozen sections were thawed in a sealed environment to 
avoid damage by frozen water crystals. Liver sections were fixed at room 
temperature for 10 minutes in 4% PFA diluted in PBS. Sections were then washed 3 
times in TBS-T (50mM Tris, 150mM NaCl, 0.05% Tween-20). The tissue sections 
were permeabilized in 1% Triton-X 100 diluted in TBS (50mM Tris, 150mM NaCl) for 
30 minutes at room temperature. The sections were then incubated in blocking buffer 
(1% BSA, 0.5% Triton-X 100 in TBS) for 30 minutes. After the blocking step, liver 
sections were incubated for 1h with rabbit anti-NONO antibody (Kowalska et al., 
2012) diluted 1:500 in blocking buffer. After 3 washes in TBS-T, the sections were 
incubated with the secondary antibody Alexa Fluor 488 conjugate anti-rabbit IgG 
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(Thermo Fisher) diluted 1:1000 in blocking buffer for 30 minutes. Sections were 
washed three times with TBS-T. At the first wash DAPI was added to the washing 
buffer at a concentration of 0.5g/ml. Sections were then mounted and imaged. 
Images were acquired with a 63x/1.4 NA Apochromat oil objective on an LSM 880 
using the Airyscan detector (Carl Zeiss Microscopy). The images were acquired in 
SR mode	, which configures the 32 GaAsP detectors on the Airyscan detector as 
equivalent to 0.2 Airy Units. The 32-channel data was then processed using Zen 
software (Carl Zeiss Microscopy) (Huff, 2015). All images were acquired with a 63X 
objective, using 1.8% laser, 750 gain, and 0.97s pixel dwell time, and they were all 
processed with an "Airyscan parameter” (Wiener filter strength) of 4.1. 
Speckle-like structures and fluorescence quantification 
For image analysis Imaris software (Bitplane) was used. For the speckle-like 
structures quantification we used the ‘spots’ option. We considered ‘speckle-like 
structures’ objects within the nuclei (identified by DAPI stained areas) with an 
estimated diameter of 0.3m, ‘quality’ above 900 and ‘intensity’ above 924. For 
fluorescence intensity quantification, average intensity within the nuclei was 
normalized to average intensity outside the nuclei (background). 
Immunoprecipitation from liver nuclear lysates 
Immunoprecipitation of NONO complexes was performed from mouse liver nuclear 
extracts. The livers were perfused with 2 ml of ice-cold PBS through the spleen and 
immediately collected. Liver nuclei were isolated from an entire mouse liver as 
previously described (Ripperger and Schibler, 2006). Briefly the dissected mouse 
liver was rapidly homogenized in 5ml of ice cold PBS and mixed to 25ml of 2.4M 
sucrose buffer (2.4M sucrose, 150mM glycine, 10mM Hepes pH7.6, 15mM KCl, 
2mM EDTA, 0.5mM spermidine, 0.15mM spermine, 1mM PMSF, 5mM  -
mercaptoethanol and protease inhibitors (pepstatin A, leupeptin, aprotinin, trypsin 
inhibitor)). The homogenate was layered on top of a 10ml cushion of 2M sucrose 
buffer (2M sucrose, 10% glycerol, 125mM glycine, 10mM Hepes pH7.6, 15mM KCl, 
2mM EDTA, 0.5mM spermidine, 0.15mM spermine, 1mM PMSF, 5mM  -
mercaptoethanol and protease inhibitors) and centrifuged for 45min at 24,000rpm at 
4C in a Beckmann SW28 rotor. Isolated liver nuclei were resuspended in 800l of 
Nuclei Dilution Buffer (100mM KCl, 0.2mM EDTA, 20% glycerol, 20mM Hepes 
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pH7.6, 1mM PMSF, 5mM  -mercaptoethanol and protease inhibitors) and 
centrifuged at 5000rpm for 30 seconds. The nuclei pellet was lysed in nuclei lysis 
buffer (25mM Tris:HCl pH7.4, 187.5mM NaCl, 2.5mM EDTA, 10% NOG and 
protease inhibitors) and incubated for 20 minutes on ice. Lysates were centrifuged at 
10000rpm for 10 minutes at 4C and the protein concentration in the supernatant 
was measured with Pierce BCA assay (Thermofisher) following manufacturers 
instructions. To immunoprecipitate NONO complexes, 600g of nuclear protein 
lysate were incubated with 10ul of protein A agarose beads cross-linked to 
polyclonal rabbit anti-NONO antibody (Kowalska et al., 2012) for 2h at 4°C. 
Immunoprecipitated NONO complexes were washed 3 times with IP washing buffer 
(75mM Tris:HCl pH7.4, 150mM NaCl, 1mM EDTA, 10% glycerol, 0.1% NOG and 
protease inhibitors) and eluted with 0.1M glycine pH 2.5. After elution the acidic 
glycine was neutralized with tris-base. 
Mass spectrometry analysis (as described in (Ma et al., 2016) 
Samples were precipitated by methanol/chloroform. Dried pellets were dissolved in 
8M urea/100mM TEAB, pH 8.5. Proteins were reduced with 5mM tris(2-
carboxyethyl)phosphine hydrochloride (TCEP, Sigma-Aldrich) and alkylated with 
50mM chloroacetamide (Sigma-Aldrich). Proteins were digested overnight at 37°C in 
2M urea/100mM TEAB, pH 8.5, with trypsin (Promega). Digestion was quenched 
with formic acid, 5% final concentration. The digested samples were analyzed on a 
Fusion Orbitrap tribrid mass spectrometer (Thermo). The digest was injected directly 
onto a 30cm, 75um ID column packed with BEH 1.7m C18 resin (Waters). 
Samples were separated at a flow rate of 200nl/min on a nLC 1000 (Thermo). Buffer 
A and B were 0.1% formic acid in water and acetonitrile, respectively. A gradient of 
1-25%B over 90min, an increase to 40%B over 30min, an increase to 90%B over 
another 10min and held at 90%B for a final 10min of washing was used for 140min 
total run time. Column was re-equilibrated with 20ul of buffer A prior to the injection 
of sample. Peptides were eluted directly from the tip of the column and nanosprayed 
directly into the mass spectrometer by application of 2.5kV voltage at the back of the 
column. The Orbitrap Fusion was operated in a data dependent mode.  Full MS1 
scans were collected in the Orbitrap at 120K resolution with a mass range of 400 to 
1600m/z and an AGC target of 5e5. The cycle time was set to 3 seconds, and within 
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this 3 seconds the most abundant ions per scan were selected for CID MS/MS in the 
ion trap with an AGC target of 1e4 and minimum intensity of 5000. Maximum fill times 
were set to 50ms and 100ms for MS and MS/MS scans respectively. Quadrupole 
isolation at 1.6m/z was used, monoisotopic precursor selection was enabled and 
dynamic exclusion was used with exclusion duration of 5 seconds. Protein and 
peptide identification were done with Integrated Proteomics Pipeline – IP2 
(Integrated Proteomics Applications). Tandem mass spectra were extracted from raw 
files using RawConverter (He et al., 2015) and searched with ProLuCID (Xu et al., 
2015) against mouse UniProt database. The search space included all fully-tryptic 
and half-tryptic peptide candidates. Carbamidomethylation on cysteine was 
considered as a static modification. Data was searched with 50ppm precursor ion 
tolerance and 600ppm fragment ion tolerance. Data was filtered to 10ppm precursor 
ion tolerance post search. Identified proteins were filtered using DTASelect (Tabb et 
al., 2002) and utilizing a target-decoy database search strategy to control the false 
discovery rate to 1% at the protein level. Interactors were sorted by average emPAI 
(Ishihama et al., 2005). The top 50 proteins (excluding contaminants and ribosomal 
proteins) were selected. 
Native RNA-immunoprecipitation (RIP) 
RIP was performed in native conditions as previously described (Keene et al., 2006; 
Zhao et al., 2008, 2010), using one mouse liver nuclear lysate per IP. The livers 
were perfused with 2 ml of ice-cold PBS through the spleen and immediately 
collected. Liver nuclei isolation from mouse liver has been previously described 
(Ripperger and Schibler, 2006); briefly the dissected mouse liver was rapidly 
homogenized in 5ml of ice cold PBS and mixed to 25ml of 2.4M sucrose buffer (2.4M 
sucrose, 150mM glycine, 10mM Hepes pH7.6, 15mM KCl, 2mM EDTA, 0.5mM 
spermidine, 0.15mM spermine, 1mM PMSF, 1mM DTT, 400M VRC and protease 
inhibitors (pepstatin A, leupeptin, aprotinin, trypsin inhibitor)). The homogenate was 
layered on top of a 10ml cushion of 2M sucrose buffer (2M sucrose, 10% glycerol, 
125mM glycine, 10mM Hepes pH7.6, 15mM KCl, 2mM EDTA, 0.5mM spermidine, 
0.15mM spermine, 1mM PMSF, 1mM DTT, 400M VRC and protease inhibitors) 
and centrifuged for 45min at 24,000rpm at 4°C in a Beckmann SW28 rotor. Isolated 
liver nuclei were resuspended in Nuclei Dilution Buffer (100mM KCl, 0.2mM EDTA, 
20% glycerol, 20mM Hepes pH7.6, 1mM PMSF, 1mM DTT, 400M VRC, 80U/ml 
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RNAse OUT and protease inhibitors). Liver nuclei were lysed in Polysome lysis 
buffer (100mM KCl, 5mM MgCl2, 10mM HEPES pH 7.0, 0.5% NP40, 1mM DTT, 
80U/ml RNAse OUT, 400uM VRC and protease inhibitors) and incubated 20 minutes 
on ice. Lysate was centrifuged and protein concentration in the supernatant was 
measured with Pierce BCA assay (Thermofisher). 0.5mg of protein were incubated 
with 40ul of protein A agarose beads pre-coated with 10µg of polyclonal rabbit anti-
NONO antibody (Kowalska et al., 2012) or normal rabbit IgG (sc-2027) for 2h at 4°C. 
Before the incubation, 1/10 of the supernatant was put aside to be used as input. 
After incubation samples were washed 4 times with NT2 buffer (50mM Tris-HCl pH 
7.4, 150 mM NaCl, 1mM MgCl2, 1% Triton-X 100). Immunoprecipitated RNA and 
input RNA were extracted using Trizol reagent (Invitrogen).  
RNA extraction 
For RNA extraction the livers were perfused with 2 ml of ice-cold PBS through the 
spleen and immediately collected. For total liver RNA extraction pieces from the 
main liver lobes were ground to a powder in liquid nitrogen. About 10mg of tissue 
were used for RNA extraction using Trizol reagent (Invitrogen). For nuclear RNA 
extraction liver nuclei were isolated as described above (see Native RNA-
immunoprecipitation section). The nuclei pellet was rapidly resuspended in Trizol 
reagent (invitrogen) and purified.  
High-throughput RNA sequencing (RNA-seq) 
Liver total, nuclear and RIP purified RNA were used for RNA-seq. RNA from two 
biological replicates per time point was pooled prior to library preparation. Libraries 
were prepared using Illumina’s TruSeq Stranded Total RNA Library Prep Kit with 
Ribo-Zero Gold according to manufacturer’s instructions. In brief, rRNA was depleted 
from total RNA (1g) by using subtractive hybridization.  The RNA was then 
fragmented by metal-ion hydrolysis and subsequently converted to cDNA using 
SuperScript II.  The cDNA was then end-repaired, adenylated and ligated with 
Illumina sequencing adapters.  Finally, the libraries were enriched by PCR 
amplification. All sequencing libraries were then quantified, pooled and sequenced at 
single-end 50 base-pair (bp) on Illumina HiSeq 2500 at the Salk NGS Core. Each 
library was sequenced on average 20 million reads. Raw sequencing data was 
demultiplexed and converted into FASTQ files using CASAVA (v1.8.2).  
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RNA-seq and RIP-seq data analysis 
Sequenced reads were quality-tested using FASTQC (available online at: 
http://www.bioinformatics.babraham.ac.uk/projects/fastqc) and aligned to the mm10 
mouse genome using the STAR aligner (Dobin et al., 2013) version 2.4.0k. Mapping 
was carried out using default parameters (up to 10 mismatches per read, and up to 9 
multi-mapping locations per read).  For transcriptome data analysis, nuclear RNA-
Seq and total RNA-Seq normalized gene expression (FPKM) was quantified across 
all gene exons and introns separately, using the top-expressed isoform as a proxy 
for gene expression.  For the RIP-seq analysis, reads uniquely mapping to the 
genome were used for peak calling with Homer (Heinz et al., 2010) assuming the 
size of 500, extending the peaks to cover the full enriched region, assuming a fold 
enrichment of at least 2 over input reads, a poisson p-value threshold relative to 
input count of 1e-4. The peaks that had less then 1.5 fold enrichment over IgG 
control and less the 200 tag count were filtered out. Homer was also used to 
generate normalized read count density tracks for visualization of peaks, motif 
enrichment analysis, and peak annotation. Motif enrichment analysis was carried out 
for the peak regions found in introns, searching for motif lengths of 8, 10, and 12, or 
using a set of all vertebrate motifs known to Homer and using default values for all 
other parameters. 
Statistical analysis of rhythmic gene expression 
All RNA-Seq samples exhibited a relatively similar expression profile, reflecting the 
low variation in sequencing depth between the samples (total RNA-seq samples 
17.4x106±4.1x106 uniquely mapped reads, nuclear RNA-seq samples 
19.7x106±4.4x106 uniquely mapped reads). We compared FPKM values from 
nuclear Introns and Exons as well as total Introns and Exons separately in both WT 
and nonogt animals based on a common list of 20770 genes. Only genes with an 
average FPKM value ≥0.3 over the 12 time points were considered as expressed. 
We then used meta2d, a function of the R package MetaCycle, to evaluate 
periodicity in the RNA seq data (Wu et al., 2016). Briefly, meta2D incorporates 
ARSER (Yang and Su, 2010), JTK_CYCLE (Hughes et al., 2010), and Lomb-Scargle 
(Glynn et al., 2006) and it implements N-version programming concepts to integrate 
their results (p and q values, period, phase and amplitude). Transcripts were 
considered to be rhythmically expressed when the integrated p value was <0.05. The 
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different analyses were run on homemade MATLAB (MathWorks) programs. 
Gene ontology and pathway over-representation analysis (ORA) (as described 
in Zambon et al., 2012) 
For gene ontology and pathway ORA analysis GO-Elite was used as previously 
described (Zambon et al., 2012). Each analyzed term was ranked according to a Z-
score. We used 2000 permutations, Z-score cut-off of 1.96, permuted p-value cut-off 
of 0.05. Ontology terms were sorted by Z-score. 
Gene Expression Analysis by RT-qPCR 
Total RNA was prepared from WT and nonogt livers as described above and 
quantified using Nanodrop 2000 spectrophotometer (ThermoFisher). 1g of RNA 
was reverse transcribed using qScript cDNA SuperMix (QuantaBio) in a final volume 
of 20l, according to manufacturers instructions. Reverse transcribed RNA was 
diluted 1:6 and 25ng of cDNA were used in qPCR reactions. qPCR reactions were 
prepared using the FastStart Universal SYBR Green Master Mix (Roche). The 
sequences of the primers used are listed in the key resources table. Reactions were 
run on a 7900HT Fast Real-Time PCR System (ThermoFisher) by the Functional 
Genomics Core Facility of the Salk Institute. Gene expression was normalized to 
18S RNA and quantified using the comparative CT method. 
Western Blotting 
For protein extraction, 10-20mg of frozen liver powder was homogenized in RIPA 
lysis buffer (10mM Tris-HCl pH8.0, 1mM EDTA, 1% Triton-X 100, 0.1% SDS, 
140mM NaCl and protease inhibitor cocktail). Samples were incubated with agitation 
for 30 minutes at 4C and clarified by centrifugation and at 13000rpm for 10 
minutes at 4C. The protein concentration in the supernatant was determined using 
the BCA assay (Pierce). Equal amounts of protein (40 g) were heat-denatured in 
Bolt LDS Sample Buffer (after addition of Bolt Sample Reducing Agent, 
ThermoFisher), resolved by SDS-PAGE using Bolt 4-12% Bis-Tris Plus Gels 
(ThermoFisher), and transferred to a nitrocellulose membrane using the iBlot Dry 
Blotting system (ThermoFisher). The membranes were blocked in 1XPBS 1% 
Casein Blocker (BioRad) diluted 1:10 for 1h at room temperature and then incubated 
with antibodies against NONO (rabbit polyclonal (Kowalska et al., 2012)), GCK 
(rabbit polyclonal, sc-7908), GLUT2 (rabbit polyclonal, ThermoFisher 720238) and 
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TBP (rabbit polyclonal, sc-273). Alexa Fluor 680 conjugate anti-Rabbit IgG 
(ThermoFisher, A-10043) was used as secondary antibody. Membrane-bound 
immune complexes were detected by Odyssey Imaging Systems (LI-COR 
Biosciences). Quantification was performed using Image Studio software (LI-COR 
Biosciences). Data were normalized to TBP protein expression. 
GTT and ITT 
For GTT and ITT mice were fasted for 12h during the light phase (ZT0-ZT12). 
Glucose (2g/kg for mice on normal chow, 1g/kg for mice on HFD) or insulin (0.5U/kg 
body weight) was injected intraperitoneally. Blood glucose level was measured using 
Nova Max plus glucose meter prior to injection and after 15, 30, 60, 90 and 120 
minutes after injection. 
Blood measurements 
For all blood measurements mice were fasted for 12h during the light phase (ZT0-
ZT12). Blood glucose content was measured through tail vein bleeding using the 
Nova Max plus glucose meter. Serum insulin levels were determined using Ultra 
Sensitive Mouse Insulin ELISA Kit (Crystal Chem), according to manufacturers 
instructions. Whole blood was withdrawn from the tail vein, and serum was 
separated by centrifugation. 5l of serum were used for quantification. Leptin and 
ghrelin levels were determined using Bio-Plex Pro Mouse Diabetes 8-Plex Assay 
(Bio-rad) following manufacturer’s instructions. Whole blood was withdrawn from the 
tail vein, and serum was separated by centrifugation and diluted 4-fold for 
quantification. 
Liver glycogen quantification 
Liver glycogen content was assayed as previously described (Passonneau and 
Lauderdale, 1974). Liver samples were ground in liquid nitrogen and 15-20mg of 
liver powder was placed in 0.5ml of 2M HCl and incubated at 100°C for 1h. After 
neutralization with an equal volume of 2M NaOH, the liberated glucose units were 
assayed enzymatically using the glucose (hk) assay kit (GAHK20, sigma). Glycogen 
content was expressed as micromoles of glucosyl units liberated per gram wet liver 
weight. 
Adeno-associated Viruses (AAV) Strains, Propagation and Injection 
Viruses were derived from pENN.AAV.TBG.PI; an adeno-associated virus, serotype 
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8 with a TBG promoter (Hogan et al., 2015). Briefly, 1-2µg of pENN.AAV.TBG.PI 
was digested with enzymes MluI and SalI (New England Biolabs). Meanwhile, the 
same amount of pUC57 constructs expressing either WT NONO (pUC57.NONO) or 
NONO with mutations F113A, F115A, K192A and I194A (pUC57.NONOmut) were 
also digested with MluI and SalI. The pUC57.NONO and pUC57.NONOmut 
constructs were produced by GenScript. The digested pENN.AAV.TBG.PI was 
ligated with the WT or mutant NONO inserts using T4 ligase (New England Biolabs) 
and transformed in One Shot TOP10 Chemically Competent E. coli (Invitrogen). The 
vectors were amplified using endotoxin-free maxi prep kit (Qiagen). The amplified 
vector sequences were verified by sequencing and checked for recombination prior 
to virus packaging. The resulting vectors (pENN.AAV.TBG.PI.NONO and 
pENN.AAV.TBG.PI.NONOmut) were packaged by the Salk Institute Gene Transfer 
Targeting and Therapeutics Core. The amplified viruses are referred to as 
AAV8.NONO and AAV8.NONOmut. Mice received a single tail vein injection of 1011 
genome copies of either one of the described viral vectors.  
Oil-Red-O staining 
Oil-red-o staining was performed as previously described (Mehlem et al., 2013). 
Briefly, mice were sacrificed and the liver was perfused with ice-cold 1XPBS to 
remove the excess of blood. Pieces from the main liver lobes were embedded in 
optimal cutting temperature (O.C.T.) compound (Tissue-Plus, Scigen, 4583) and 
frozen at -80°C. For cryosectioning the embedded liver was equilibrated at -20°C in 
a cryostat chamber and 14m thick sections were cut. Unfixed tissue slides were 
stained with ORO and images were taken with a Zeiss VivaTome microscope at a 
20X magnification. 10 images were taken per mouse and ImageJ was used for 
quantification of liver lipid content. 
Liver triglycerides quantification 
Livers were collected from ad libitum fed mice. The livers were perfused with 2 ml of 
ice-cold PBS through the spleen and immediately collected. For triglycerides 
quantification, Triglyceride Quantification kit (abcam) was used, following 
manufacturer’s instructions. Briefly 100mg of liver powder were homogenized in 5% 
NP-40 using a dounce homogenizer. The samples were then heated to 80-100°C for 
2-5 minutes and cooled down to room temperature. The heating step was repeated 
one more time and the samples were centrifuged at top speed for 2 minutes. 
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Supernatants were diluted 1:10 before proceeding with the assay.  
Body composition 
Magnetic resonance imaging scans for fat and lean mass were performed using an 
Echo MRI-100 instrument according to the manufacturer’s instructions. 
Indirect calorimetry 
Mice were individually housed for at least 3#days before calorimetry experiments. 
Food intake, locomotor activity, oxygen consumption and carbon dioxide production 
were simultaneously measured for individually housed mice with a LabMaster 
system (TSE Systems). Data were collected for 3-4 days and analyzed. 
Histology 
Mouse abdominal fat tissue was fixed in 10% formalin and paraffin embedded. 
Sections (6m) were used for haematoxylin and eosin staining. 
Metabolomics analysis 
Frozen liver powder aliquots were used for detection and relative quantification of 
metabolites by Metabolon as described (Evans et al., 2009). The dataset comprises 
a total of 588 compounds of known identity (named biochemical). An identical mass-
equivalent of each liver was extracted and run across the platform; no additional 
normalization was applied prior to statistical analysis. Following log transformation 
and imputation of missing values, if any, with the minimum observed value for each 
compound, ANOVA contrasts were used to identify biochemicals that differed 
significantly between experimental groups.  Only biochemicals with p≤0.05 were 
considered statistically significant. Analysis by two-way ANOVA identified 
biochemicals exhibiting significant interaction and main effects for experimental 
parameters of genotype and treatment.  
Quantification and statistical analysis 
Statistical parameters, including the exact value of n, descriptive statistics and 
statistical significance are reported in the method details, figures and the figure 
legends. All samples represent biological replicates. Unless otherwise specified in 
figure legends, all values shown in graphs are represented as mean±SEM. For 
statistical significance of the differences between the means of two groups, we used 
Student’s t test. Statistical significance of differences among multiple groups (≥3) 
was calculated by performing ANOVA multiple comparisons. Statistical tests were 
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performed using Graph Pad Prism 5. 
Data and software availability 
The data discussed in this study have been deposited in NCBI's Gene Expression 
Omnibus (Edgar et al., 2002) and are accessible through GEO Series accession 
number GSE98042 
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE98042). 
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In this work we report a novel role for the nuclear RNA-binding protein NONO in 
metabolic homeostasis. Specifically, NONO binds to pre-mRNAs encoding several 
key regulators of liver anabolic metabolism and enhances the processing of these 
pre-mRNAs, allowing for robust daily oscillation in mRNA levels. This facilitates 
subsequent translation of these anabolic regulators, which is necessary to store 
excess nutrients (as glycogen and triglycerides) during the postprandial period. Mice 
that lack NONO expression exhibit disruptions in this temporal regulation, such that 
animals shift from storing glucose as glycogen and fat to fat oxidation. This results in 
reduced glucose tolerance, reduced levels of glycogen and triglycerides in the liver, 
and reduced levels of body fat and body weight.  
The liver is the central tissue maintaining metabolic homeostasis as the 
animal shifts between fed and fasted states. Indeed, the liver has first access to most 
ingested nutrients by virtue of their absorption into the hepatic portal vein. As a result 
the liver is exposed to higher nutrient levels than are other peripheral tissues (Moore 
et al., 2012). Fasting induces hepatic glycogen depletion, and glucose and ketone 
body production. Feeding a carbohydrate containing meal stimulates hepatic glucose 
uptake and glycolysis, replenishes glycogen stores, and induces fatty acid synthesis, 
while inhibiting β-oxidation and ketogenesis (Geisler et al., 2016). Understanding the 
elasticity of hepatic metabolite flux and the central role of the liver in providing 
nutrients to peripheral tissues is essential to studies of metabolic perturbation. In 
opposition to the relatively slow metabolic adaptation to fasting, feeding of a meal 
results in rapid metabolic changes. These metabolic changes require rapid changes 
in gene expression. As gene lengths vary by many orders of magnitude, their 
transcription would require highly variable amount of time assuming constant 
transcription rate. It is thus likely that for genes that require fast activation, like in 
case of response to feeding, modulation of both transcription and processing rates 
might play a role in fine tuning gene expression. In this work, we showed that NONO 
act as a post-transcriptional regulator to synchronize expression of mature mRNA 
with the fasting/feeding cycle.  
NONO is one of the main components of nuclear paraspeckles and is 
essential for paraspeckle integrity (Sasaki et al., 2009). Paraspeckles are RNAse-
sensitive structures whose formation depends on transcription by RNA polymerase II 
(Fox et al., 2002, 2005). It has been recently shown that liver weight, protein and 
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RNA content oscillate in a circadian fashion with maximum amounts overlapping with 
the mouse active/feeding phase (Sinturel et al., 2017). This suggests that feeding 
triggers a general increase in RNA and protein synthesis. It is likely that a general 
increase in transcription requires a parallel increase in pre-mRNA processing; we 
can hypothesize that the increased number of NONO-containing speckles might be 
due to increased recruitment of NONO and NONO-interacting factors to actively 
transcribed pre-mRNAs. Alternatively, specific phosphorylation events could play a 
role, as suggested in the case of MNK kinases (Buxadé et al., 2008) or during mitosis 
(Proteau et al., 2005). However, we speculate that the feeding-induced speckle-like 
structures we describe here are spatially and functionally distinct from paraspeckles. 
Recent research suggests that several different classes of NONO-containing nuclear 
speckles may exist (Li et al., 2017). Although the function of paraspeckles is still 
unclear, they have been shown to retain mRNAs that have undergone A-to-I editing 
by dsRNA-dependent adenosine deaminases (ADARs). mRNAs subject to this type 
of regulation include those with inverted repeated Alu (IRAlu) elements within their 
3’UTR. Previous studies also showed that a NONO-containing complex specifically 
interacts with mRNAs having structured or edited 3’-UTRs to prevent their nuclear 
export (Chen and Carmichael, 2009; Chen et al., 2008; Zhang and Carmichael, 
2001). One example of RNA regulated in this way is the mouse nuclear transcript 
CTN-RNA, which is edited within its 3’UTR and localizes to paraspeckles. During 
stress, CTN-RNA is cleaved and released into the cytoplasm as mCat2 mRNA 
(Prasanth et al., 2005). In this work we found that NONO binds to introns and may 
instead function as a molecular scaffold to assemble the mRNA processing 
machinery on target RNAs and enhance pre-mRNA processing and mRNA stability. 
For example, levels of Gck mature mRNA peak toward the end of the night, yet 
NONO binds to Gck pre-mRNA at all time points tested (ZT10, ZT14 and ZT22). 
Thus, we hypothesize that NONO may prime its target pre-mRNAs for processing. In 
the absence of NONO, this recruitment is less efficient, leading to delays in the 
phase of oscillation or loss of rhythmicity. 
In agreement with what has been demonstrated for NonA, the Drosophila 
homolog of NONO (McMahon et al., 2016), we found that NONO bound primarily to 
introns. Only 5% of the average, 27-kilobase (kb) human gene encodes protein; the 
majority is intronic sequence (Venter et al., 2001). Thus, transcription represents a 
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significant commitment of both energy and time (Swinburne and Silver, 2008). The 
number and size of introns contribute to the high variability observed in gene lengths 
(Heyn et al., 2015). How long it takes to transcribe a eukaryotic gene will be 
significantly affected by the gene architecture, in particular by the presence and 
abundance of introns. At one end, highly expressed genes tend to have short introns 
(Castillo-Davis et al., 2002; Jeffares et al., 2008), while in the opposite extreme, such 
as for the 2400 kb human dystrophin gene that is 99% intronic, transcription can take 
more than 16 h due to the gene’s excessive length (Tennyson et al., 1995). Despite 
intron causing significant delay in transcription, the size of introns varies widely and 
there is a general trend for shorter introns in more basal species and longer ones in 
primates (Gelfman et al., 2012). The reason why evolution favored larger introns is a 
subject of debate. There is evidence that the presence of introns in genes enhances 
their transcription (Brinster et al., 1988; Furger et al., 2002). Possible mechanisms 
are that co-transcriptional processes feedback to the promoter or change the 
processivity of RNAPII (Heyn et al., 2015). Furthermore, the presence of long introns 
may serve as a timing mechanism for biological signals in feedback regulatory 
networks (Lewis, 2003; Oswald and Oates, 2011; Swinburne et al., 2008). Since 
transcription takes time, the expression of a gene will be significantly delayed if it 
contains long introns in comparison to shorter ones, this phenomenon is called intron 
delay (Swinburne and Silver, 2008). Delays might be important to generate 
oscillations in gene expression (Lewis, 2003). It was reported that intron length can 
indeed increase the period of oscillation (Swinburne et al., 2008). We can 
hypothesize that in the circadian clock system introns may play a role in modulating 
the period and phase of oscillation of the genes. NONO might be one of the factors 
involved in this modulation. Indeed absence on NONO leads to either loss of 
rhythmicity or significant phase delay in its target genes.  
In particular, our data show that NONO preferentially bound promoter-
proximal introns. It was postulated that introns have different functions according to 
their relative position on the DNA and mRNA. In particular, promoter-proximal introns 
are more likely to contain signal sequences responsible for intron-mediated 
enhancement (IME) (Rose et al., 2008), a mechanism by which introns positively 
affect gene expression. In this model: 1) the intron increases mRNA accumulation; 2) 
large portions of the intron can be deleted without eliminating its effect on 
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expression; and 3) the intron only increases mRNA levels when downstream of, and 
close to, the start of transcription. It is possible that the unusual characteristics of 
IME and the very large effect that some introns have on mRNA production reflect a 
major unrecognized method of gene regulation. IME has been described in diverse 
organisms, suggesting that it is a fundamental feature of gene expression (Gallegos 
and Rose, 2015). The mechanism of IME is largely unknown, but one possibility is 
that introns may increase gene expression by recruiting components of the splicing 
and mRNA export machineries. Indeed, studies over the past few years have 
revealed that virtually all of the steps in the gene expression pathway are extensively 
coupled to one another (Bentley, 1999; Hirose and Manley, 2000; Proudfoot et al., 
2002). Consistent with this emerging concept, pre-mRNA splicing is thought to be 
coupled to transcription, mRNA export, and other steps in gene expression (Reed 
and Hurt, 2002). Assembly of specific factors in a specific order on the nascent 
mRNA might thus affect transcription as well as several other downstream steps 
regulating gene expression. 
NONO and its paralogues, SFPQ and PSPC1, often function as heterodimers, 
and have been described as multifunctional proteins whose specific role in cellular 
processes may depend on the molecular and cellular context (Knott et al., 2016). 
Further studies will be required to assess whether the PSPC1 and SFPQ play a 
similar role or cooperate with NONO to regulate metabolic homeostasis. Recent 
studies have shown that PSPC1 plays a role in adipose tissue development (Wang 
et al., 2017). It is therefore likely that DBHS proteins play complementary roles in 
different organs to regulate different aspects of metabolism. In this respect, NONO 
itself has been shown to: 1) regulate phosphodiesterase mRNA splicing and 
degradation in human adrenocortical cells to affect glucocorticoids production (Lu 
and Sewer, 2015), 2) positively regulate lipogenesis in breast cancer cells through 
SREBP1 (Zhu et al., 2015), and 3) act as an mTOR cofactor (Amelio et al., 2007). 
We predict that each member of the DBHS family will have unique and common 
targets in each tissue, and mediate both unique and redundant functions.  
DBHS proteins are emerging to be clinically relevant also in the context of 
development, immunity and cancer. DBHS proteins belong to the group human 
genes with the lowest tolerance for mutations. This suggests their strong 
involvement in disease phenotypes in humans (Knott et al., 2016). Mutations in 
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NONO have been identified in patients with intellectual disability, and neither PSPC1 
nor SFPQ can compensate for these defects. Consistent with this, NONO-deficient 
mice exhibit a similar neurological defect (Mircsof et al., 2015). NONO and SFPQ 
directly interact with the c-Jun N-terminal Kinase (JNK1) in an RNA-dependent 
manner and they are necessary for neuronal growth (Sury et al., 2015). Similarly, in 
neuronal cells, NONO and SFPQ directly interact with Protein degylcase-1 (DJ-1) 
and display a neuroprotective role (Xu et al., 2005). In photoreceptor development, 
NONO acts as an enhancer and post-transcriptional splicing regulator for rod-
specific genes such as rhodopsin (Yadav et al., 2014). As many gene regulators 
DBHS protein can act either as tumor suppressors or as oncogenes depending on 
the contexts. Breast cancers with loss of NONO were associated with increased 
tumor size, likely due to increased proliferation (Traish et al., 1997). This is in line 
with NONO acting as a regulator of the cell cycle (Kowalska et al., 2013). In contrast, 
increased NONO abundance has been associated with enhanced melanoma 
progression (Schiffner et al., 2011), and malignant progression of breast tumors 
(Pavao et al., 2001). It is likely that the association of NONO with active transcription 
alters gene expression in these examples. NONO can facilitate interaction with the 
long noncoding RNA lncUSMycN and the N-Myc mRNA and leads to post-
transcriptional up-regulation of the oncoprotein N-Myc (Liu et al., 2014). 
Given the widespread role of DBHS proteins in both transcriptional and post-
transcriptional regulation in many cell types, it is possible that additional clinical roles 
may be hidden by the functional redundancy of the three DBHS proteins. Here we 
demonstrated that NONO functions specifically in the liver to maintain whole-
organism glucose homeostasis. We found that NONO-deficient mice have impaired 
glucose tolerance but similar insulin sensitivity compared to wt mice. The cause of 
the reduced glucose tolerance in NONO-deficient mice could thus be either a 
reduced glucose uptake from the liver and other tissues, or a reduced insulin 
secretion from the pancreas. After a carbohydrate meal, ~33% of the glucose is 
taken up by the liver, another ~33% is taken up by muscle and adipose tissue, and 
the remaining glucose is taken up by the brain, kidney and RBCs (Moore et al., 
2012). By re-expressing NONO specifically in the liver we were able to rescue, at 
least in part, the glucose intolerance in NONO-deficient mice. This demonstrated that 
NONO expression in the liver is important for efficient glucose uptake. However, we 
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cannot exclude that insulin secretion in response to glucose might be impaired. We 
predict that NONO might play a similar function in other organs involved in the 
regulation of glucose homeostasis (like the adipose tissue and the muscle). It will be 
interesting in the future, using tissue specific NONO-deficient mouse models, to 
assess tissue specific functions of NONO both in regulating response to nutritional 
stimuli and circadian gene expression.  
In this work we characterized NONO protein interactors in the mouse liver at 
different times of the day. We did not find significant differences between time points, 
but future investigations should adopt a more quantitative approach, like SILAC 
proteomics, in order to accurately determine whether time-dependent differences in 
the pool of NONO interactors exist. Our data suggest that there are at least two main 
classes of NONO interactors: (1) RNA-binding proteins involved RNA metabolism, 
and (2) components of chromatin modifying complexes. Previous studies have 
shown that NONO and related factors function as transcriptional cofactors, binding to 
histone modifiers to regulate chromatin structure and circadian function (Brown et al., 
2005; Duong et al., 2011). Gel filtration analyses suggest that only a subset of 
NONO-containing speckle-like structures are circadian in nature (Brown et al., 2005). 
It is thus tempting to speculate that NONO might be part of at least two distinct 
macromolecular complexes with roles in either RNA-processing or transcription. In 
the future it will be interesting to investigate whether one or the other function is 
predominant at certain times of the day. NONO and SFPQ were also found to 
interact with RNAPII CTD. Both hypo- and hyperphosphorylated CTD matrices 
bound these proteins with similar selectivity. NONO and SFPQ can interact with the 
CTD and RNA simultaneously, therefore they may provide a direct physical link 
between the RNAPII CTD and pre-mRNA processing components, at both the 
initiation and elongation phases of transcription (Emili et al., 2002). More recently, 
NONO and SFPQ were identified as a components of chromatin-associated mRNP 
particles integrating transcript elongation with the regulation of splicing (Close et al., 
2012). Similarly, NONO and SFPQ were identified as component of RALY-containing 
ribonucleoprotein particles, known to be involved in several aspects of RNA 
metabolism (Tenzer et al., 2013). Several interactors identified in these studies were 
also present in our dataset. To summarize, current evidences suggest that NONO 
might be acting at the interface of transcription and other downstream mRNA 
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processing events in macromolecular complexes whose composition and specific 
function may be context-dependent. 
Several studies have shown that DBHS proteins may play an important role to 
adapt to different cellular stress conditions. Evidence suggests that NONO:SFPQ 
dimers have function in DNA repair. Purified NONO:SFPQ dimers stimulate DNA 
end joining by ten-fold or more in a reconstituted in vitro assay system (Bladen et al., 
2005; Udayakumar and Dynan, 2015; Udayakumar et al., 2003). Deficiency in 
NONO and SFPQ in cultured cell models is associated with radiosensitivity and 
delayed double strand break repair (Ha et al., 2011; Krietsch et al., 2012; Li et al., 
2009, 2014). Various lines of evidence also link NONO and SFPQ to homologous 
recombination repair, nucleotide excision repair, interstrand cross-link repair, and 
DNA damage-dependent cell cycle checkpoint control (Alfano et al., 2016; Jaafar et 
al., 2017; Kowalska et al., 2013; Morozumi et al., 2009). Furthermore, DBHS 
proteins have been implicated in the immune response to viruses and can bind viral 
RNAs, bind to host ncRNAs, or interact with other proteins to regulate the 
transcription of immune related genes upon immune stimuli (Cao et al., 2015; 
Emmott et al., 2010; Greco-Stewart et al., 2006; Imamura et al., 2014; Kula et al., 
2013; Landeras-Bueno et al., 2011; Lee et al., 2016; St Gelais et al., 2015). Feeding 
can be regarded as a stress stimulus for the cell. Nutrients have to be kept within a 
narrow concentration range in the blood to avoid tissue damage. Furthermore, 
nutrient metabolism generates oxidative stress. Indeed fasting and caloric restriction 
have been associated with several health benefits (Froy and Miskin, 2010; Kopeina 
et al., 2017; Mattson et al., 2017). As mentioned above, the liver has first access to 
most ingested nutrients by virtue of their absorption into the hepatic portal vein and is 
exposed to higher nutrient levels than are other peripheral tissues. Our data provide 
evidence that the RNA-binding protein NONO is important for coordinating hepatic 
gene expression with the feeding/fasting cycle, and for efficient nutrient uptake and 
metabolism. Indeed, absence of NONO affects whole-organism metabolic 
homeostasis and leads to impaired glucose tolerance and reduced body weight due 
to increased utilization of fat deposits as energy source. Disruption of the temporal 
coordination between metabolic demand and gene expression leads to the 
development of metabolic diseases, like obesity and diabetes. The role of RNA-
binding proteins in regulating gene expression under diverse environmental 
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conditions is only now beginning to be elucidated. Our findings help to better 
understand how metabolic homeostasis is maintained in mammals, and identify 
novel therapeutic targets for treating diabetes and other associated metabolic 
dysfunctions. 
5. ACKNOWLEDGEMENTS !
First of all I would like to thank my thesis supervisor prof. Steven A. Brown for giving 
me the opportunity to perform my PhD project in his lab. In particular I would like to 
thank him for being always eager to discuss about science and ideas and for being 
so supportive. Whenever there is a problem he always has a good answer and a 
good solution. He is for me an example of fairness and good leadership.  
I also would like to thank my thesis supervisor at the Salk Institute, prof. 
Satchidananda Panda for accepting me in his lab, for encouraging me to try new 
things and follow my ideas and for granting me freedom and independence in the 
lab.   
I am very grateful also to my committee members prof. Michael Arand and prof. 
Christian Wolfrum for their help and guidance over the years. 
Many thanks also to all my lab colleagues at the University of Zurich and at the Salk 
Institute for their support and useful scientific and non-scientific discussions. I have 
been so lucky to have the opportunity to interact with two different labs in two 
different continents and get in touch with so diverse cultures, scientific projects 
personalities and points of view. 
Many many thanks to all the staff of the core facilities at the University of Zurich and 
at the Salk Institute, their help and expertise has been instrumental for the progress 
of my project. 
I would also like to thank all my friends in Zurich and in San Diego; Arianna Mei, 
Gabriele Sulli, Maryna Mosalenko, Paola Orsolini, Stefano Malvezzi, Andrea Arcifa, 
Michela Puddu, Giuseppe De Gregorio, Sergio Leone and many many others. In 
particular I would like to thank Paola that is always there whenever I need anything! 
Many thanks also to Gabriele that has been a great colleague as well as a great 
friend!  
I want to express all my gratitude especially to my life partner and colleague Ludovic, 
for his invaluable help, advice and support over the years.  
Last but not least I would like to thank all my family. Thanks to my sisters for all their 
support and help. Many thanks also to my wonderful parents, I can never thank them 
enough for being so supportive and loving. 
!! 102 
 
 
6. LIST OF ABBREVIATIONS !
 
AANAT Arylalkylamine N-acetyltransferase 
AAV Adeno-Associated Virus 
ACLY ATP-Citrate Lyase 
ADAR Adenosine Deaminase, RNA specific 
AMP Adenosine Monophosphate 
AMPK AMP Kinase 
ANOVA Analysis Of Variance 
ATP Adenosine Triphosphate 
BCA Bicinchoninic Acid 
BMAL1 Brain and Muscle ARNT-Like Protein 1 
BSA Bovine Serum Albumin 
cAMP Cyclic Adenosine Monophosphate 
CCG Clock Controlled Gene 
cDNA Complementary Deoxyribonucleic Acid 
ChIP-Seq Chromatin Immuno-Precipitation followed by Sequencing 
CIRBP Cold Inducible RNA Binding Protein 
CLOCK  Circadian Locomoter Output Cycles Kaput Protein 
CoA Coenzyme A 
CPEB2 Cytoplasmic Polyadenylation Element Binding Protein 2 
CPEB4 Cytoplasmic Polyadenylation Element Binding Protein 4 
CPT1A Carnitine Palmitoyltransferase 1A 
CRY1 Cryptochrome 1 
CRY2 Cryptochrome 2 
CT Circadian Time 
CTD Carboxy-Terminal Domain 
DAPI 4',6-diamidino-2-phenylindole 
DBHS Drosophila Behavior Human Splicing 
DBP D-box Binding PAR BZIP Transcription Factor 
2D-DIGE Two Dimensional Difference Gel Electrophoresis 
DDX5 Dead-box polypeptide 5 
DHX9 DEAH-box protein 9 
DNA Deoxyribonucleic Acid 
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dsRNA Double Strand RNA 
DTT Dithiothreitol 
4E-BP 4E Binding Protein 
EDTA Ethylenediaminetetraacetic acid 
E2F1 E2F Transcription Factor 1 
E2F2 E2F Transcription Factor 2 
EIF4A Eukaryotic Translation Initiation Factor 4A 
EIF4B Eukaryotic Translation Initiation Factor 4B 
EIF4E Eukaryotic Translation Initiation Factor 4E 
EIF4F Eukaryotic Translation Initiation Factor 4F 
EIF4G Eukaryotic Translation Initiation Factor 4G 
EIF4H Eukaryotic Translation Initiation Factor 4H 
ELISA Enzyme-Linked Immunosorbent Assay 
eRNA Enhancer RNA 
FAA Food Anticipatory Activity 
FFA Free Fatty Acid 
FAD Flavin Adenine Dinucleotide 
FBXL3 F-Box And Leucine Rich Repeat Protein 3 
FPKM Fragments Per Kilobase per Million mapped reads 
GCK Glucokinase 
GEO Gene Expression Omnibus 
GLUT2 Glucose Transporter 2 
GPAM Glycerol-3-Phosphate Acyltransferase, Mitochondrial 
GRO-Seq Global-Run-On sequencing 
GSK-3 Glycogen Synthase Kinase 3 
GTT Glucose Tolerance Test 
GYS2 Glycogen Synthase 2 
HCl Hydrogen Chloride 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HFD High Fat Diet 
HGP Hepatic Glucose Production 
H3K9ac Histone 3-Lysine 9 acetylation 
H3K27ac Histone 3-Lysine 27 acetylation 
H3K4me1 Histone 3-Lysine 4 monomethylation 
H3K4me3 Histone 3-Lysine 4 trimethylation 
H3K36me3 Histone 3-Lysine 36 trimethylation 
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H3K79me2 Histone 3-Lysine 79 dimethylation 
HMGCS2 Hydroxy-Methylglutaryl-CoA Synthase 2 
hnRNP Heterogeneous Nuclear Ribonucleoprotein  
hnRNPI Heterogeneous Nuclear Ribonucleoprotein I 
hnRNPD Heterogeneous Nuclear Ribonucleoprotein D 
hnRNPQ Heterogeneous Nuclear Ribonucleoprotein Q 
IgG Immunoglobulin G 
ILF3 Interleukin Enhancer Binding Factor 3 
IME Intron-Mediated Enhancement 
IP Immunoprecipitation 
IP-MS Immunoprecipitation followed by Mass Spectrometry 
IRAlu Inverted Repeated Alu 
IRES Internal Ribosome Entry Site 
ITT Insulin Tolerance Test 
KEGG Kyoto Encyclopedia of Genes and Genomes 
KCl Potassium Chloride 
LDS Lithium Dodecyl Sulfate 
mCAT2 Mouse Cationic Amino acid Transporter 2 
MgCl2 Magnesium Chloride 
MODY2 Maturity Onset Diabetes of the Young 2 
mRNA Messenger Ribonucleic Acid 
mRNP Messenger Ribonucleoprotein  
mTOR Mechanistic Target Of Rapamycin 
NaCl Sodium Chloride 
NAD+/NADH Nicotinamide Adenine Dinucleotide 
NAMPT Nicotinamide Phosphoribosyltransferase 
NaOH Sodium Hydroxide 
NEAT1 Nuclear Enriched Abundant Transcript 1 
NOC Nocturnin 
NOG n-Octylglucoside 
NonA no on or off transient A 
NONO Non-POU Domain Containing Octamer Binding 
NOPS NonA/paraspeckle 
OCT Optimal Cutting Temperature 
ORA Over-Representation Analysis 
ORO Oil-Red-O 
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PAR Polyadenylate Rhythmic 
PARN Polyadenylate Specific Ribonuclease 
PBS Phosphate Buffered Saline 
PEP Phosphoenol pyruvate 
PER1 Period 1 
PER2 Period 2 
PER3 Period 3 
PFA Paraformaldehyde 
3-PG 3-Phosphoglycerate 
PHAX Phosphorylated Adaptor For RNA Export 
PKA Protein Kinase A 
PMSF Phenylmethylsulfonyl Fluoride 
p54nrb 54 KDa Nuclear RNA- And DNA-Binding Protein 
Poly(A) Polyadenylate 
pre-mRNA Premature Messenger Ribonucleic Acid 
PSF PTB associated Splicing Factor 
PSP1 Paraspeckle Protein 1 
PSPC1 Paraspeckle Protein Component 1 
PTB Polypyrimidine Tract Binding Protein 
qPCR Quantitative Polymerase Chain Reaction 
RIP RNA Immunoprecipitation 
RIPA Radioimmunoprecipitation Assay 
RIP-Seq RNA Immunoprecipitation followed by Sequencing 
RBC Red Blood Cell 
RBM4 RNA Binding Motif Protein 4 
RBP RNA Binding Protein 
RER Respiratory Exchange Ratio 
RNA Ribonucleic Acid 
RNAPII RNA polymerase II 
RNA-Seq RNA Sequencing 
ROR RAR Related Orphan Receptor 
RP Ribosomal Protein 
RPF-Seq Ribosome Profiling coupled with RNA Sequencing 
RRM RNA Recognition Motif 
rRNA Ribosomal RNA 
RT-PCR Reverse Transcription Polymerase Chain Reaction 
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SCN Suprachiasmatic Nucleus 
SDS Sodium Dodecyl Sulfate 
SDS-PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
Ser5 Serine 5 
SETX Senataxin 
SFPQ Splicing Factor Proline and Glutamine rich 
SIRT Sirtuin 
SILAC Stable Isotope Labeling with Amino acids in Cell culture 
siRNA Small Interfering RNA 
snRNA Small Nuclear Ribonucleic Acid 
SREBP1 Sterol Regulatory Element Binding Protein 1 
TBG Thyroxine Binding Globulin 
TBP TATA Binding Protein 
TBS Tris-Buffered Saline 
TCA Tricarboxylic Acid 
TIM Timeless 
TNF Tumor Necrosis Factor Alpha 
TPA Tetradecanoylphorbol Acetate 
Tris Tris(hydroxymethyl)aminomethane 
Tris-HCl Tris(hydroxymethyl)aminomethane Hydrochloride 
TSS Transcription Start Site 
U2AF26 U2-auxiliary-factor 26 
U2AF26∆E67 U2-auxiliary-factor 26 exon 6/7 deleted 
UTR Untranslated Region 
VRC Vanadyl Ribonucleoside Complex 
WT Wild-Type 
XRN2 5'-3' Exoribonuclease 2 
ZT Zeitgeber Time 
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 Abstract  The circadian oscillator is based on transcription-translation feedback 
loops that generate 24 h oscillations in gene expression. Although circadian regula-
tion of mRNA expression at the transcriptional level is one of the most important 
steps for the generation of circadian rhythms within the cell, multiple lines of evi-
dence point to a disconnect between transcript oscillation and protein oscillation. 
This can be explained by regulatory RNA-binding proteins acting on the nascent 
transcripts to modulate their processing, export, translation and degradation rates. 
In this chapter we will review what is known about the different steps involved in 
circadian gene expression from transcription initiation to mRNA stability and 
 translation effi ciency. The role of ribonucleoprotein particles in the generation of 
rhythmic gene expression is only starting to be elucidated, but it is likely that they 
cooperate with the basal transcriptional machinery to help to maintain the precision 
of the clock under diverse cellular and environmental conditions. 
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1  Introduction 
 To adapt to predictable daily changes in the environment, organisms developed 
mechanisms to anticipate these changes and respond appropriately. Central to this 
coordination is an intrinsic  oscillator that generates  circadian rhythms of behavior, 
physiology and metabolism. Anatomically, in mammals, the hypothalamic 
Suprachiasmatic Nucleus (SCN) consisting of ~20,000 neurons functions is the 
master circadian oscillator. However, the molecular mechanism of the circadian 
clock is cell autonomous and is present in almost every cell of our body. The SCN 
oscillator uses synaptic and diffusible factors to orchestrate rhythms in peripheral 
tissues in appropriate phases. 
 The molecular  circadian oscillator is based on transcription-translation feedback 
loops with time-delays that generate 24-h oscillations in many of its constituents. 
Circadian rhythms in animals are endogenous self-sustaining ~24 h rhythms gener-
ated by the basic mechanism of cell autonomous transcriptional feedback loops 
conserved from fl ies to human. Both components and mechanisms of circadian 
rhythms are largely conserved in animals [ 1 ]. The transcriptional activators CLOCK 
and BMAL1 dimerize and activate the transcription of Period (per) and Cryptochrome 
(cry). The PER/CRY heterodimer, in turn, represses the transcriptional activities of 
CLOCK/BMAL1 [ 2 ]. In an interconnected loop, nuclear hormone receptors REV-
ERB and ROR act as repressors and activators to drive rhythmic transcription of 
several clock components [ 3 ,  4 ]. 
 The molecular  circadian clock drives rhythmic transcription from a large number 
of genes by (a) directly binding to the respective  cis -regulatory sites, (b) indirectly by 
their immediate targets that are also transcription factors, (c) by post transcriptional 
regulations, and (d) by functional interactions with several signaling and transcrip-
tional regulators. In any given tissue in insects and mammals, up to 15 % of the 
expressed genome exhibit a circadian expression pattern, with peak levels of expres-
sion of different transcripts timed to different times of the day or night [ 1 ]. 
 Genomics studies have shown that the steady-state levels of a large number of 
transcripts show daily oscillations. Immediately after transcription initiation and 
throughout their life cycles, RNAs are bound by a large number of proteins, some 
of which remain stably bound while others are subject to dynamic exchange. These 
complexes containing RNAs and their associated proteins constitute the ribonucleo-
protein particles (RNPs). The combination of factors binding to a particular RNA 
and their position along the transcript determines every step of RNA regulation 
throughout its lifetime. Given the large number of protein coding, small RNAs, 
miRNAs, ncRNAs that show circadian rhythm in different tissues, and the indirect 
evidence for circadian rhythm in ribosome turnover, proteins that bind to these 
RNAs to process, transport, stabilize, translate or degrade can have a profound 
impact on circadian rhythms in cellular and organismal function. 
 Upon transcription, not all mRNAs immediately enter the translationally active 
pool. Some destined for a particular subcellular location travel in multi-mRNA pack-
ets or particles and are held in a quiescent state awaiting either proper  subcellular 
localization or a signal that timing is now right to make protein [ 5 ]. Similarly it is 
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also conceivable that some RNAs accumulate in ribonucleoprotein bodies inside the 
nucleus waiting to be processed or exported until a second signal is received. This 
integrated model for the regulation of gene expression fi ts very well to the features of 
biological clocks, whose function is to synchronize and adapt internal biological 
processes to environmental stimuli. Furthermore, the time lag between nascent RNA 
and mRNA for many of the circadian transcripts is specifi c to the transcript, which 
suggests that some type of post-transcriptional regulation at splicing or polyadenyl-
ation must play a role to maintain such phase relationship. Posttranscriptional events 
can also buffer variable transcriptional output to generate robust and reproducible 
rhythms of mRNA expression and protein synthesis. Overall, there is ample evidence 
for potential roles of RBPs in circadian organization; however, there are very few 
RBPs with known function in the circadian function. We will review all the different 
levels at which gene expression shows circadian variation, from transcription initia-
tion to mRNA stability and translation effi ciency and cite specifi c examples of RBPs 
regulating circadian function. 
2  Circadian Regulation of Transcription Initiation 
 With increased  understanding of the mechanism of  transcription initiation, it is 
becoming apparent that in addition to the RNA polymerase complex, several pro-
teins involved in  chromatin modifi cation and several RNAs, including enhancer 
RNAs, non-coding RNAs, and antisense RNAs, play an integral role in initiation 
and initiation rate. Transcription is the fi rst step of gene expression, and it starts 
with the binding of the enzyme RNA polymerase II to a segment of DNA. Of par-
ticular importance for transcription initiation is the  carboxy-terminal domain (CTD) 
of RNA polymerase II. 
 The RNA polymerase II CTD typically consists of up to 52 repeats of the sequence 
Tyr-Ser-Pro-Thr-Ser-Pro-Ser and it serves as a fl exible binding scaffold for numer-
ous nuclear factors, determined by the phosphorylation patterns on the CTD repeats. 
RNA polymerase II can exist in two main forms: RNAPII0, with a highly phosphory-
lated CTD, and RNAPIIA, with a nonphosphorylated or hypophosphorylated 
CTD. The phosphorylation state changes as  RNAPII progresses through the tran-
scription cycle: the initiating RNAPII is form IIA, and the elongating enzyme is form 
II0. The phosphorylated CTD physically links pre-mRNA processing to transcription 
by tethering processing factors to elongating RNAPII, e.g., 5′-end capping, 3′-end 
cleavage, and polyadenylation. Nearly all of our knowledge of genome-wide tran-
scriptional and post-transcriptional regulation of circadian transcription comes from 
experiments done in several labs on male mouse liver. In these experiments the adult 
mice are fed a normal diet ad libitum and entrained to 12 h light: 12 h dark (LD) cycle 
for a few days. If the mice are held under LD cycle conditions during sample collec-
tion, the sampling times are represented as Zeitgeiber time (ZT), where the time of 
lights-on is considered ZT0. If the mice are transferred to constant darkness prior to 
sample collection, the timing is represented as Circadian time (CT), where CT0 
roughly corresponds to the subjective time of lights-on (or equivalent to ZT0). The 
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data collected from different times of at least a full day is analyzed by fi tting to a 
wave function, so that the probability values related to robustness of oscillation, peak 
and trough time/phase of oscillation can be derived. Detected oscillation in given 
molecules or their activities and the associated phase or time of peak or trough level 
can be used to explain potential sequence of regulatory events. Due to changes in 
experimental conditions and sampling frequency, the circadian rhythm parameters 
might be slightly different in different manuscripts. Therefore, it is relevant to com-
pare the phase information from the same experiment. 
 Among several published circadian ChIP-seq experiments, the large number of 
histone modifi cations, oscillator components binding to chromatin, RNA pol binding, 
and transcripts from mouse liver reported in Koike  et al . makes this study relevant to 
compare the timing of various steps in circadian transcription regulation. In this study 
CTD phosphorylation status shows a circadian variation, with RNAPIIA signal 
 reaching its peak level at CT14.5 and the RNAPII0 signal peaking at CT0.6. The 
hypophosphorylated RNAPIIA peak at CT14.5 coincides closely with the peak of 
intron-containing or nascent transcripts at CT15.1. On the other hand, the peak of 
hyperphosphorylated RNAPII0 signal coincides with the peak of CRY1 occupancy at 
CT0.4. At this time CLOCK and BMAL1 are beginning a new cycle of binding but 
are transcriptionally silent, likely because CRY1 is bound at the same sites. One pos-
sible scenario is that RNAPII can be recruited by CLOCK:BMAL and that RNAPII 
initiation occurs but then pauses or stalls and accumulates at CT0. Alternatively, 
RNAPII0 occupancy at CT0 could be independent of CLOCK:BMAL1 and could 
refl ect a peak of transcription at CT0 [ 6 ]. 
 In addition to circadian oscillations at promoter activity, oscillations in enhancer 
activities are also found. Fang et al. recently identifi ed circadian transcriptional 
activity at enhancer regions in mouse liver. This transcriptional activity produces 
cycling enhancer associated non-coding RNAs called enhancer RNAs ( eRNAs ; 
[ 7 ,  8 ]). The circadian eRNAs oscillate in diverse phases and each phase group is 
enriched in binding motives for different classes of clock transcription factors. The 
motif enrichment in a given eRNA  group is predictive of the specifi c transcription 
factor binding. Moreover, circadian eRNAs transcription correlates and can predict 
rhythmic transcription of nearby genes. The authors propose that circadian tran-
scription factors like CLOCK/BMAL and Rev-erba can bind multiples sites in the 
genome; however, many of these genes are bound but not controlled, due to inactive 
binding or long distance looping at different genes. Transcriptional activity at 
enhancers can be used as markers to assess where a transcription factor is actually 
functional and they suggest that only the genes that are expressed in phase with 
CLOCK/BMAL binding are true BMAL1/CLOCK targets [ 9 ]. 
 Also  chromatin modifi cations associated with transcription initiation and elonga-
tion show circadian variations. Histone H3K4me3, H3K9ac, and H3K27ac are 
enriched at promoters and show robust circadian rhythms in occupancy at transcrip-
tion starting sites (TSSs). Histone H3K4me1, a marker that is characteristic of 
enhancer sites and gene bodies, exhibits a very subtle circadian modulation. There is 
an antiphase rhythm in H3K4me1 and H3K4me3 occupancy at the Dbp intron1 site. 
Histone H3K27ac is also highly enriched at both intragenic and intergenic enhancer 
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sites. The elongation marks, H3K36me3 and H3K79me2, also express very low-
amplitude circadian modulation. On a genome-wide level, circadian rhythms in 
RNAPIIA, RNAPII0, H3K4me3, H3K9ac, and H3K27ac occupancy at TSSs can be 
seen in all classes of expressed genes and are stronger in intron RNA cycling genes. 
Unexpectedly, noncycling intron expressed genes also show circadian modulation of 
RNAPII occupancy and histone modifi cations. Genome-wide analysis of the period-
icity and phase of these histone marks reveals that large number of genes exhibit 
circadian rhythms in histone modifi cations. The overall number of histone modifi ca-
tion sites does not appear to vary on a circadian basis; rather the recruitment (and 
initiation) of RNAPII appears to underlie the variation in the amplitude on histone 
marks. Circadian modulation of RNAPII occupancy and histone modifi cations 
occurs not only at promoter proximal regions but also at distal intergenic enhancer 
sites. Thus, circadian transcriptional regulation appears to be involved in the initial 
stages of RNAPII recruitment and initiation and the histone modifi cation associated 
with these events to set the stage for gene expression on a global scale [ 6 ]. 
3  Circadian Regulation of Transcription Termination 
 Although most focus in circadian  regulation  has been on daily oscillations in tran-
scription initiation by alternating action of activators and suppressors, recent 
results have  indicated that transcription termination may also be rhythmic. In 
mammals, PER and CRY proteins accumulate, form a large nuclear complex, and 
associate with the dimeric transcription factor CLOCK-BMAL at  Per and  Cry 
promoters, repressing their own transcription. PER complexes include the RNA-
binding protein NONO and the histone methyltransferase WDR5 [ 10 ], and they 
function in part by recruiting a SIN3 histone deacetylase complex to clock gene 
promoters [ 11 ]. In addition to known PER-associated proteins, Padmanabahn 
et al. identifi ed the RNA helicases DDX5, DHX9 and SETX in mouse PER com-
plexes. DDX5 and DHX9 function in transcription and pre-mRNA processing 
[ 12 ]. Both are associated with elongating RNA polymerase II [ 13 ] and are com-
ponents of the 3′ transcriptional termination complex [ 14 ]. After cleavage of the 
nascent transcript, unwinding of the RNA-DNA duplex by SETX at the 3′ termi-
nation site permits the XRN2 nuclease to degrade the downstream 3′ RNA and 
thereby release the polymerase [ 15 ]. PER complex inhibits SETX activity, block-
ing subsequent processing by XRN2 and thus blocking transcription termination. 
Inhibition of termination reduces the rate of transcription, and as a consequence 
during the negative feedback, RNA polymerase II accumulates at the 5′ site as 
well as at the 3′ site of  Per and  Cry genes [ 16 ]. The mammalian PER complex has 
at least two actions in circadian feedback. It represses transcription by recruiting 
a SIN3 hystone deacetylase complex to clock gene promoters [ 11 ], and it inhibits 
termination by antagonizing the action of SETX at the 3′ termination site. Both 
processes contribute to circadian Per gene repression, but one or the other could 
predominate at different target genes [ 16 ]. 
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4  Evidence for the Relevance of Posttranscriptional Events 
on Circadian Gene Expression 
 Although  circadian regulation of mRNA expression at the transcriptional level is one 
of the  important  steps for circadian rhythms in cellular function, multiple lines of 
evidence point to a disconnect between transcript oscillation and protein oscillation, 
which can be explained by regulatory RNA-binding proteins acting on the transcripts. 
The transcription rate itself varies signifi cantly in cells from different tissues [ 17 ], yet 
the free-running endogenous circadian oscillator shows remarkable stability in period 
length among tissue types. Thus it is likely that the oscillator possesses a mechanism 
that allows compensating for differences in transcription rates. Indeed, partial inhibi-
tion of transcription by a-amanitin treatment in mouse fi broblasts reduces RNA PolII 
dependent transcription rate by up to threefolds, but doesn’t stop cell-autonomous 
oscillator. The circadian oscillator as measured by translated  protein continues to 
oscillate, albeit with dampened amplitude and slightly shorter periodicity [ 18 ]. 
Similarly, in  Drosophila , constitutively high mRNA expression of a circadian clock 
component does not stop the clock; rather, the translated protein level continues to 
oscillate. These results suggest a posttranscriptional mechanism potentially involving 
mRNA-binding proteins that can support translational rhythm even when transcrip-
tional oscillation is blunted or inhibited [ 18 ,  19 ]. 
 Furthermore a systematic analysis of the mammalian “ circadian proteome ” 
revealed that up to 20 % of soluble proteins in mouse liver are subject to circadian 
control; however, almost half of the cycling proteins lack a corresponding cycling 
transcript, further supporting the hypothesis that posttranscriptional mechanisms 
play a signifi cant role in mammalian circadian rhythms [ 20 ,  21 ]. Interestingly, human 
red blood cells, which have no nucleus (or DNA) and therefore cannot perform 
 transcription, display robust, temperature-entrainable and temperature- compensated 
circadian rhythms in peroxiredoxin redox cycles, consistent with the presence of a 
circadian clock within these cells despite the lack of ability to make new RNA [ 22 ]. 
 More recently, additional evidence underlined the importance of posttranscriptional 
regulation in circadian gene expression. Through high-throughput sequencing or 
Nascent-Seq and  RNA-Seq , Rodriguez at al. identifi ed 136 robust “nascent cyclers” 
and 237 robust  mRNA cyclers in fl y heads. Despite a highly signifi cant overlap, most 
genes in the two data sets are distinct. They propose a model in which transcriptionally 
active genes can be organized in four groups: genes with both robust nascent and robust 
mRNA cycling, genes with robust nascent RNA cycling but little or no mRNA cycling, 
genes with robust mRNA cycling with weak nascent RNA oscillations and genes with 
robust mRNA cycling but even weaker, and perhaps no,  nascent RNA cycling [ 23 ]. 
 Menet et al. conducted a similar study in mouse liver. Although many genes are 
rhythmically transcribed in mouse liver (~15 % of all detected genes), only 42 % of 
these show mRNA oscillation. More importantly, about 70 % of the genes that exhibit 
rhythmic mRNA expression do not show transcriptional rhythms, suggesting that 
posttranscriptional regulation plays a major role in defi ning the rhythmic mRNA 
landscape. Also the way in which CLOCK:BMAL1 regulates the transcription of its 
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target genes differs from what would be expected. Although CLOCK:BMAL target 
genes are signifi cantly enriched for rhythmic transcribed genes, there is a large 
 discrepancy between the phases of rhythmic BMAL1 DNA binding and those of 
rhythmic transcription. This is because BMAL1 binding is essentially uniform at 
ZT3-5, whereas the transcription peaks are much more broadly distributed. The dra-
matic, genome-wide disconnect between the phases of rhythmic CLOCK:BMAL1 
DNA binding and rhythmic target gene transcription suggests that other transcription 
factors and/or mechanisms collaborate with CLOCK:BMAL1 binding and are criti-
cal to determine the phase of clock gene [ 24 ]. 
 Another way of assessing the presence of posttranscriptional regulation in cir-
cadian gene expression is to sequence the transcriptome and consider the intron 
signal as a representation of pre-mRNA expression or nascent transcription and the 
exon signal as a representation of mRNA expression, which can refl ect not only 
transcriptional activity but also posttranscriptional processing events. Koike and 
collegues quantifi ed intron and exon signals for cycling transcripts in mouse liver 
and found 1371 intron and 2037 exon RNA cycling transcripts. The intron cycling 
transcripts are clustered, whereas the exon cycling transcripts have three peak 
phases. Only 458 genes are in common, and this set of common genes is enriched 
for known circadian clock genes and high-amplitude cycling target genes reported 
previously. The phases of the common intron and exon cycling transcripts are cor-
related, suggesting that transcriptional cycles primarily drive these mRNA rhythms. 
In the intron-cycling/exon non-cycling class, the cycling pre-mRNA transcripts are 
clustered at the same phase as the overall intron cycling class, but the steady-state 
mRNAs are likely to have long half-lives, which would dampen oscillation gener-
ated at the transcriptional level. By contrast, in the intron not cycling/exon cycling 
class, the phases are widely distributed as seen in the overall exon cycling class, 
and these rhythms likely arise from posttranscriptional regulatory processes such 
as circadian changes in RNA splicing, polyadenylation, or mRNA stability [ 6 ]. 
5  Circadian Regulation of Alternative Splicing 
 Alternative splicing is  a  regulated process during gene  expression that results in a single 
gene coding for multiple proteins. In this process, particular exons of a gene may be 
included within, or excluded from, the fi nal, processed messenger RNA (mRNA). 
Alternative splicing is of particular importance amongst the posttranscriptional  processes 
that regulate gene expression, as it allows the human genome to direct the synthesis of 
many more proteins than would be expected from its 20,000 protein-coding genes. 
 Alternative splicing is widespread in mammalian genes, affecting approxi-
mately 95 % and 80 % of multi-exon genes in humans and mice, respectively [ 25 , 
 26 ]. Moreover, alternative splicing is highly regulated by the activity, abundance 
and binding position of various splicing factors and heterogeneous nuclear 
 ribonucleoproteins, and by the kinetics of transcription elongation and chromatin 
modifi cations [ 27 – 29 ]. 
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 Using an Affymetrix  exon array , McGlincy and collegues demonstrated that the 
circadian clock regulates alternative splicing in the mouse. 55 exon-probesets from 
47 genes where identifi ed to have signifi cant circadian variation. The 47 genes were 
enriched in pathways representing the circadian clock itself, drug detoxifi cation, 
caffeine and retinol metabolism and the peroxisome proliferator-activated receptor 
(PPAR) signaling pathway. The circadian regulation of alternative splicing is tissue 
dependent, in terms of both phase and amplitude. For some of the exons identifi ed 
the temporal relationship between alternative splicing and transcript level  expression 
was preserved across tissues, suggesting that these two processes may be coupled in 
these particular cases. Fasting conditions modulate circadian alternative splicing in 
an exon dependent manner, but they also modulate the temporal relationship 
between circadian alternative splicing and circadian mRNA abundance in a gene-
dependent manner. Moreover, the alternative splicing of the identifi ed exons is 
under the control of the local liver clock [ 30 ]. 
 At least 15 splicing factors where shown to be robustly cycling in the mouse liver. 
They include well characterized regulators of alternative splicing ( Srsf3 ,  Srsf5 ,  Tra2b 
and  Khdrbs1 ( Sam68 )), a component of the U2 snRNP ( Sf3b1 ), two RNA helicases 
( Ddx46 (also component of U2 snRNP) and  Dhx9 ), three hnRNP proteins better known 
for their roles regulating RNA stability and translation ( Hnrnpdl ,  Cirbp (hnRNP-A18) 
and  Pcbp2 (hnRNP E2)), and six other proteins with less well characterized roles in 
RNA processing ( Gtl3 ,  Rbms1 ,  Thoc3 ,  Pcbp4 and  Topors ). Some of these circadian 
splicing factors were under the control of the local liver clock, while others are likely 
rhythmic in response to systemic rhythmic cues. Some of the known exon targets of 
these splicing factors where previously identifi ed to be cycling exons. The discovery of 
robustly circadian splicing factors, and the fact that a number of their previously charac-
terized target exons are circadian, provide candidates for further study into the molecular 
mechanisms regulating circadian exons and other posttranscriptional processes [ 30 ]. 
 Recently, Preußner et al. demonstrated that the rhythmic alternative splicing of the 
mRNA encoding U2-auxiliary-factor 26 (U2AF26) contributes to the regulation of 
Period 1 stability. More in detail they found that U2AF26 undergoes circadian alterna-
tive splicing of exons 6 and 7 in peripheral clocks (U2AFΔE67) and that the splicing 
switch generates a shift in the mRNA reading frame. Skipping of U2AF26 exons 6 and 
7 generates a domain with homology to  Drosophila TIM and enables cytoplasmic, cir-
cadian expression of the U2AF26ΔE67 isoform. Furthermore, U2AF26ΔE67 interacts 
with PER1 and induces its proteasomal degradation; this limits the light induced increase 
of PER1 and it’s proposed as buffering mechanism against sudden light changes [ 31 ]. 
6  Circadian Polyadenylation 
 The addition of a poly(A)  tail  to a primary transcript RNA is known as RNA polyade-
nylation. In nuclear  polyadenylation , a poly(A) tail is added  to  an RNA at the end of 
transcription. The  poly(A) tail consists of multiple adenosine monophosphates; in other 
words, it is a stretch of RNA that has only adenine bases. In eukaryotes, polyadenylation 
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is part of the process that produces mature messenger RNA (mRNA) for translation. 
The poly(A) tail protects the mRNA molecule from enzymatic degradation in the cyto-
plasm and aids in transcription termination, export of the mRNA from the nucleus, and 
translation [ 32 ]. Almost all eukaryotic mRNAs are polyadenylated [ 33 ]. The tail is 
shortened over time, and, when it is short enough, the mRNA is enzymatically degraded 
[ 32 ]. Regulation of poly(A) tail length is traditionally considered to be unidirectional, 
going from long to short. However more recent evidence has demonstrated that the 
ultimate poly(A) tail length is determined by a balance between concomitant deadenyl-
ation and polyadenylation, and this balance is controlled in a highly regulated and 
mRNA-specifi c manner. In some cases mRNAs with short poly(A) tails can be stored 
for later activation by re-polyadenylation in the cytosol [ 34 ]. 
 Some evidences suggest that  poly(A) tail  length regulation may take part in con-
trolling circadian-regulated rhythmic gene expression. The deadenylase  nocturnin 
(NOC) removes poly(A) tails from its target RNAs and this process is thought to 
control target RNA expression by either enhancing RNA degradation or silencing 
translation. NOC shows rhythmic expression in many tissues such as spleen, kidney 
and heart in mice with peak levels at the time of light offset. This rhythmicity has been 
shown to be particularly robust in liver. The mouse NOC gene ( mNoc ) is expressed in 
a broad range of tissues and in multiple brain regions including suprachiasmatic 
nucleus and pineal gland. The widespread expression and rhythmicity of  mNoc mRNA 
parallels the widespread expression of other circadian clock genes in mammalian tis-
sues, and suggests that NOC plays an important role in clock function or as a circadian 
clock effector [ 35 ].  mNoc is also an immediate early gene, and its expression is acutely 
induced by stimuli such as serum and 12-O-tetradecanoyl- phorbol-13-acetate (TPA) 
in cultured cells. Remarkably,  mNoc is the unique deadenylase induced by serum 
shock. Thus NOC may act in turning off the expression of genes that are required to 
be silenced as a response to extracellular signals [ 36 ]. 
 More recently, it has been shown that 2.3 % of all expressed mRNA exhibit sta-
tistically signifi cant rhythmicity in the  poly(A) tail length (i.e. the ratio between the 
“long tail” and the “short tail” fraction of an RNA). The “ poly(A) rhythmic” (PAR) 
mRNAs include mRNAs with peak tail lengths at all phases of the daily cycle but 
with signifi cantly higher numbers of mRNAs with peak long/short ratios during the 
night. Based on the pre-mRNA and steady-state mRNA profi les, the PAR mRNAs 
can be categorized into three classes: Class I PAR mRNAs (49.2 %) are rhythmic in 
their poly(A) tail length and pre-mRNA and steady-state mRNA levels, class II 
PAR mRNAs (32.3 %) are rhythmic in their poly(A) tail length and pre-mRNA 
expression but not in steady-state mRNA levels, and class III PAR mRNAs (18.5 %) 
are rhythmic in their poly(A) tail length rhythms but not in pre-RNA or steady-state 
mRNA levels. There are signifi cant differences in mRNA half-lives among the dif-
ferent PAR classes; class III mRNAs are the most stable, followed by class II 
mRNAs, with class I mRNAs being the least stable [ 37 ]. 
 The rhythmic poly(A) lengths of both class I and II mRNAs refl ect nuclear polyad-
enylation (likely by the canonical poly(A) polymerase α), coordinated with rhythmic 
transcription during classical 3′ end processing. The defi ning characteristics of these 
two classes are the differences in the steady-state mRNA rhythmicity and mRNA 
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stability, suggesting that the lack of rhythmicity in the class II PARs refl ects the longer 
half-lives of these mRNAs. The mechanism of poly(A) rhythmicity in both class I and 
II mRNAs results from the addition of long tails following rhythmic synthesis and 
subsequent deadenylation that does not cause immediate decay. This delay in decay is 
more pronounced in the class II mRNAs and results in the arrhythmic steady-state 
levels. It appears that class I/II PAR mRNAs can exist in short- tailed states and that 
rhythmic control of poly(A) tail length is somehow correlated with delayed accumula-
tion of steady-state mRNA and may be part of a regulatory mechanism to regulate the 
timing of mRNA/protein rhythmicity [ 37 ]. 
 Class III mRNAs exhibit robust rhythmicity in  their  poly(A) tail length, yet 
are not rhythmically transcribed and have longer half-lives. Thus, class III PARs 
must employ transcription-independent mechanisms to control their rhythmic 
poly(A) tail lengths. Peak distribution analysis of class III PAR mRNAs revealed 
that >80 % had their longest poly(A) tails during the day, which is distinct from 
the nighttime poly(A) rhythmic profi le of class I and many of the class II 
mRNAs. The poly(A) rhythms of class III mRNAs are likely to be controlled by 
rhythmic cytoplasmic polyadenylation. Indeed, the steady-state mRNA level of 
several putative cytoplasmic polyadenylation machinery components in the 
liver, including  Cpeb2 ,  Cpeb4 ,  Parn , and  Gld2 , are rhythmically expressed with 
phases similar to the majority of the class III PAR mRNAs, peaking in the early 
day [ 37 ]. 
 In mouse liver rhythmic  poly(A) tail lengths  correlate strongly with the ulti-
mate circadian protein expression profi les, with the protein peaking ~4–8 h after 
the time of the longest poly(A) tail. Therefore poly(A) tail rhythms can generate 
rhythmic protein levels even when there is no rhythm in the steady-state mRNA 
levels [ 37 ]. 
7  Regulation at Translation Initiation and Ribosome 
Biogenesis 
 Many oscillating proteins in the mouse liver  are  encoded by  constantly expressed 
mRNAs and among  the rhythmically expressed genes in the liver, there are  several 
genes encoding proteins involved in mRNA translation, including components of 
the translation pre-initiation complex [ 38 ]. The circadian clock controls the tran-
scription of translation initiation factors as well as the rhythmic activation of signal-
ing pathways involved in their regulation. Initiation in eukaryotes requires at least 
ten proteins, which are designated  eIFs (eukaryotic initiation factors). The mRNAs 
of most of the factors involved in translation initiation are rhythmically expressed 
with a period of 24 h. There isn’t a signifi cant variation in protein abundance, but 
these factors undergo strong rhythmic phosphorylation [ 38 ]. The initiation factors 
eIF4E and eIF4G, in association with eIF-4A and eIF-4B, are involved in binding 
the mRNA and bringing it to the 40S ribosomal subunit. eIF4E, which recognizes 
the 5′ cap of the mRNA, is mostly phosphorylated during the day, with a peak at the 
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end of the light period (ZT6-12). eIF4G, eIF4B and 4E-BP, and ribosomal protein 
(RP) S6 (RPS6) are mainly phosphorylated during the night, which is, in the case of 
nocturnal animals like rodents, the period when the animals are active and consume 
food. Phosphorylation of these factors is well  characterized and involves different 
signaling pathways whose reported activity perfectly correlates with the observed 
phosphorylation rhythm [ 38 ]. eIF4E is phosphorylated by the extracellular signal-
regulated protein kinase (ERK)/mitogen activated protein kinase (MAPK)-
interacting kinase (MNK)  pathway, which is most active during the day, at the time 
when eIF4E reaches its maximum phosphorylation. On the other hand, eIF4G, 
eIF4B, 4E-BP1, and RPS6 are mainly phosphorylated by the target of rapamycin 
(TOR) complex 1 (TORC1), which is activated during the night at the time when the 
phosphorylation of these proteins reaches its maximum level. It has been shown that 
mTOR, its partner Raptor, as well as its regulating kinase Map3k4, are also rhythmi-
cally expressed, thus potentially further contributing to the rhythmic activation of 
TORC1. The rhythmic phosphorylation of 4E-BP1 results in the release eIF4F, 
allowing its binding to the mRNA and the initiation of translation [ 38 ]. 
 The polysomal RNA fraction (RNA sub-fraction composed mainly of actively 
translated RNAs) in mouse liver also follows a diurnal cycle, showing that a 
rhythmic translation does occur in this tissue. Approximately 2 % of the expressed 
genes are translated with a rhythm that is not explained by rhythmic mRNA 
abundance as in most cases the total mRNA levels are constant. Among transla-
tionally regulated genes, 70 % were found in the polysomal fraction during the 
same time interval, starting at ZT8 before the onset of the mouse feeding period 
and fi nishing at the end of the dark period [ 38 ]. 
 The circadian clock was shown to regulate also ribosome biogenesis by infl u-
encing the transcription of ribosomal protein (RP) mRNAs and ribosomal RNAs 
(rRNAs). RPs show a rhythmic abundance with highest expression during the 
night. Pre-mRNA accumulation of several RPs exhibits a rhythmic pattern too, 
with a peak at ZT8, just before the activation of their translation. As for rRNA 
transcription, the synthesis of the ribosome constituent precursor 45S rRNA (con-
taining 28S, 5.8S and 18S rRNAs) is rhythmic and synchronized with RP mRNAs 
transcription, indicating that all elements involved in ribosome biogenesis are 
transcribed in concert and coordinated with the feeding period. In mammals rRNA 
transcription is highly regulated by the upstream binding factor (UBF). Not sur-
prisingly UBF1 is rhythmically expressed in mouse liver too, at both mRNA and 
protein levels, in phase with RP mRNAs and rRNA transcription. Mice devoid of 
a functional circadian clock lose the rhythmic activation of TORC1 and ERK 
signaling pathways, and the rhythmic expression of UBF1. In addition these ani-
mals show lack of synchrony and coordination of 45S rRNA and RP pre-mRNA 
transcription, highlighting the crucial role of the circadian clock in this mecha-
nism. Ribosomal protein synthesis in eukaryotes is a major metabolic activity that 
involves hundreds of individual reactions; this energy-consuming process has to 
be confi ned to a time when energy and nutrients are available in suffi cient amounts, 
which, in the case of rodents, is during the night [ 38 ]. 
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8  RNA-binding Proteins Regulating mRNA Stability 
and Translational Effi ciency Are Important for Oscillation 
of Core Clock Components 
 The number of RNA-binding  proteins  and  those with RNA-binding motifs encoded 
by the human genome is remarkable. As an example a single type of RNA-binding 
domain, the RNA recognition motif (RRM), is represented in nearly 500 different 
human genes.  RNA-binding proteins (RBPs) couple transcription and subsequent post-
transcriptional steps by interacting with their target transcripts. Even though some RBPs 
bind to  common elements present in almost every mRNA in a sequence- independent 
and nonspecifi c manner, the majority of RNA-binding factors target particular structures 
or sequences present in some RNAs but not others [ 39 ]. The posttranscriptional events 
involving multiple mRNAs must be highly coordinated and RBPs, including export pro-
teins, provide coordinating functions at all steps along the posttranscriptional regulatory 
chains. RBPs allow the mRNA molecules to interface with other intracellular  machineries 
mediating their splicing, transport, stabilization or degradation, localization, or transla-
tion into protein, as well as the response to stimuli. Indeed individual mRNAs contain 
binding sites for different RBPs and can respond to a wide range on inputs, so that their 
expression can be adjusted to changing environmental conditions. RBPs are thus the 
leading actors of an intricate regulatory network, which is equally complex as that con-
trolling initial RNA synthesis. Because RBPs can bind to more than one RNA with 
sequence specifi city, the existence of a “posttranscriptional operon” has been postulated 
whose function is to expand the regulatory plasticity of our relatively “small” genome. 
In fact the expression of proteins with common functional themes or subcellular distri-
butions is coordinated by large-scale regulatory networks operating at the mRNP level. 
The fi nal outcome of protein synthesis is thus an mRNP-driven process that responds 
dynamically to the environment and cellular growth conditions [ 5 ,  39 ]. 
 In particular the posttranscriptional regulation of mRNA stability and transla-
tional effi ciency are often mediated by cis elements in mRNAs that interact with 
RNA-binding proteins and/or microRNAs. In most cases, these cis elements reside in 
the  3′ untranslated region (UTR) , and several 3′ UTR motifs have been identifi ed that 
are critical for mRNA splicing, transport, stability, localization, and translation. 
 The 3′UTR-dependent mRNA decay is involved in the regulation of circadian 
oscillation of Period 2 (per2) mRNA. In particular the polypyrimidine tract-
binding protein (PTB), also known as heterogeneous nuclear ribonucleoprotein 
I (hnRNP), binds to  per2 3′UTR and has an mRNA destabilizing activity. Indeed 
the cytoplasmic PTB expression pattern is reciprocal with per2 mRNA oscilla-
tion and depletion of PTB with RNAi results in  per2 mRNA stabilization [ 40 ]. 
A similar study reported that the 3′UTR is also important for the mRNA stability 
of another core clock component, mouse cryptochrome 1 ( cry1 ). The 3′UTR of 
 cry1 contains a destabilizing cis-acting element that contributes to the stability of 
 cry1 mRNA. The binding of hnRNP D to  cry1 3′UTR is responsible for the rapid 
decay of  cry1 mRNA during its declining phase and modulates  cry1 circadian 
rhythm [ 41 ]. 
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 Also, the stability of mouse Period3 (per3) is dramatically changed in a circadian 
phase-dependent manner. In the case of (per3), the control of its circadian mRNA 
stability requires the cooperative function of both the 5′ and 3′ UTRs. Several stud-
ies reported that mRNA stability can be regulated by the 5′UTR, a mechanism 
called translational regulation-coupled mRNA decay. In such cases translational 
inhibition causes mRNA stabilization. Similarly hnRNP Q binds to both 5′ and 
3′UTR in the  per3 mRNA and not only reduces the translation effi ciency but also 
increases the mRNA stability.  per3 mRNA decay is connected to its translation 
kinetics and the central region of  per3 5′UTR is responsible for coupling of transla-
tion and mRNA decay. The binding of hnRNP Q of  per3 5′UTR is phase dependent 
and maintains robust mRNA oscillation [ 42 ]. 
 Mouse LARK, another RBP, has been shown to activate the posttranscriptional 
expression of the mouse period1 ( per1 ) mRNA. A strong circadian cycling of the 
LARK protein is observed in the suprachiasmatic nuclei with a phase similar to that 
of PER1, although the level of the lark transcripts are not rhythmic. LARK protein 
binds directly to a cis-element in the 3′ UTR of the  per1 mRNA and causes increased 
PER1 protein levels, by activating per1 mRNA translation. Alterations of lark 
expression in cycling cells causes signifi cant changes in circadian period, with lark 
knockdown by siRNA resulting in a shorter circadian period, and lark overexpression 
resulting in a lengthened period [ 43 ]. 
 Many studies have shown that mammalian cells utilize  internal ribosome entry site 
(IRES)-mediated translation for rapid adaptation to certain environments, such as che-
motoxic stress [ 44 ], mitosis [ 45 ] and apoptosis [ 46 ], and generally under conditions 
when cap-dependent translation is compromised. For IRES-mediated translation, pro-
teins known as IRES  trans -acting factors (ITAFs) must recognize IRES elements in a 
structure or sequence-dependent manner. Recent evidences suggest that IRES-mediated 
translation might be one of the mechanisms regulating the protein oscillation of key 
clock components like Rev-erb α. Also known as Nr1d1, Rev-erb α was identifi ed as a 
regulator of lipid metabolism [ 47 ]. It also plays an important role in the maintenance of 
circadian timing in brain and liver tissue [ 48 ,  49 ] and it is a well-known transcriptional 
repressor in the positive limb of circadian transcription [ 3 ,  50 ]. Kim and colleagues 
have demonstrated that hnRNP Q and PTB modulate mRev-erb α IRES-mediated 
translation. Knockdown of hnRNP Q and PTB leads to the alteration of the mRNA 
levels of several clock genes, thus posttranscriptional regulation by hnRNP Q and PTB 
is necessary to maintain the circadian feedback loop [ 7 ,  8 ]. 
9  Conclusion 
 There is increasing evidence that the RBPs play an important role in homeostatic con-
trol of the periodicity of circadian oscillator and its output regulation. RBP mediated 
regulation of various steps in the transcription, RNA processing and RNA half-life 
helps maintain the precision of the clock under diverse cellular and environmental con-
ditions. Circadian regulation of cellular physiology and metabolism is mediated by 
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daily oscillations in the steadystate levels of nascent RNA, mRNA, and protein levels. 
However, large fraction of oscillating proteins or mRNA does not exhibit a correlated 
rhythm in nascent RNAs, which suggests that post- transcriptional regulation involving 
RBPs is most likely involved. Since many RBPs bind and regulate the location, trans-
port, translation of a large number of target RNAs, a rhythmic level of a given RBP 
likely helps temporally coordinate the function of the target RNAs. Another challenge 
in circadian regulation is the newly recognized role of eating pattern and nutrition 
 quality in the daily oscillations of RNA and proteins. In rodent liver, the circadian 
 transcriptome in peripheral organs appears to be heavily determined by the nutrition 
quality and time of eating. This implies that the nutrition information encoded in sev-
eral metabolites might affect the circadian transcriptome by both transcriptional and 
post-transcriptional mechanisms and RBPs will likely play an important role in inte-
grating nutrition status with the endogenous circadian oscillator function. 
 Much of the evidence for the roles of RBPs in circadian regulation is indirect. 
Although genome-wide transcriptome studies have shown circadian rhythms in the 
mRNA levels of several RBPs, whether the RBP proteins and their cellular localiza-
tion are also circadian is yet to be determined. Similarly, as the target RNAs for 
many of the RBPs are discovered, informatics approaches to integrate these fi nd-
ings with circadian transcriptome datasets will begin to explain post-transcriptional 
mechanisms of circadian regulation. Overall, the area of investigation on how RBPs 
are involved in the circadian regulation is a nascent fi eld with plenty of opportunities 
for discoveries and mechanistic insight. 
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